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Abstract 
Background: Bacterial meningitis and meningococcal septicaemia are important 
causes of morbidity and mortality in the UK and elsewhere. There have been 
achievements in paediatric care, including vaccination; however mortality amongst 
otherwise healthy young adults remains high. 
Objective: I undertook this study to examine the way by which the public health 
burden of meningitis in adults can be reduced. 
Methods: I used routine surveillance data (laboratory reports, clinical notifications, 
hospital activity, mortality data) to examine the epidemiology and determine the 
changing trends. I undertook a capture-recapture study to quantify the underreporting 
through the routine surveillance. I conducted a retrospective review of clinical 
management of adult patients with meningitis in England and Wales using medical 
records of patients diagnosed with meningitis or meningococcal septicaemia. I 
examined the association of clinical management with the outcome of the disease 
(CABM and MS). 
Findings: The epidemiology of adult meningitis in England and Wales is changing. 
Overall forms of CABM show no significant changing trend, whilst meningococcal 
septicaemia shows an increasing trend. Tubercular meningitis is increasing 
significantly, whilst pneumococcal, HiB and Listeria meningitis are falling. Mortality 
generally remains in a steady trend. There are differences by age-group and 
causative organisms. There is considerable (-50%) underreporting of both, incidence 
and mortality from all major routine surveillance systems. Hospital management of 
meningitis is largely sub-optimal. Main areas of deficiency in clinical care are: timely 
diagnosis and consequently administration of antibiotics, assessment of severity, and 
record keeping; and these appeared to vary between the hospitals. It is difficult to 
examine the association between clinical with the outcome of meningitis primarily 
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due to confounding by severity of illness which in my study was further jeopardised 
by the lack of recorded data and study power. 
Conclusion: This study has identified areas within public health interventions, such 
as vaccination policies, and clinical care, such as improved diagnosis and severity 
assessment, where there is potential for improvement towards a reduced public 
health burden of adult meningitis in England and Wales. 
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Preface 
In 1967 the United States' Surgeon General, Dr William Stewart declared that "with 
the advent of antibiotics and the broad use of vaccines, the war against infectious 
diseases had been essentially won". 
Forty years on, however, the Director of the European Centre for Disease Prevention 
and Control, using less aggressive vocabulary, emphasised that it is "a never-ending 
dance in which the human race needs to constantly find new technologies and tools 
to keep in step with changing and new microbesf'1 
As the research for this thesis has shown - if we fall out of the meningitis dance-step, 
the consequences are serious and in almost half of cases even tragic. 
1 Jakab, Z. (2007). "Why a burden of disease study?" Euro Surveill12(12): E1-2. 
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A case from the hospital review: A young man, in his mid 30s, is admitted 
to hospital late at night presenting with "headache, confusion, and generally unwell". 
He is treated for symptoms of alcohol absenteeism. He doesn't improve, his 
conscious level deteriorates and in less then 48 hours later he is deceased. The 
results of the blood culture, a day after his death, show growth of Neisseria 
Meningitidis. 
This tragic case presents the three main messages of my research from this thesis: 
1) Meningitis and septicaemia amongst adults occurs and is grave; 
2) It is often undetectable; 
3) The prevention and clinical management can and should do more to reduce the 
burden and improve the outcomes of this, yet another infectious death-causing 
disease. 
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Chapter One 
Introduction to the thesis 
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1.1 Introduction 
This thesis presents an examination of the epidemiology and the clinical 
management of bacterial meningitis and meningococcal septicaemia. It focuses on 
the community acquired forms of meningitis, amongst adults aged 16 and above in 
England and Wales between 1990 and 2002. 
The term Community Acquired Bacterial Meningitis (CABM) and Meningococcal 
Septicaemia (MS) will be used to define and include the relevant forms of meningitis 
included in this research. 
1.2 The public health relevance 
Bacterial meningitis and meningococcal septicaemia are important causes of 
preventable morbidity and mortality in the UK (Abbott, Jones et al. 1985; Stanek and 
Mufson 1999; Short and Tunkel 2000; Williams and Nadel 2001; Cartwright 2002). 
All forms of bacterial meningitis examined in this thesis are notifiable diseases under 
the Public Health (Infectious Disease) Regulations 1988. Since 1998, an enhanced 
surveillance system records individual patient factors and links them to 
microbiological information from the national reference laboratories. 
Understanding the epidemiology of bacterial meningitis and meningococcal 
septicaemia is essential to appropriate vaccine implementation and clinical 
management. 
Amongst children, these conditions are important infectious causes of death and 
disability worldwide. Over the last decade, new protein-conjugate vaccines against 
Haemophilus influenzas type b (Hib) and Neisseria meningitidis serogroup C (Men C) 
have had a dramatic effect on the epidemiology of childhood meningitis in several 
industrialised countries, including the United Kingdom (Ramsay, McVernon et al. 
2003)'(Ramsay, Andrews et al. 2003). More recently, improvements in clinical 
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approach to meningococcal sepsis in particular, have been associated with a 
reduced mortality (Booy, Habibi et al. 2001). 
Amongst adults, changes in the epidemiology of acute bacterial meningitis and 
meningococcal septicaemia, over this time period, are less well documented. In 
particular, it is uncertain whether an increasingly ageing population, a paediatric 
population with reduced carriage of common causative pathogens after vaccination 
and the resurgence of infections such as tuberculosis, have modified the spectrum of 
disease (MacLehose, McKee et al. 2002). Also, as the incidence of bacterial 
meningitis in children declines the relative public health importance of bacterial 
meningitis in adults increases. 
The clinical management of meningitis and meningococcal septicaemia is 
challenging and is associated with high morbidity and mortality. There have been 
significant improvements in clinical management of paediatric meningitis, however in 
adults case-fatality remains high. The spectrum of the disease in adults differs from 
children and there are few comprehensive stUdies to determine the epidemiology of 
bacterial meningitis in this age-group. The demographics of the population of 
England and Wales is changing with an increasing proportion of older people. The 
number of immunocompromised people is also rising mostly due more chronic 
disease in the elderly and HIV infections. Therefore, information on the epidemiology 
of adult meningitis in this context will have important implications for public health as 
well as clinical management. 
As will be presented in greater detail in the next chapter (2) BaCkground, 
Understanding the epidemiology and early recognition, stabilisation, assessment of 
severity and institution of specific therapy are crucial to patient outcome (NOTE: 
references to this chapter are merged into the refernces in Chapter 2, pg 81 - 101. 
Most adults with bacterial meningitis or meningococcal septicaemia present to 
clinicians with little experience of these conditions. To address this issue, in 1999 the 
14 
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British Infection Society (BIS) published consensus guidelines for the management 
of acute bacterial meningitis in immunocompetent adults. However, these were not 
widely disseminated and there remains a perception amongst infection specialists 
that management of these conditions continues to be imperfect (Ninis, Phillips et al. 
2005). 
Therefore I set out this research, which is a national review of the epidemiology and 
the clinical management of community acquired bacterial meningitis and 
meningococcal septicaemia amongst adults in England and Wales. 
1.3 Aim and objectives 
To identify the potential areas for intervention to improve the prevention and clinical 
management and provide appropriate recommendations to decrease the morbidity 
and mortality from CABM in adults in England and Wales. 
The objectives of this research were: 
Objective 1. To examine the current epidemiology of CABM and MS among adults in 
England and Wales. 
Objective 2. To improve current estimates of the incidence and mortality associated 
with acute bacterial meningitis and meningococcal septicaemia in adults. 
Objective 3. To review the clinical management, including diagnosis and treatment, 
of adults presenting to randomly selected acute healthcare trusts, focusing on BIS 
standards. 
Objective 4. To identify key areas of deficiency in current management of bacterial 
meningitis and meningococcal septicaemia in adults and make recommendations to 
improve management. 
Objective 5. To examine any association between clinical management and the 
outcome of CABM and MS. 
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Objective 6. To generate appropriate recommendations for the public health and 
clinical management of bacterial meningitis and meningococcal septicaemia in 
England and Wales. 
1.4 Layout and structure of the thesis 
The thesis comprises: analysis of the changing epidemiology, application of statistical 
methods for improving the estimates from routinely available data, a review of the 
clinical management of these conditions, and an examination of the potential 
associations between clinical management and outcome of CABM and MS. 
Identifying and recommending changes that have the potential of preventing these 
conditions and improving the outcome when they occurred, is a central aim of this 
research. 
The thesis is structured as follows: 
Following this Introduction, Part 1, Chapter 2 - Background to bacterial meningitis, 
covers a synthesis of the existing published literature on CABM and MS from regions 
with a similar context to that of the UK, including demographic, cultural and health 
system. Included with this is a brief overview of the history and recognition of 
meningitis in the health arena; its epidemiology world-wide; a brief account of its 
pathology and microbiology; and a background to, both, clinical and public health 
management of these conditions. I then argue the rationale for this study and 
introduce the aims and objectives of this research. 
Chapter 3 presents the data and methods used in this research. Including a detailed 
account of: the background of the available data sources used, the specifics of this 
data, the collection of new data, the epidemiological approaches used, and the 
statistical methods and analysis undertaken. 
Part 2 presents, separately, the results and findings of the research I undertook to 
address the first four objectives. The last objective that relates to generating 
16 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
recommendations for improved prevention and management of CABM and MS is 
presented in Chapter 9, following discussion of my findings in a broader context in 
Chapter 8. 
Understanding the epidemiology of any condition, in this case of CABM and MS, is 
the first step in any examination of policies for management or prevention of the 
condition. I have undertaken a detailed analysis of the epidemiology of CABM and 
MS using the available routine surveillance data for the causative forms of CABM 
and MS. I have examined the potential changes in the epidemiology of CABM and 
MS in terms of time-trends but also demographical and geographical differences. I 
have also presented and discussed these findings in context of prevention policies in 
England and Wales in Chapter 4. 
To examine and quantify the potential uncertainty and inaccuracy of the reports 
within the routine surveillance data I have used the available data on incidence and 
mortality associated with pneumococcal meningitis, applying a capture-recapture 
method. Chapter 5 presents this work, which is not only an examination of the 
methodology of capture-recapture in this context, but also a consideration of the 
implications of these findings for the practice and policy in England and further a 
field. 
Clinical management of CABM and MS is clearly the most important issue when the 
disease has occurred, Le. when an individual is affected. Chapter 6 present a 
retrospective review of clinical management in randomly selected hospitals across 
England and Wales. The characteristics of the hospitals, the patients, and the 
diagnosis and treatment of them is presented. The diagnosis and treatment, referred 
to further on in this thesis as clinical management, will be assessed against the then 
current guidelines published by the British Infection Society (BIS). 
In Chapter 7, I examine the potential associations of clinical management indicators 
with the outcome of CABM and MS. I also focus on assessing and comparing 
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different statistical methodologies used in examinations of risk factors in clinical 
practice, with particular focus in dealing with missing data and controlling for 
confounding in observational clinical management studies. 
All the results chapters (Chapter 4 to 7) include a short background to the issue, brief 
mention of the methods and the data used, results and a concise discussion of the 
strengths and limitations of that particular study. 
Chapter 8 discusses the findings of my research, in relation to the strengths and 
weaknesses of the study, linking my work to previous published relevant research, 
and in context of health policy in England and Wales. Based on the above I then 
present the recommendations, in Chapter 9, to be implemented to improve the 
prevention and management of bacterial meningitis in England and Wales. Finally, I 
discuss what I consider should be done to take the findings and recommendations 
from this research further. 
1.5 Short title 
The research for this thesis has been known with the short title of "Bacterial 
meningitis amongst adults". This title is used as heading throughout the thesis 
document; it has been used in much of the correspondence for the research, and 
sometimes at the different forums. 
1.6 Contributions 
The initial project proposal was written by my external advisors: Prof R Heyderman, 
the Principal Investigator (PI) of the study; Prof J Stuart, co-investigator, and Prof K 
Cartwright, CO-investigator. The proposal was for reviewing the clinical management 
of bacterial meningitis amongst adults in England and Wales, submitted to the 
Department of Health (DH). A copy of this proposal is included in Appendix 1.1. 
18 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
I was the research fellow for this study, and had the responsibility for developing and 
undertaking the study, including: recommending to the PI appropriate members for 
the Expert Panel; developing the standards and indicators, studying case-report 
forms; establishing contact and enrolling hospitals; collecting, maintaining and 
managing the data; generating appropriate questions for the study, analysing the 
data, writing up reports and papers for publication; identifying and developing 
appropriate forums for presentation, publication and dissemination. 
Having taken the research fellow post and inherited the initial project proposal to the 
DH, I developed the full study protocol for the review of the clinical management; 
including the study design and protocol for the statistical analysis. I worked with the 
support of the study statistician, Mr. Tom Nichols, who was member of the Expert 
Panel for the national review of clinical management. His specific support was to help 
calculate the study sample, organise the data for analysis, merge the data on clinical 
management with hospital size and coverage population; weighting the data based 
on the annual reported number of cases of CABM and MS per regions, support 
around calculations and definitions of variables measuring time to a clinical 
management indicator and measuring the severity of illness. 
I held the ultimate responsibility for the data management and analysis and was 
solely responsible for the choice of which analyses to undertake, running the 
analyses in appropriate statistical software, choosing definitions and tests to be used 
to interpret, the results. 
I generated the research questions, identified the data sources, developed the study 
protocols and analysis as well as conducted the analysis for the other three parts of 
the original research within this thesis, including: the epidemiological review, the 
capture-recapture analysis and the examination of the association of the clinical 
management indicators with the outcome of CABM and MS. 
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My main external advisor, Prof R Heyderman, closely and regularly supervised and 
advised on my work throughout the research. He was the PI for the review of the 
clinical management study, and as such advised and assisted when needed in the 
process of recruiting the Hospital Trusts. Prof R Heyderman was also mainly 
responsible for steering the overall direction of the study. 
Prof R Heyderman and Prof Stuart contributed to the formulation of the research 
question for the review of the epidemiology and the risk factors studies. They both 
supervised and advised on the strategies and results of the analysis of all the 
studies; and contributed to the writing of the peer-review publications resulting from 
these studies. 
Prof 0 Lawlor supervised and advised on my work throughout the research as 
needed, focusing on advice around the epidemiological rigor of the studies 
undertaken and interpretation of the results. Prof 0 Lawlor also contributed to the 
writing of the peer-review publication on the review of the epidemiology. 
The Internal supervisors, Prof P Farrington and Dr K McConway, advised me 
regularly on the overall direction of the PhD research. Specifically adviSing on the 
statistical strategies and methods undertaken or considered for the studies I 
undertook throughout this research. 
The part of the research which was funded by the OH to review the clinical 
management of CABM and MS was steered by a panel of experts in the different 
fields relevant to the study. The Expert Panel (EP) included: a General Physician 
(GP), an infectious disease consultant, an epidemiologist, a public health consultant, 
a paediatrician and a statistician. The role of the EP was to regularly oversee the 
design, data collection, analysis and recommendations to the DH. The EP also 
contributed to the writing of the report and peer-review publication for this study. The 
list of the EP members and their affiliations at the time of the study is included in 
Appendix 1.2. 
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1.7 Publications resulting from this research 
Peer-reviewed: 
The following peer-reviewed publications, in order of relevant parts appearing in the 
thesis, have resulted from my research: 
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2.1 Introduction to this chapter 
This aim of this chapter is to set the scene for the research that I carried out and to 
acquaint the reader with the importance of adult CABM and MS for the population of 
England and Wales. The information presented here is primarily based on a review of 
the published literature; however my critical understanding of this literature has a role 
in the way it is interpreted here. 
I start by briefly describing the literature search approach and give a brief account of 
the relevant historical developments in the occurrence and management of 
meningitis. Followed by a description of the global epidemiology and where it is 
relevant to England and Wales. 
The microbiology and pathology of the disease is essential to the epidemiology and 
management and I will therefore give a brief review of both. A background of the 
clinical presentation and management; and the existing public health recommended 
practice then follows. This is accompanied with a background to the reporting and 
surveillance of this disease and the current prevention strategies for CABM and MS, 
including chemo and immuno-prophylaxis. 
2.2 Literature search 
The available literature was reviewed to appraise and synthesise evidence on 
disease epidemiology, management guidelines, and current practises in diagnosis 
and management of bacterial meningitis and meningococcal septicaemia. Major 
electronic databases of peer reviewed scientific literature were searched for relevant 
publications, as well as other sources of publications, i.e. DH, UK and CDC, US. The 
review will especially focus on existing literature concerned with adult population. 
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2.2.1 The search strategy 
To inform this chapter I searched published literature on the relevant topics as 
follows. 
i) Definition of the topic 
The research, and therefore the literature used include the areas of: epidemiology of 
meningitis; disease presentation and management, health policy and relevant 
epidemiological and statistical methods. 
Within the disease presentation and management the main issues considered are 
concepts of different forms of bacterial meningitis and meningococcal septicaemia, 
diagnostic procedures related to acute severe infections in general and meningitis in 
particular, treatment and management, as well prophylaxis and prevention strategies. 
ii) Scope and boundary 
The focus of the research is meningitis and meningococcal septicaemia among 
adults in England and Wales. However, there are a few aspects of this that can be 
generalised further, such as: 1) the early clinical presentation of a meningitis case is 
often the same as of other serious infections and hence its clinical management is 
similar. 2) the literature reviewed reflects the studies and evidence across the globe, 
therefore this research can be generalised and applied to any countries with similar 
epidemiology of the disease, demographics of the population, context, and provision 
of health care and prevention. 
III) Data sources 
I have used various electronic databases; libraries located within University of Bristol 
and Open University; proceedings of conferences; recommendations from experts in 
the field, the Internet and others, to find the relevant information. 
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2.3 A brief history of meningitis 
It is important to note that in literature the term 'meningitis' often, if not specified 
otherwise, refers to meningococcal meningitis, with or without septicaemia. This is 
primarily because the other common causes of bacterial meningitis, such as Hib and 
S. pneumoniae present in greater proportion as other forms of infection including ear, 
throat infections, pneumonia and sepsis. Whilst, meningococcal infection almost 
exclusively presents as meningitis and meningococcal septicaemia it is usually 
described as meningococcal disease (MD). 
2.3.1 Recognition of meningitis 
Meningitis as a clinical presentation is probably as ancient as the human race. The 
first known description of meningitis is, however, thought to date back to the Greek 
philosopher, Hippocrates, around the 15th Century BC. There are records accounted 
to Hippocrates that refer to meningitis: "if during a fever the neck is twisted ... it is a 
fatal sign". However, it is probably Avicenna in "The Canon of Medicine" at the 
beginning of the 10th Century who gives the first most accurate and detailed 
description of meningitis; indeed some argue that Avicenna's description is almost as 
accurate and relevant today as it was 1,000 years ago (Skinner 2001). 
The actual term 'meningitis' is thought to have had been first used by the British 
doctor Thomas Willis (1621-75) in 1661 (Williams and Sunderland 2001), whereas, 
in the United States, the disease was first described in Medfield, Massachusetts, by 
Danielson and Mann in 1806. Subsequently, the disease referred to as 'malignant 
spotted fever' continued to be reported in the medical journals of the time (Grady 
1965). The first epidemiological study on the disease was reported in a dissertation 
work for a medical degree by Nathan Strong in 1810 (Scriabine 2003) who strongly 
suggested that there may possibly be more then one form of 'spotted fever', he goes 
on to acknowledges himself as being "profoundly ignorant". It is also interesting to 
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note that Strong attempts to describe that clinical presentation as dual, i.e. in the 
form of meningitis - with "stiffened and spasm of extensors muscles of the head and 
the neck" and in the form of septicaemia - with "spots and heat of the skin up to and 
rarely above the natural temperature" (Strong 1810). 
Meningitis' potential for outbreaks is now well acknowledged, but the first description 
of an MD outbreak is thought to be from Geneva, Switzerland, probably in the early 
19th Century, c.1805 (Vieusseux 1806). Around that time Strong, also, noted the 
disease's potential for sporadic or outbreak occurrence (Strong 1810). The literature 
shows that the outbreak pattern of MD continued throughout the 19th and 20thC in 
Europe, with a fatality of 75 to 80% of affected people (Segall and Pollard 2006). 
The cause of the disease, though, remained unknown and even the contagious 
nature of the disease was not acknowledged until the late 19th Century; 
understandingly so, as it is generally transmitted by healthy carriers, and is not as 
contagious as other infections recognised at the time, e.g. typhoid fever (Grady 
1965). In 1887 Anton Weichselbaum reported to have discovered the causative 
organism of cerebrospinal meningitis, which he named Diplococcus intracellularis 
meningitides (Weichselbaum 1887; Yazdankhah and Caugant 2004). 
The two other major causes of bacterial meningitis, Haemophilus influenzae type b 
(Hib) and Streptococcus pneumoniae are not quite so distinctly described as causes 
of meningitis. This is probably because they are major causes of other clinical 
manifestations, including upper and lower respiratory tract infections, and therefore 
described in conjunction with these clinical manifestations of infection with these 
bacteria. 
Streptococcus pneumoniae is reported to have been first isolated in 1881 , 
simultaneously and independently by two scientists in the U.S. Army physician 
George Sternberg and the French chemist Louis Pasteur. The organism was 
renamed Streptococcus pneumoniae in 1974. 
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Hib was isolated during the 1889 influenza pandemic by Dr Richard Pfeiffer and was 
then thought to be the cause of Influenza. Only in the early 1930s it was recognised 
that this bacteria was a secondary infection, not the cause of influenza. 
2.3.2 Treatment 
In the 19th and early 20th centuries, i.e. in the pre-antibiotic era, the treatment of 
infections was mainly treating the symptoms, and at best using an appropriate animal 
or human serum. Stimulants (wine, brandy, etc) and opium were the treatments of 
choice, though the use of evacuants - blood release and emetics, was debated by 
some. 
Regarding the use of serum, for treatment of and protection from pneumococcal 
infection, serum from rabbits immunized against pneumococcus or from humans was 
recognised in the early twentieth century (Brown 1910). In 1913, Simon Flexner 
(1863-1946) was the first to report success in treating bacterial meningitis with 
intrathecal equine meningococcal antiserum. He reported that amongt 1300 patients 
with epidemic meningitis treated the mortality was reduced to 31 percent (Flexner 
1913; Flexner 1913). 
Discovery and consequently the use of penicillin in 1944, and the sulphonamides 
only a few years before, dramatically improved the outcome of patients with 
meningitis (Rosenberg and Sylvester 1944; Rosenberg and Arling 1984). The case-
fatality with the use of penicillin dropped from up to 90% with no treatment to around 
40% (Dowling, Sweet et al. 1949; Dowling, Sweet et al. 1949). 
With the continued use of, but also further developments in, antibiotics, penicillin has 
been replaced, either because of resistance to, or simply because of increased 
effectiveness against a wider range of bacteria, with other antibiotics, e.g. most 
recently the 3rd generation cephalosporins. 
31 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
2.3.3 Vaccination 
Meningococcal 
In 1978 the first polysaccharide vaccine to protect against meningococcal meningitis 
was introduced in the US (Grabenstein 1997). The vaccination programme was 
extended to small children, however one of the serious limitations with polysacharide 
vaccines was the lack of immunity generated in children under 2. In the early 1990's 
the medical community recognised that teenagers and young adults were at 
increased risk for meningococcal disease. In the late 1990s the relevant 
governmental bodies in the developed countries, including the Department of Health 
UK, the American College Health Association (ACHA), and others recommended that 
colleges and universities should inform all new students about the risk of 
meningococcal disease; and offer vaccination (Fischer, Hedberg et al. 1997; Neal, 
Nguyen-Van-Tam et al. 1999). However, the cost-effectiveness of this strategy has 
been debated (Jackson, Schuchat et al. 1995). 
Development and licensing of meningococcal conjugate C vaccine in the late nineties 
provided improved benefits for control of meningococcal vaccine. In 1999 England 
became the first country to undertake a national vaccination campaign for teenagers 
with Meningococcal C Conjugate vaccine (Men C) to be followed as part of the 
routine childhood vaccination. Meningitis C then accounted for 36% of all 
meningococcal cases. In May 2008 the Health Protection Agency (HPA) reported 0 
deaths from meningococcal C. HPA figures show that there were only 13 cases of 
Meningitis C in 2008/09 compared to 955 in 1998/99 - a decline of 99% largely due to 
the use of meningococcal C vaccine (HPA 2009). 
Pneumococcal 
With regard to pneumococcal vaccination, the efficacy of immunisation against the 
pneumococcus was first demonstrated in South African miners in the early 20th 
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Century (Wilson 1972). In 1930 it was learned that carbohydrate molecules on the 
surface of the pneumococcus are important contributors to immunogenicity and in 
1936, a pneumococcal capsular polysaccharide vaccine was used to abort an 
epidemic of pneumococcal pneumonia (Butler, Shapiro et al. 1999; Ortqvist 2001). 
The polysaccharide vaccine has had, continues to have, a wide-spread use amongst 
the older people though effectiveness is uncertain. Recently there has been 
introduction of pneumococcal conjugate vaccine I various countries around the world, 
in the UK it was introduced in the childhood vaccination programme in 2006 (CMO 
Letter 2006). Nonetheless, invaisve pneumococcal disease still remains the leading 
couse of death in children world-wide, causing more deaths than malaria and HIV 
together. 
Haemophilus Influenzae Type b 
In the 1970s the first polysaccharide vaccine against Haemophilus influenzae type b 
was In use but, as with other polysaccharide vaccines, it had limited effectiveness in 
children under 2 years old, the age-group most at risk. In 1985 the first 
polysaccharide vaccine was licensed for the under 18 month's olds, but still 
effectiveness was not high. 
In 1987 the first conjugate Hib vaccine was licensed, and began to be rolled out as a 
national vaccination in many countries in the early 1990s. Nonetheless, Haemophilus 
infections even today remain a leading cause of illness and death among children 
worldwide causing around 700,000 deaths a year 
(http://www.hibdisease.com/hib2005professional.swf). 
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2.4 A brief background on the global epidemiology of meningitis 
2.4.1 Overview 
Bacterial meningitis and meningococcal septicaemia cause a significant morbidity 
and mortality world-wide (Apicella 2005). These are serious and potentially life-
threatening conditions with over 10% fatality and 30% long-term sequelae despite the 
availability and use of potent antibiotics. Until a few decades ago major epidemics 
occurred across the globe, and still do so generally in the poorer regions of the world, 
such as sub-Saharan Africa (Greenwood 1999; Apicella 2005; Greenwood 2006; 
Boisier, Mainassara et al. 2007). 
It is difficult to measure the numbers of cases and deaths, primarily due to multiple 
causation (meningococcus, pneumococcus, Hib, etc), but it is estimated that 
numbers world-wide are in the millions for cases and hundreds of thousands for 
deaths (Quagliarello and Scheid 1992; Adegbola, Usen et al. 1999). The disease 
affects all populations and age groups, but is most common in children under 5 and 
in the 'Meningitis belt'. Despite the parenteral antibiotic, and further, treatment the 
outcome of these conditions still remains grave. About 15-20% of adult cases die and 
a further 30% suffer long-term sequelae (Greenwood 1984; Durand, Calderwood et 
al. 1993; Stanek and Mufson 1999). 
Several reviews have characterised the epidemiology of each of the main causative 
bacteria separately (Abbott JD 1985; Bijlmer 1991; Miller, Waight et al. 2000; 
Cartwright, Noah et al. 2001). There are relatively few reviews of the global 
epidemiology of bacterial meningitis (Schwartz, Moore et al. 1989). The reviews of 
the bacterial meningitis, inclusive of causative organism, usually are restricted to a 
defined population, either geographical, or age-related (Fortnum and Davis 1993; 
Urwin, Yuan et al. 1996; Gold 1999; Rosenstein, Perkins et al. 1999; Spanjaard, van 
der Ende et al. 2000). Even though the disease is much more common and graver in 
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the less developed world, namely Africa, most of the published research, however, 
comes from the western developed countries. Another point is that commonly in 
published literature the term 'meningitis' is used unspecified. As mentioned above, 
most often in such cases the authors will refer to Meningococcal meningitis; generally 
because the other causative organisms present with other forms of invasive disease 
more often then as meningitis (Jolly and Stewart 2001). 
I will analyse and interpret in greater detail the current and changing epidemiology of 
the CABM and MS amongst the adult population in England and Wales, further in this 
thesis (Chapter 4), but here I will give a brief background of the global epidemiology 
of CABM and MS. 
2.4.2 What are the factors that influence the epidemiology of meningitis? 
Although factors that are considered to increase the risk of meningitis and MD in 
humans, to some extent, are not well understood, it has been documented that the 
individuals' susceptibility, poor living conditions, and introduction of new pathogenic 
strains, are associated with a higher risk of disease. The epidemiology of the disease 
is determined by several factors, and these can broadly be grouped into: 
• the characteristics of the pathogenic agent; 
• the host factors; 
• socio-economic; and 
• environmental factors 
2.4.2.a The characteristics of the pathogenic agent 
These are of great importance in the epidemiology of the disease. The bacteria that 
are responsible for most cases of meningitis are effective at colon ising the human 
nose or throat. Some strains have higher pathogenicity or virulence, i.e. the ability to 
cause disease as opposed to mild or asymptomatic infection. The ability of the 
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agents to survive in the environment is also of great importance, and most of the 
CABM causes survive only for short periods outside the body i.e. require close and 
direct contact with the aerosols from the infected person for transmission. However, 
M. tuberculosis can survive for long periods in the environment, and L. 
monocytogenes is generally transmitted through the oro-faecal route. Capsulated 
bacteria display higher pathogenicity, i.e. N. meningitidis, S. pneumoniae and H. 
influenzae type b. 
2.4.2.b Host factors 
These are mostly related to immunity of the host, and specifically humoral and local 
immunity (such as mucosal, both respiratory and digestive). As mentioned above, for 
most causes of CABM, apart from L. Monocytogenes, the route of infection is 
droplets or aerosols and the port of entry is the upper respiratory tract, hence a 
damaged respiratory mucosa is thought to increase the risk of invasion. For example, 
it is thought that during the dry season, particularly in the meningitis belt, the mucosa 
is more fragile and offer less effective prevention. Similarly the effect of smoking in 
an increased risk of infection is partially explained by damaged mucosa (Stuart, 
Cartwright et al. 1988; Fischer, Hedberg et al. 1997). 
Several reports have also suggested that having flu and/or another respiratory 
infection increases the risk of meningitis by up to four times (Cartwright, Jones et al. 
1991) . People who have compromised humoral immunity, e.g. HIV infected, long-
term conditions, cancers, long-term treatment with corticosteroids, etc, are at 
increased risk of infection. 
2.4.2.c Soclo-economlc factors 
Poverty, overcrowding, and poor living conditions have been well established as a 
risk factors for meningitis (Baker, McNicholas et al. 2000). Historically there have 
been major epidemics following major social disruptions, like the first and second 
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World Wars. More recent and perhaps more localised humanitarian emergencies 
have been associated with local or regional outbreaks (Santaniello-Newton and 
Hunter 2000; IRC 2002; MSF 2005). Therefore one of the first public health 
measures in such circumstances is vaccination against forms of bacterial meningitis 
(WHO 2001). 
In normal social circumstances, and frequently in the developed countries, it is rather 
different social factors. Commonly it is amongst teenagers and young people who 
attend crowded venues, for example night clubs, that present an increased risk of 
infection with CABM and MS (Cookson, Corrales et al. 1998; Finn, Groves et al. 
2001; Harrison, Pass et al. 2001). The health-care system, as mentioned above, 
access to health care facilities, but also provision of prevention programmes, such as 
vaccination influence greatly the epidemiology of the disease (Molesworth, Cuevas et 
al. 2002). 
2.4.2.d Environmental factors 
in the African meningitis belt epidemics occur following periods of very low humidity 
and dusty conditions, it tends to die-off with the onset of the rains. This suggests that 
environmental factors also have an important role in the epidemiology of the disease 
(Greenwood, Blakebrough et al. 1984; Besancenot, Boko et al. 1997; Greenwood 
1999; Molesworth, Thomson et al. 2002). A recent study on the spatial distribution 
and spatial forecasting of meningitis epidemics in Africa indicated that absolute 
humidity, land-cover types (savanna, urban, grassland, dryland, forest wetland, etc) 
and population density are associated with areas with high and low risk of epidemics 
(Molesworth, Cuevas et al. 2003). 
In the northern industrialised countries, like the UK, outbreaks usually occur during 
winter times, December through to February. Although relative humidity is high, the 
absolute humidity is lower (Millon 1989). 
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2.4.3 Which are the most common causative agents of meningitis? 
Causative organisms of CABM and MS are numerous, and vary according to the 
geographical region and age-groups, nonetheless there are a few that are commonly 
more prevalent and relevant in England and Wales, including: 
• the capsulated bacteria: Streptococcus pneumoniae, Haemophilus 
influenzae type B, Neisseria meningitidis; these three bacteria are 
responsible for 75-85% of all cases of CABM worldwide (Greenwood 1984) 
• the Gram negative enterococci, predominantly Escherichia coli; 
• Listeria monocytogenes; and 
• Mycobacterium tuberculosis. 
Each of these bacteria causes various diseases, where meningitis is often not the 
most frequent but likely the most severe presentation of the infection. The common 
forms of the clinical presentation of the infection being upper respiratory infections, 
including: otitis media and sore throat; pneumonia; sepsis; meningitis and other 
forms. Neisseria meningitdis is an exception in as much as it almost exclusively 
causes meningitis and meningococcal septicamiae (MS). As mentioned above, these 
two manifestations often occur jOintly and known with the term Meningococcal 
Disease (MD). The clinical presentation and the pathology of CABM and MS will be 
reviewed further in this chapter. 
Because of many overlapping, but also varying features in epidemiology, pathology, 
clinical presentation and management of the common causes of CABM and MS it is 
difficult to review the epidemiology of CABM and MS as a unique condition globally 
or to follow a logical and structured approach in one review. After several attempts of 
various outlines, I decided to follow the 'Agent - Host - Time - Place' framework for 
each of the pathogens reviewed in this research. 
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The capsulated bacteria, N.meningitidis, S.pneumoniae and Hib (Figure 2.1) are the 
most common forms of CABM, though with the implementation of the conjugate 
vaccines, Hib and Men C, and recently S.pneumoniae, their burden is reducing 
significantly. 
Figure 2.1 - Capsulated bacteria, common causes of CABM. 
Capsulated 
Bacteria 
The agent 
using this image. 
S. pneumoniae 
H. influenzae type b 
Neisseria meningitidis (N. meningitidis) is a gram negative diplococcus. The major 
outer membrane components of the bacteria, capsular polysaccharide, outer 
membrane proteins, and lipo-oligosaccharide (endotoxin) are linked to the ability of 
meningococcus to be virulent to the humans. There are 13 serogroups of N. 
meningitidis based on different capsular polysaccharide structures, but only 6 (A, B, 
C, W-135, X, and Y) cause the most life-threatening disease (Rosenstein, Perkins et 
al. 2001) . 
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The immunotype is determined by the differences in Ii po-oligosaccharide (12 
imunotypes, i.e. LI-L 12), whilst the serotype (20 groups, e.g . 1, 2a, 2b, 21) and 
serosubtype (10 groups, e.g. P1.1 , P1 .2 to P1 .16) are identified by differences in the 
outer membrane proteins (Verheul, Snippe et al. 1993; Raymond, Reeves et al. 
1997; Dolan-Livengood, Miller et al. 2003) 
Figure 2.2 - A cross sectional view of N. meningitidis taken from: D. S. Stephens, B. 
Greenwood, et al. Lancet. 2007. 
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Epidemic meningococcal meningitis occurs in many parts of the world but the largest 
and most frequently recurring epidemics have been in the area of sub-Saharan Africa 
where a recent pandemic was associated with attack rates exceeding 500 per 
100,000 and thousands of deaths. In this region, commonly referred to as the 
meningitis belt, meningococcal disease presents predominantly as meningitis alone 
(Molesworth, Thomson et al. 2002). 
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In the Americas and Europe serogroup B is the predominant agent causing systemic 
disease, followed in frequency by serogroup C. Serogroup C has caused relatively 
higher fatality associated with both clusters or local outbreak to larger outbreaks 
(Brooks, Woods et al. 2006). Serogroup A meningococcus was historically the main 
cause of epidemic meningococcal disease globally and still predominates in Africa 
and Asia. Generally, serogroup B is responsible for most sporadic cases; serogroup 
C causes large or small outbreaks (De Wals, Hertoghe et al. 1981; Cooke, Riordan et 
al. 1989). 
Serogroup W-135 has emerged as a cause of outbreaks associated with the Hajj 
pilgrimage and as the cause of disease in the African meningitis belt, including a 
large epidemic in Burkina Faso (Aguilera, Perrocheau et al. 2002). Since the mid 
1990s, serogroup Y has caused increased rates of disease in the USA and Israel, 
and serogroup X has caused local outbreaks in parts of sub-Saharan Africa (Djibo, 
Nicolas et al. 2003; Nicolas, Djibo et al. 2006). 
The host 
N. meningitidis infects only humans; there is no animal reservoir. The bacterium is 
found in the back of the throat, of about 5 to 30% of healthy people, normally called 
carriage. It is transmitted from person to person through respiratory droplets or throat 
secretions. When it invades the blood-stream it causes meningococcal septicaemia 
and lor meningitis. Usually septicaemia is the more dangerous clinical syndrome, 
causing a higher fatality (Thomson and Riordan 2000). World-wide MD accounts for 
around 500,000 cases and 50,000 deaths per year (World Health Organization 
1998). Up to 20,000 deaths are reported from the sub-Saharan African countries 
only. 
All ages are affected but young children, under 5, and teenagers are at highest risk of 
the disease (Harrison, Pass et al. 2001). People living in crowded conditions are also 
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at higher risk. The clinical manifestation is either meningitis, which generally has a 
lower case fatality rate, or septicaemia, or the combination of both (Peltola 1983). 
New military recruits have consistently been found to have a higher risk of both 
sporadic meningococcal disease and outbreaks of disease than other military 
personnel or the general population (Brundage JF 1987). Students living in university 
accommodation have an increased risk of disease, perhaps for similar reasons, for 
meningococcal disease than other people of similar age (Jackson, Schuchat et al. 
1995). 
Place 
Meningococcal disease occurs sporadically all over the world, with seasonal 
variations. Incidence rates vary from 1 to 5 per 100,000 in the western countries (UK, 
US, Netherlands) to 10 to 25 per 100,000 in the less developed regions (Africa, 
Asia). In Europe, North America and Africa meningococcal meningitis is common 
and dominant form of CABM; but much less common in South East Asia (Chiou, liao 
et al. 2006). 
In the UK N. meningitidis is the main cause of CABM and MS and the incidence is 
relatively high compared to other European countries. 
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Figure 2.3 - Incidence of meningococcal disease in Europe. Source EU - IBIS 2007. 
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In Europe, the Americas, Australia, and New Zealand generally N. meningitidis 
serogroups Band C are the most common cause of disease and tend to occur more 
frequently in winter and spring . Whilst in Africa and Asia it is serogroup A which is the 
main cause of disease and, as mentioned above, often causes large epidemics 
regularly across the meningitis belt. 
For the successful control of MD globally the crucial challenge will be effective 
introduction of new meningococcal vaccines into developing countries, especially in 
the meningitis belt of sub-Saharan Africa , where they are urgently needed 
(Tikhomirov, Santamaria et al. 1997). A new conjugate meningococcal A vaccine 
(MenA) is on trial through the Meningitis Vaccine Project (MVP) (Hodgson, Forgor et 
al. 2008). 
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Figure 2.4 - World map of outbreak regions of MD. 
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Time 
Seasonal pattern As mentioned above, MD has a regular seasonal pattern of 
occurrence, being at highest peak during the dry-seasons, and in winter in Europe 
and North America. Due to herd immunity (whereby transmission is low when a 
relevant percentage of the population has acquired immunity due to disease or 
vaccination), the epidemics in the meningitis belt occur in a cyclic mode. The role of 
climatic factors is not well understood; but it is thought that the effect is probably in 
minor damages made to the respiratory mucosa, facilitating thus the invasion by the 
bacteria. 
Changing epidemiology 
New strains As recently as throughout the 1960s, 70s and 80s N. Meningitidis 
caused pandemics spreading in about 30 countries around the world caused mainly 
by the group A. More recently, other groups, such as W135 and serogroup X have 
been cause of major outbreaks, particularly so in he western countries (Djibo, Nicolas 
et al. 2003; Nicolas, Ojibo et al. 2006). In 2000, a large outbreak caused by N. 
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meningitidis group W135 occurred during the Muslim pilgrimage in the Hajj; and 
since then W135 has continued to cause small outbreaks and sporadic cases 
throughout the world (Singer, Maur et al. 1980, Hahne, S. J., Gray, S. J., et al. 2000). 
Age A changing epidemiology in the 1990s compared with the disease in previous 
years, has been reported in the US (Rosenstein, Perkins et al. 1999). A shift of 
disease towards older age groups and a change in the predominant serogroups with 
a higher proportion of cases caused by serogroup V, are the most notable features. 
Vaccination In the late 19905 a conjugate meningococcal C vaccine was introduced 
in most of the western countries, followed by some other countries around the world. 
This has had a big impact in the epidemiology of MD around the world, with a 
dramatic decrease in incidence of group C close to elimination (Trotter, Andrews et 
al. 2004). 
2.4.3.b Haemophilus influenzae 
The agent 
Haemophilus influenzae type b, or Hib, is a capsulated bacteria which is a major 
cause of morbidity and mortality around the world and is responsible for most of 
bacterial meningitis (Peltola 2000; Uduman, Adeyemi et al. 2000). It is a common 
pathogen in adults, often causing meningitis (Strausbaugh 1997). 
The host 
It is estimated to cause about 3 million serious illnesses and close to 400 000 deaths 
per year, primarily due to meningitis and pneumonia. The most at risk are children 
under the age of 5, with those between 4 and 18 months of age especially vulnerable 
(Bijlmer 1991). Treated early, it has a fatality rate of under 10%, but up to 30% of 
patients who recover suffer residual neurological effects. In the UK it has been one of 
the most common causes of meningitis, in the pre conjugate vaccine era (Urwin, 
Yuan et al. 1994). 
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Place 
Until the implementation of the conjugate vaccine Hib was the most common of 
bacterial meningitis, in Europe as well as in USA, Southern Pacific, including 
Australia and New Zealand. 
The infection is wide-spread with highest incidence rates reported from the poorest 
countries, rangingi from 95 to less then 10/100,000 in under 5s in population without 
conjugate vaccine programmes (Gessner 2002); however these reports are strongly 
subject to the ascertainment differences between the developed and developing 
countries. 
Hib invasive disease, and meningitis in particular, is most common in developing 
countries, estimated to cause 3 million cases of serious illness (mainly pneumonia 
and meningitis) in children under 5 years of age each year and about 400,000 deaths 
(Adegbola, Usen et al. 1999). 
Time 
Since the early 1990s, due to the introduction of the Hib conjugate vaccine into the 
childhood vaccination programmes, the disease has been almost eradicated from 
Western Europe, North America, Australia and New Zealand (Peltola 2000). Until the 
introduction of the HiB conjugate vaccine Hib accounted for over 50% of all 
meningitis cases in Europe. However, the disease still represents a large burden in 
the developing world, causing hundreds of thousands of needless deaths every year 
and leaving 15 to 35% of survivors with permanent disabilities. By November 2006 
about 106 countries had introduced the Hib conjugate vaccine into their childhood 
vaccination programmes. And only 26 of 72 resource limited countries have 
introduced Hib vaccine or are approved by GAVI to introduce Hib soon. 
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2.4.3.c Pneumococcal meningitis 
The agent 
Streptococcus pneumoniae (the pneumococcus) is a Gram positive capsulated 
diplococcus that causes a range of invasive disease, including sepsis and 
pneumonia as the common ones. Meningitis is the presenting diagnosis in about 
10% of cases of invasive disease but is usually the most serious form of the infection. 
The host 
Young children and then older adults are most often affected, especially the under 5s 
and over 65s (Butler and Schuchat 1999; Wasier, Chevret et al. 2005). 
Pneumococcal infections represent the leading cause of vaccine-preventable deaths. 
Around 40% of all adults and children, healthy or otherwise, carry the pneumococcus 
in their nasopharynges. This disease often infects young children and the elderly. 
The case fatality rate for pneumococcal meningitis remains high, as high as 30% 
especially amongst the very young and very old (Butler and Schuchat 1999), but 
fatality remains high for other IPD as well (Feikin, Schuchat et al. 2000). 
Time 
There has not been any significant change in the epidemiology of pneumococcal 
meningitis (or the IPD for that matter) in recent times (Laurichesse, Grimaud et al. 
1998). A slight rise in incidence of IPD overall has been reported from some Western 
countries, mainly attributed to an increase of the disease in the elderly (Ortqvist 
1999). 
The biggest change, however, has been in the increasing incidence of antibiotic 
resistant strains in S. Pneumoniae isolates, both blood and CSF. Although the rates 
of resistance in England and Wales is reported to be lower than in some other 
Western countries, they have been in an increasing trend, nonetheless (Laurichesse, 
Grlmaud et al. 1998). 
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Until the mid 2000s the vaccination policies did not change significantly the 
epidemiology of pneumococcal meningitis. The polysaccharide vaccines have been 
in use throughout the world, but offering protection to adults, generally, and have had 
no or little effect in children less than 5 years of age and do not prevent carriage 
without symptoms. Lately, with the introduction of the conjugate pneumococcal 
vaccines, there has been a significant drop in the rates of disease amongst children, 
a decrease in carriage rates, an increase in herd immunity, and a decrease in rates 
of antibiotic resistant strains (Cartwright 2002; Hennessy, Singleton et al. 2005; 
Kyaw, Lynfield et al. 2006). Another significant effect of the PCV on the epidemiology 
of the pneumococcal meningitis and overall IPD, has been on the serotype switching, 
ie since the introduction of the PCV proportionately more disease is caused by the 
non-vaccine serotypes. In the UK a seven valent conjugate vaccine (PCV7) is in use, 
and in the last few years reports through active and enhanced surveillance of all 
pneumococcal infections show that the serotypes not included in the vaccine are 
becoming more prevalent (Kaye P, Malkani R, et a/. 2009; Albrich, Baughman et a/. 
2007; Hsu, Shutt et al. 2009). 
Place 
Pneumococcal meningitis is most common in sub-Saharan Africa; but is also 
common in South East Asia where it account for almost one third of all CABM cases 
(Chotmongkol and Techoruangwiwat 2000). In Europe, including the UK, and the 
United States, S. pneumoniae is the most common community acquired bacterial 
pneumonia and meningitis, estimated to infect over 100 per 100 000 adults each 
year. The annual incidence rate for meningitis in Europe is estimated to be 1-2 per 
100,000 (WHO 2003). The invasive pneumococcal infection is prevalent world-wide 
but most of the burden in the less developed word, where it accounts over 60 percent 
of invasive disease worldwide. 
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2.4.3.d Escherichia coli 
The agent 
Escherichia coli are Gram-negative, straight rod shaped bacteria cells that are 
grouped with other related bacteria (that normally live and form part of the intestinal 
microflora in humans and warm-blooded animals) as 'enteric' bacteria (Thomas 
2005). Cases of community acquired bacterial meningitis caused by E. coli occur 
occasionally. They are most common in the neonates and older. 
The host 
A 27 year review of CABM in a Massachusetts hospital reported that 3% of all 
infections by G-negative bacilli where community acquired G-negative cocci, other 
than H. Influenzae (Durand, Calderwood et al. 1993). The majority of the affected 
are elderly orland neurosurgical patients (Harder, Moller et al. 1999). 
Time 
There has not been much significant evidence of change in the epidemiology of E. 
coli meningitis amongst adults or neonates over recent time. A small drop in fatality 
among neonates has been reported, but no reports about adults are available (Holt, 
Halket et al. 2001). 
Place 
In Europe, North America and Australia the incidence of community acquired E. coli 
meningitis is low (Bouadma, Schortgen et al. 2006). In parts of Africa and Asia, in the 
Far East in particular, however, E. coli is a more common cause of bacterial 
meningitis accounting for up to 15% of adult meningitis cases (Chotmongkol and 
Techoruangwiwat 2000), (O'Oempsey, McArdle et al. 1994). 
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2.4.3.e Listeria monocytogenes 
The agent 
Listeria monocytogenes is a Gram-positive rod-shaped bacterium. The invasive 
infection caused is referred to as listeriosis; and is generally caused by eating food 
contaminated with the bacteria. 
The host 
The majority of cases of meningitis caused by L Monocytogenes occur in neonates or 
the elderly, aged 65+, pregnant women and adults with weakened immune systems 
are also at increased risk of infection (Lavetter, Leedom et al. 1971). The incidence 
of listeriosis in Europe is not high, around 0.3 cases per year per 100,000, but it is 
characterised by a high case-fatality rate which can exceed 30% (Goulet and 
Marchetti 1996; de Valk, Jacquet et al. 2005). 
The increase in HIV incidence has been reported to have also resulted in an increase 
in the incidence of invasive disease due to L Monocytogenes in general, and in 
particular a relatively greater increase in meningitis (Jurado, Farley et al. 1993) 
Time 
Since the 1990s there has been a fall in the incidence of meningitis due to L 
monocytogenes in Europe, as also a fall in other invasive disease (Tappero, 
Schuchat et al. 1995). As most infections occur via the oral route, increased food 
hygiene measures are thought to have contributed to the drop in the incidence. This 
fall is in contrast to the increased incidence observed in the African countries, in 
particular in the high HIV prevalence countries (Jurado, Farley et al. 1993). 
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Place 
Meningitis due to L. monocytogenes is common world-wide. In Western countries it is 
one of the most common forms, following Meningococcal and pneumococcal 
meningitis (Schlech, Ward et al. 1985; Sigurdardottir, Bjornsson et al. 1997). 
2.4.3.f Group B streptococcus (GBS) 
The agent 
Group B Streptococcus (GBS), also known as Streptococcus aga/actiae, is a Gram 
positive bacteria, a common coloniser of the gastrointestinal and the urogenital 
tracts. 
GBS is the most common bacterial infection in newborns in the UK, resulting in 
sepsis, pneumonia and meningitis. It causes around 700 new infections each year, 
with a case fatality rate of over 10%. Most of the serious disease and fatality from 
GBS infections is due to meningitis and occurs in the first week of birth (RCOG and 
LSHTM 2007). 
The host 
Neonates are at highest risk with incidence around 10/100,000; case fatality rate 
around 5% (Zangwill, Schuchat et al. 1992; Kyaw, Clarke et al. 2002). Most of the 
infection occurs in the first weeks after birth and is associated with perinatal infection 
(Schuchat, Deaver-Robinson et al. 1994). In the UK the prevalence of GBS infection 
in infants is estimated to be 46 per 10,000, and over half of those infections result in 
clinical meningitis (Heath, Balfour et al. 2004). Screening strategies for GBS infection 
of mothers to be have been examined and vary around the developed world (Jafari, 
Schuchat et al. 1995). A substantial burden of GBS related illness occurs outside the 
perinatal period, i.e. in pregnant women and infants. 
The risk of community-acquired group B streptococcal meningitis in adults increases 
with increasing age and presence of long-term chronic (Jackson, Hilsdon et al. 1995). 
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Amongst adults the most common clinical presentation of GBS is sepsis, followed by 
pneumonia and then meningitis, accounting for around 5% of GBS cases (Jackson, 
Hilsdon et a\. 1995). 
Time 
The GBS meningitis emerged as a disease in the late 1970s - as a significant cause 
of neonatal disease but also owing to its rising incidence in adults (Farley, Stephens 
et a\. 1992; Farley, Harvey et a\. 1993). In the last decade or so there has been a fall 
in the incidence of GBS invasive disease amongst infants, coinciding with advanced 
prevention guidelines in most of the Western countries (Farley, Harvey et a\. 1993). 
However, the disease burden in adults remains substantial and a study in the US 
reported a significant increase between late 1990s and 2005 (Phares, Lynfield et al. 
2008). 
Place 
Worldwide, colonisation by Group B Streptococcus (GBS) is highly prevalent among 
pregnant women and amongst the elderly, varying between 4% and 30% (Hickman, 
Rench et al. 1999; Edwards and Baker 2005). World-wide the most common 
neonatal meningitis is caused by GBS, and it is also prevalent in older adults 
(Schwartz, Schuchat et al. 1991). As with other infections, globally, the people at 
higher risk are those in deprived and marginalized communities (Mayon-White 1985; 
1995; Collins, Calderon et al. 1998; Zusman, Baltimore et al. 2006). 
2.4.3.g Mycobacterium tuberculosis 
The agent 
Mycobacterium tuberculosis (M.tuberculosis) is a pathogenic aerobic bacteria that 
stains poorly on Gram stain, and stains better with Ziehl-Neelsen or acid-fast 
staining. It is the causative agent of tuberculosis (TB), including tuberculous 
meningitis (TBM) (Jenkins 1994; Plorde 2003). 
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The host 
Only about 10% of infections with M.tuberculosis progress to an active disease. 
Predisposing factors for the development of active TB include malnutrition, 
alcoholism, substance abuse, diabetes mellitus, corticosteroid use, malignancy, head 
trauma, and HIV infection (Berenguer, Moreno et al. 1992; Verdon, Chevret et al. 
1996). Homeless persons, people in correctional facilities, and residents of long-term 
care facilities also have a higher risk of developing active TB compared with the 
general population (Aviglione and Nunn 1997). 
Approximately 15-20% of these cases occur in children younger than 15 years. In the 
developing world, 10-20% of persons who die of TB are children. 
In the developed countries rates of the disease are highest in the ethnic minorities 
and the younger and elderly are at an increased risk of the disease (Stead, Senner et 
al. 1990; Grange and Yates 1994). Children under 5 are also more likely to develop 
TBM compared to other forms, including pulmonary TB. Older men also are at a 
higher risk compared to women of similar ages (Nelson, Schneider et al. 2004). 
Time 
During the last 2 decades there has been a re-emergence of TB and tubercolous 
meningitis (TBM) (Nelson, Schneider et al. 2004). The co-epidemic of HIV is thought 
to be the greatest factor for the recent increase of active TB, along with the social 
disturbances including, poverty, lack of functioning public health and health service 
infrastructure leading to large movements of populations as well as emergence of 
resistant M.tuberculosis. In particular there are reports to show that TBM's 
proportionate increase has been larger than all other forms of TB in recent decades, 
for example in the 1990s the US saw TBM constituted 6.2% of morbidity attributed to 
extrapulmonary TB compared to 4.7% in the period before 1990s (CDC 2008). 
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Place 
The incidence of TBM is related to the prevalence of TB in the community, and is still 
the most common type of chronic eNS infection in developing countries (Karstaedt, 
Valtchanova et al. 1998; Ramachandran 2007). In many areas of Africa and Asia, the 
annual incidence of TB infection for all ages is approximately 2% (CDC 2007). 
2.4.4 How the disease is transmitted 
Generally, the bacteria causing meningitis are transmitted from person to person 
through exhaled respiratory droplets. The exception is E. coli and L. monocytogenes, 
which are transmitted primarily through direct contact via the oral-oral route. Also, 
GBS is often, and most commonly in neonates, transmitted through direct skin 
contact. 
Most of these bacteria usually inhabit the nose, throat and respiratory tracts of warm 
blooded animals, including humans, with the exception of N. meningitidis which only 
infects humans and it is not know to infect animals. The bacteria are commonly 
carried in the pharynx (so called asymptomatic nasopharyngeal carriage) which 
sometimes, for reasons not fully understood, may invade the bloodstream and reach 
the brain. In this way, these bacteria can cause much illness, including infections of 
middle-ear, lungs (pneumonia), sepsis and meningitis (Trotter and Greenwood 2007). 
Factors that influence the spread of bacteria have been described to be behavioural 
frequent and close person-to-person contact with an infected person (e.g. kissing, 
sneezing and coughing.) Also included within this is demographic; movement of 
populations such as social disruptions or pilgrim movements, environmental; drought, 
economic; poor nutrition and overcrowding leading to reduced immunity, 
epidemiologic; agent and host interactions, and social; smoking, overcrowding, living 
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in close quarters or dormitories (as do military recruits and students) (Cartwright 
1994). 
2.4.5 Carriage and invasive disease 
The 3 main pathogens responsible for causing CABM (N.meningitidis, S. pneumonia 
and HiB) are normally carried on the back of the throat (nasopharynx) of healthy 
people. It is estimated that between 10 to 25% of the population carry HiB, 
N.meningitidis whilst pneumococci up to 40%, at any given time, the carriage rate 
may be much higher in epidemic situations and day care centres (Stephenson, Doern 
et al. 1985; Crook, Brueggeman et al. 2004). The rates of carriage vary by population 
groups, seasonality and outbreak occurrence; and in all of these instances the 
carriage transmission follows a trend as in disease transmission. As such, the 
carriage is higher in young children and adolescents, in populations living in 
overcrowded settlements, in winter times and in times .of outbreaks or epidemics 
(Cartwright, Stuart et al. 1987). 
The pathway of the transmission of the pathogens from one individual to another can 
result in colonisation (carriage), disease or it can be just transient. As per disease 
acquisition, the risk factors for carriage include: smoking, severe overcrowding, and 
age-group (Cartwright 1994). 
55 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
2.5 Pathology, clinical presentation and management of bacterial 
meningitis 
2.5.1 Recognition of meningitis 
Figure 2.5 - The central nervous system 
Early recognition of suspected meningitis cases followed by prompt institution of 
therapy is central to improving patient outcomes. The clinical features of meningitis in 
its early stages are often non-specific and a high index of suspicion is needed in 
order for the clinician to identify a case of meningitis from the many patients with 
febrile illnesses that present to the emergency departments. It is supposed that in 
some patients, the severity of the illness may be masked by the prior administration 
of antibiotics. 
Presenting symptoms vary with age at onset and, as per causation, the clinical 
presentation can be grouped into the newborns (from birth to one month of age), 
infants (2 months to 2 years), children over 2 years of age and young teenagers and 
adults. The common symptoms and signs, across all age-groups include fever, 
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headache, neck stiffness, photophobia, nausea and vomiting, impaired or fluctuating 
mental status, focal neurology and seizures (Durand, Calderwood et al. 1993). 
Amongst adults a headache is the most common symptom of meningitis followed by 
neck stiffness, both present in around 80% of cases (however neck sitffenes 
sometimes less, particualry in the elderly, see below), and focal neurology and 
seizures which affect up to 15% of adults (van de Beek, de Gans et al. 2004). 
However, the recognised typical triad of diagnostic signs of stiff-neck, fever and 
altered mental status is present in only 44% of all adult cases (Thomas, Hasbun et al. 
2002). Non-specific muscles aches, back pain and cold extremities are common 
complaints of adult patients (Thompson, Ninis et al. 2006). A petechial or purpuric 
rash is almost exclusively seen in meningococcal disease, but particularly in the early 
stages of the disease the rash may be non-specific erythematous or macula-papular 
in character (Heyderman and Habibi 2000). The presence of a characteristic rash is 
highly suggestive of meningococcal infection, and meningococcal sepsis may occur 
in the absence of meningitis. However, as many as 50% of patients with confirmed 
meningococcal meningitis may not have a rash at presentation. 
This is difficult to be made with precision through diagnosis in clinical examination 
alone (Carpenter and Petersdorf 1962; Durand, Calderwood et al. 1993; Attia, Hatala 
et al. 1999). The absence of all 3 classical features of meningitis, i.e. fever, headache 
and altered mental status, essentially excludes the diagnosis. Meningitis is 
particularly difficult to diagnose in the elderly because of high prevalence of 
underlying illnesses and the less specific presentation. Neck stiffness has been 
reported to be present in as few as 35% of patients older than 60 years (Puxty, Fox 
et al. 1983) and a depressed level of consciousness may occur in many forms of 
severe infection in this age group (Behrman, Meyers et al. 1989; Choi 2001) { Miller, 
1997 60 lid} (Gorse, Thrupp et al. 1984). A high index of suspicion is therefore 
needed across all age groups, not only children and teenagers (Table 2.1). It is 
57 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
recommended that the diagnosis of meningitis should be carefully considered in any 
patient with headache, confusion , irritability or lethargy, with or without a fever. 
Table 2.1 - Symptoms and signs of meningitis in adult patients adapted from Durand 
et al. and Attia et al. 
Signs and symptoms Percenta e present 
Fever 95% 
Neck stiffness 88% 
Altered level of consciousness 79% 
Headache and/or photophobia 50% 
Seizures or focal neurology 23% 
Rash 11% 
2.5.2 Initial assessment and management 
Meningitis is a disease with a sudden onset and a rapid progress, therefore 
immediate intervention is required if a diagnosis of meningitis is suspected. In 2005 
the British Infection Society (8IS), to assist clinicians in diagnosing and treatment of 
meningitis, developed a management algorithm for the management of adults based 
on previously published guidelines (www.britishinfectionsociety.org or 
www.meningitis.org) (8egg, Cartwright et al. 1999). These guidelines constitute the 
core benchmarking document for the review of clinical management of CABM and 
MS and in the formulation of the standards against which the clinical hospital 
management are reviewed (Chapter 6). A copy of the standards and indicators 
developed for use in the review of clinical management is presented in Appendix 3. 
Initial Assessment 
A number of clinical signs / symptoms and laboratory tests are recommended to be 
assessed and documented in the initial assessment of a patient with 
meningitis/septicaemia. Below are some of the key ones, grouped as per clinical 
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relevance which has formed the basis of the data-collection instrument for the review 
of clinical management, presented in Chapter 6. 
• Assessment of the patient's airway, breathing (respiratory rate and oxygen 
saturation) and circulatory status (pulse, urine output, capillary refill time). 
• Assessment of the warning signs of severe disease (Table 2.2), including 
the level of consciousness. 
• A number of laboratory examinations, including a full blood count, blood 
glucose, urea and electrolytes, liver function tests, C-reactive protein, a 
clotting profile are needed (Corless, Guiver et al. 2001; Jordens, Williams et 
al. 2002) 
• In presence of the warning signs of severe disease it is recommended to 
seek assistance from the critical care team. 
There are a few issues that have been debatable and controversial in the recent 
years in the management of CABM and MS. I will review these here in context of my 
research. 
2.5.2.a Rationale for diagnostic lumbar puncture 
The approach to the diagnosis of bacterial meningitis by lumbar puncture (LP) has 
markedly changed over the last 10-15 years (Ramsay, Kaczmarski et al. 1997). It 
has been debated whether, now that we have potent antibiotics, a LP will be 
beneficial to inform the management of patients. There is a fear amongst clinicians 
that a LP is associated with unacceptable hazards in meningitis, primarily cerebral 
herniation. There are, however, specific and well-accepted contraindications to LP in 
patients with meningitis (see Table 2.2) and it is essential that these are followed 
carefully. Otherwise, a LP can be performed safely in the absence of 
contra indications and provided that it can be undertaken within 30 minutes of initial 
assessment, does not introduce a significant delay in treatment. 
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LP provides opportunity for confirmation of the diagnosis, bacteriological culture of 
CSF may yield the aetiology and antibiotic sensitivities, these being important 
prognostic information. There are also concerns that performing a LP delays the 
administration of antibiotics. These indicators have been explicitly addressed in the 
review of hospital management. Chapter 6. 
2.S.2.b Recognition of raised intracranial pressure 
Evidence of raised intracranial pressure (ICP) in bacterial meningitis most commonly 
manifests itself as a fluctuating or deteriorating level of consciousness, or prolonged 
seizures . These can be confused with the features of cerebral hypoperfusion in the 
absence of meningeal inflammation with those of raised intracranial pressure in 
patients with meningitis. Appropriate identification of raised intracranial pressure is 
key to the indication (or contra-indication) of LP, because of the potential risk of 
cerebral herniation, discussed below. 
Table 2.2 - Signs of raised intracranial pressure (ICP) 
Signs of raised intracranial pressure 
Marked depression of conscious level: GCS<13 or a fall in GCS >2 
Focal neurological signs e.g . 6th or 3rd cranial nerve palsies, hemiparesis 
Persistent seizures 
Bradycardia and hypertension (Cushing reflex) 
Papilloedema (rare in meningitis) 
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Table 2.3 - Signs of shock and respiratory failure 
Signs of shock and respiratory failure 
Poor peripheral perfusion 
Capillary refill time >4 seconds 
Oliguria (urine output <20mLlhour) 
Systolic BP <90mmHg 
Respiratory rate <4 or >30 breaths per minute 
Pulse rate <40 or >140 
Acidosis: pH <7.3 or Base Excess worse than -5 
White blood cell count <4.0 x 10lol/L 
2.S.2.c Rationale for diagnostic computerised tomography before lP 
To address the suspicion of raised intracranial pressure (discussed above) it is a 
common practice to arrange a CT brain scan prior to undertaking a LP in patients 
with suspected meningitis. This approach is poorly supported by available evidence. 
Clinically significant raised ICP cannot be ruled out by brain CT and therefore a 
normal scan can be falsely reassuring (Durand, Calderwood et al. 1993; Hasbun, 
Abrahams et al. 2001). 
Meningitis patients presenting with clinical signs of raised rcp are in the minority and 
they should not undergo LP regardless of the CT findings. Transporting patients to a 
CT scanner before they have been adequately stabilised is unsafe and may result in 
sudden deterioration in an uncontrolled environment. 
It is argued that the inevitable delay in undertaking the CT scan requires that 
empirical antibiotics are given while awaiting the procedure, therefore impairing the 
diagnostic yield from a subsequent LP, as discussed above. Brain imaging is 
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considered useful in the investigation of the immunocompromised with suspected 
cerebral infection and may define a dural defect, in adult patients with otitis media or 
mastoiditis. However, in the context of community acquired meningitis this approach 
infrequently identifies conditions requiring neurosurgical intervention (Heyderman, 
Robb et al. 1992; Durand, Calderwood et al. 1993; Hasbun, Abrahams et al. 2001). 
A recent prospective study of adults with suspected meningitis that examined clinical 
characteristics before CT of the head could be used to identify patients who were 
unlikely to have abnormalities on CT, concluded that clinical features can be used to 
identify those who are unlikely to have abnormal findings on CT of the head. 
Absence of an abnormal level of consciousness, neurological palsy, papilloedema, 
and abnormal language (e.g. aphasia), yielded a negative predictive value of 97 
percent (Hasbun, Abrahams et al. 2001). 
2.S.2.d The effect of clinical management in the outcome of meningitis and MS 
Much resource is used in developing clinical guidelines, however little is known about 
their impact in the outcome of the respective conditions. With regard to the 
management of CABM and MS much emphasis is put on the rapid assessment and 
management of the suspected cases. 
A recent study in meningitis in children and teenagers raised doubts about the benefit 
of early antibiotic treatment of these conditions (Harnden, Ninis et al. 2006). Also, not 
much is known on the effect of recommendations that seriously ill patients should be 
reviewed by a consultant within a set time. I will be examining the association of key 
clinical management indicators with the outcome of CABM and MS in the last chapter 
of the results of my research, Chapter 8. 
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2.5.3 Treatment 
2.5.3.a Antibiotics 
Antibiotics are the mainstay of treatment and have dramatically reduced the very high 
morbidity and mortality of meningitis seen in the pre-antibiotic era (Table 2.4). 
Earlier in this chapter I briefly presented the historical developments in antibiotic 
therapy, with sulfonamides, penicillin being in use since the early 1940s and a bit 
later chloramphenicol. These treatments resulted in significantly reduced morality 
from meningitis. However, it is only in the last 2 decades or so that mortality fell to 
around 5 % for HiS meningitis and around 10% for meningococcal meningitis. On the 
other hand, mortality from pneumococcal meningitis has remained at over 20 percent 
(Dowling, Sweet et al. 1949; Whitney, Farley et al. 2003). 
Deciding on the effective antibiotic treatment of bacterial meningitis depends upon 
local epidemiology, e.g. the distribution of causative organism across age groups the 
prevalence of antibiotic resistance. Nonetheless, the third generation cephalosporins 
are generally used as first drug of choice as they are effective in most cases. 
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Except where the patient is well and the diagnosis very uncertain, antibiotics are 
recommended to be administered empirically, awaiting and depending on the result 
of a LP. Based on evolving antibiotic resistance and good pharmacological 
characteristics, the 3rd generation cephalosporins, cefotaxime and ceftriaxone are 
now the common practice in most industrialised countries, eventhough for MS benzyl 
penicillin is the recommended first line agent for empirical therapy. Listeria 
monocytogenes is not susceptible to these agents and an amidopenicillin (ampicillin 
or amoxicillin) is recommended to be given in addition to a 3rd generation 
cephalosporin in patients older than 55 years, i.e. due to the increased proportionate 
risk of Listeria being a causative agent. Antibiotic resistance has become an 
important issue in the treatment of meningitis. 
It is recommended that patients suspected of having a highly penicillin resistant 
organism (indications include: recent travel to areas with high levels of penicillin 
resistant pneumococci such as Southern Africa, Spain and the USA, some of the 
Eastern European countries) are administered vancomycin together with rifampicin in 
addition to a cephalosporin. Generally, appropriate antibiotics have a quick effect in 
cerebrospinal fluid (CSF), sterilising it within 24 - 48 hours after the initiation of 
therapy, but it is recommended that treatment should continue intravenously for at 
least 7 days, and for organisms other than Neisseria meningitides, usually up to 14 
days. 
2.S.3.b The use of dexamethasone in adult meningitis 
The cerebral damage that occurs in bacterial meningitis is largely due to a host 
mediated inflammatory response (Pfister and Scheid 1997; Nau and Eiffert 2002). 
This process is triggered by the release of bacterial toxins and is exacerbated by 
antibiotic treatment. Several well conducted controlled trials have demonstrated 
improvements in morbidity (deafness or neurological deficit) but not mortality with 
adjunctive dexamethasone therapy for suspected bacterial meningitis in children (van 
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de Beek, de Gans et al. 2003), (Duke, Curtis et al. 2003). Until recently, in contrast to 
paediatric practice, there has been little evidence to support the routine use of steroid 
therapy in the management of adult patients with meningitis. A large multicentre, 
double-blind, randomized and placebo controlled trial of 301 patients (de Gans and 
van de Beek 2002) has shown a significant benefit in outcome (mortality and 
morbidity) with the administration of 10mg dexamethasone together with or within 20 
minutes of the first dose of antibiotic and given every 6 hours for 4 days. Importantly, 
there was no increase in adverse events attributable to dexamethasone therapy in 
the treatment group compared to the control group. 
A systematic review states that "dexamethasone should be given to all adults with 
bacterial meningitis and should be initiated before or with the first dose of antibiotics" 
(van de Beek, de Gans et al. 2003). In light of this study it is now recommended an 
adjunctive dexamethasone in all adult patients presenting with suspected bacterial 
meningitis in the absence of known contra-indications to steroid therapy. Should an 
alternative diagnosis be made subsequently then the steroids can be stopped. The 
benefit of steroid therapy underlines the importance of diagnostic lumbar puncture in 
order to confirm the presumptive diagnosis (Quagliarello 2004). 
When I designed and undertook the review into clinical management there was no 
recommendation for use of dexamethasone in treatment of adults with meningitis 
therefore I have not examined this practice in my research. 
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2.5.4 Follow-up and long-term complications 
The outcome for the individual patient with bacterial meningitis is influenced by many 
factors including age, time before effective antibiotic therapy, aetiology and the 
intensity of the host inflammatory response. This is an area that attracts little 
attention particularly in adult practice. 
Neurological deafness is the commonest complication associated with bacterial 
meningitis but over 30% of individuals will have some form of long-term complication 
including behavioural problems, cognitive impairment, seizures and focal 
neurological deficits (Erickson and De Wals 1998; Erickson, De Wals et al. 2001). 
Therefore, it is recommended that all patients undergo audiological assessment 
before discharge and in convalescence. 
2.5.5 Public health management of CABM and MS 
Clinicians are required to notify all suspected cases of meningitis to the local 
Consultant in Communicable Disease Control (CCDC) for contact tracing and 
provision of prophylaxis (in cases of meningococcal meningitis), within the first 12 
hours of diagnosis. The recommendation is that close contacts of the patient (defined 
as household, kissing, or other close contact) are treated with a prophylactic 
antibiotic, rifampicin, cirprofloxacin or ceftriaxone. The aim of this prophylaxis is to 
reduce the carriage for direct reduction of the risk of the disease to close contacts. All 
index cases of MD should also receive chemoprophylaxis in order to clear the throat 
carriage of N. Meningitidis (Public Health Laboratory Service, Public Health 
Medicine Environmental Group et a/. 2002). This will be described in more detail 
further in this chapter. 
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2.6 Reporting of cases of CABM and MS 
Cases of the suspected or confirmed bacterial meningitis and MS in England and 
Wales are reported through 2 major routine sources: the clinical notifications and the 
laboratory reports. 
All forms of bacterial meningitis examined in this thesis are notifiable diseases under 
the Public Health (Infectious Disease) Regulations 1988. Below I will give a very brief 
introduction to the 2 major routine reporting systems of forms of CABM and MS. 
Table 2.5 presents the main characteristics of routine data sources available in 
England and Wales and used in my research. A detailed description of the routine 
data sources used in my research is presented in the following chapter, 'Data and 
Methods.' 
2.6.1 Clinical notifications 
The Department of Health (DH) guidance on Notification of Infectious Diseases 
states: "Section 11 (1) of the Public Health (Control of Disease) Act 1984 provides 
that if a registered medical practitioner becomes aware, or suspects, that a patient 
whom he is attending is suffering from a notifiable disease or food poisoning, he shall 
forthwith send to the relevant local authority a certificate with details of the case. This 
requirement applies to any registered medical practitioner in England (or Wales). 
Under section 11(4), it is a criminal offence to fail to comply with an obligation 
imposed by section 11 (1). (DH 2006). The available data on notifications of 
infectious diseases (NOlO) include listing for: date of birth; sex; suspected diagnosis 
based on IC010 codes; residential address; reporting clinician. These notifications 
are collected, collated and maintained by the Office for National Statistics (ONS), and 
are available usually with a year time lag. 
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Table 2.5 - Routinely available data sources used in this research 
Relevant 
Data Source Description results chapter 
Population data Usually based on the census of the population in the Chapter 4 
UK. Undertaken once ever ten years . They present 
mid-year population estimates, derived from the 
latest census. 
Clinical notifications All clinicians in E&W have a duty to report cases of a Chapter 4; 
list of infectious diseases. The data includes: Chapter 5 
demographics, address, suspected I confirmed 
causative agent I disease. 
Hospital Episode A minimum data set is kept that includes information Chapter 5 
Statistics on all inpatients and outpatient. Information 
comprises of: demographics, clinical information 
including: ICD 10 codes for diagnosis, treatment, 
ward, consultant's specialty, etc. 
Laboratory data The Centre for Infection of the HPA collects the data Chapter 4; 
on laboratory confirmations (culture, titre, PCR and Chapter 5 
other test) of infectious diseases. Data comes from a 
number of sources, including: NHS/HPA laboratory 
reports, samples sent directly to Cfl from GP 
practices, reference laboratories, etc. 
2.6.2 Laboratory reporting 
Laboratory confirmation of samples tested for certain pathogens' , including the 
bacterial causes of meningitis and MS, across the NHS laboratories in England and 
Wales are reported to a designated part within the Centre for Infections of the Health 
Protection Agency (HPA). 
The reporting is done as part of two systems: 
• Routine lab reports and 
• Enhanced laboratory surveillance - for some of the microorganism 
additional data about cases reported under routine surveillance is 
collected. This information may be sought from the reporter, the case, the 
laboratory or from another surveillance data set. Enhanced surveillance 
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for S.pneumoniae and N. meningitidis for example contains information on 
the age, sex, address, vaccination status; this information is collected 
from various sources and is then collated into one database. 
2.6.3 Surveillance of CABM and MS in England and Wales 
Data on the epidemiology of CABM and MS in England and Wales usually comes 
from the routine surveillance systems. Surveillance is often defined briefly as data for 
action. The full definitions reflect exactly that, eg the WHO definition 
"The process of systematic collection, orderly consolidation and evaluation of 
pertinent data with prompt dissemination of the results to those who need to know, 
particularly those who are in a position to take action." (WHO 1999). 
Surveillance data have been useful in following trends and documenting the effect of 
the new protein-conjugate vaccines against Haemophilus influenzae type b (Hib) and 
Neisseria meningitidis serogroup C (MenC) that were introduced in the 1990s 
(Ramsay, McVernon et al. 2003),(Ramsay, Andrews et al. 2003). 
2.6.3.a The usefulness of routine data 
There are a number of advantages and opportunities in using routinely collected data 
for examining the epidemiology of infectious diseases in general and CABM and MS, 
in particular (Doyle, Glynn et al. 2002). Some of these are: 
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Resource efficiency 
Routine surveillance data is available at low cost to researchers I health 
professionals, providing an opportunity for not only yielding useful results but also 
developing and improving data management and interpretations skills. 
Comprehensiveness and completeness 
Routinely collected data sources, and in particular data on CABM and MS, usually 
contain sufficient information for following trends from the whole population of 
England and Wales (McCormick 1993). As described above these data are collated 
and published nationally, by the ONS, and are therefore readily available for research 
purposes. 
Geographical trends 
Routinely collected data for CABM and MS are based on standard reporting forms, 
enabling, generally, a meaningful comparisons between geographical areas, health 
care services or regional figures (Thacker, Redmond et al. 1986). Provided there are 
no major differences in the definitions of a case, comparison can be made across 
national figures, e.g. between different EU countries, as well. I have examined the 
regional differences in the incidence rates of CABM and MS in England and Wales, 
presented in Chapter 4. 
Time-trends 
Surveillance data have been shown to be useful for trend analysis of the disease 
over time; as discussed above for HiB and Men C, for instance. Also population data 
for England and Wales Is available to make time trend comparisons, as population 
censuses are carried out every 10 year, following similar methodologies and data 
collection formats. I have applied time trends analysis in examinig the epdiemioogy of 
CABM and MS in England and Wales, and these will be presented in Chapter 4. 
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2.6.4 Limitations of routine data sources 
Despite the usefulness of routine data, their shortcomings and limitations are well 
acknowledged (MacLehose, McKee et al. 2002). Common problems with routine data 
are time-lag, lack of completeness of data and lack of representativeness. Probably the 
biggest problem is that only a proportion of the cases that should be reported are 
actually reported. 
It is widely accepted that infectious diseases, including CASM and MS, are commonly 
underreported (Reintjes, Termorshuizen et al. 1999). Population based surveys and 
active surveillance systems, the ideal methods for estimating prevalence and incidence 
of disease, are resource intensive, whereas passive surveillance systems are not. To 
obtain more realistic estimates of prevalence, methods such as capture-recapture 
(Smith, Stuart et al. 1998) have been used effectively for both chronic disease and 
infectious disease epidemiology (Hook and Regal 1995; Faustini, Fano et al. 2000). I 
applied this method, which is described in detail in Chapter 3 (Data and Methods) and 
the results are presented in Chapter 5. 
2.6.5 International surveillance of CABM and MS 
A number of European surveillance networks have been developed between the 
countries of the EU over recent years, including: influenza networks, EuroHIV and 
EuroTS, food and waterborne and vectorborne diseases. 
The ECDC's programme on vaccine-preventable diseases (VPO) was set up in 2006 
and covers vaccination issues in general, including surveillance of invasive bacterial 
infections, which are common causes of CABM,: Haemophilus influenzae type B (HiS), 
Neisseria meningitidis, and Streptococcus pneumoniae (Pierluigi Lopalco 2008). The 
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specific priorities with regard to invasive bacterial diseases, which cause most of the 
CABM and MS, for ECOC are: 
• Harmonising and strengthening surveillance of N. meningitidis, H. influenzae and 
S. pneumoniae in the Member States; 
• Improving laboratory capacities; 
• Standardising laboratory surveillance methodologies in the Member States; 
These efforts not only will improve surveillance and public health capacities in the 
member states but also will make the systems comparable and strengthen our evidence 
for action (Lopalco 2008). 
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2.7 Prevention of CABM and MS 
Prevention of CABM and MS is an important factor in the overall control of the disease. 
There are 2 main forms of public health intervention in prevention, namely prophylaxis 
with antibiotics and vaccination. 
The public health policies and practices on managing cases of CABM and MS vary 
across European countries. The public health management, which normally includes 
prophylaxis and I or vaccination to close contacts, is aimed at 1) reducing the risk of 
transmission of N meningitidis from the index case; or 2) reducing the risk of infection, 
respectively. A European survey revealed differences in definitions of close contacts and 
prophylactic regimens between countries and recommended the development of 
guidance for best practice in priority areas, based on evidence or consensus (Hoek, 
Hanquet et al. 2008). 
2.7.1 Prophylaxis 
In cases of meningococcal meningitis, and to some extent of HiB meningitis, prophylactic 
treatment of close relatives with antibiotics (e.g. rifampicin, ciprofloxacin or ceftriaxone) 
reduces the carriage and may reduce the risk of further cases (Fraser, Gafter-Gvili et al. 
2006). The index case is also treated with a prophylactic antibiotic, usually rifampicin 
before discharge from hospital, or if the treatment course included benzyl penicillin it is 
effective in reducing nasopharyngeal carriage (Fraser, Gafter-Gvili et al. 2005). 
Nonetheless, because only about 2% of meningitis cases are linked to an index case, 
chemo-prophylaxis to close contacts of an index case has probably a limited effect on 
the overall epidemiology of meningitis. 
2.7.2 Vaccination 
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Vaccination is an important and significant preventative measure for CABM and MS. 
Different vaccines are available for the most common causes of CABM, and the most 
commonly used include: vaccines against N. meningitidis (some groups); S. 
pneumoniae; H. influenzae type B; the BCG (against TB). 
2.7.2.a Meningococcal vaccination 
Several meningococcal vaccines are available and in use. Including polysaccharides A, 
C, W135; and the Conjugate C vaccine. 
Several vaccines are available to prevent the disease. Polysaccharide vaccines, which 
have been available for over 30 years, exist against serogroups A, C, Y, W135 in various 
combinations. A monovalent conjugate vaccine against serogroup C has recently been 
licensed in developed countries for use in children and adolescents. This vaccine is 
immunogenic also for children under 2 years of age in contrast to polysaccharide 
vaccines, which are not. All these vaccines have been proven to be safe and effective 
with infrequent and mild side effects. 
The serogroup C caused high number of deaths in young children and teenagers. The 
high mortality, anxiety and public health impact, together with the resulting media 
pressure, are argued to have contributed to the decision to introduce Men C vaccination 
into routine childhood immunisation schedule in 1999. This vaccination programme has 
resulted in more than 90% reduction rate of Men C infections (Ramsay, Andrews et al. 
2001; Ramsay, Andrews et al. 2003) and in April 2008 the news headlines where - "No 
deaths from Men C" (news.bbc.co.ukl2/hi/health/7354722.stm). However, serogroup B 
continues to be a high cause of disease in children in UK. 
With regard to a vaccine for serogroup B there has been some progress, but we still do 
not have an effective vaccine in use. Current N. Meningitidis serogroup B vaccines 
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based on outer-membrane proteins do not provide protection for infants or long-lasting 
immunity in adults. Therefore alternative vaccinations strategies have been explored. 
Below are summarised research attempts to use: 
• mucosal immunisation, rather then humoral immunisation, and 
• immunisation with Neisseria lactamica (a non-pathogenic type of Neisseria 
bacteria), rather then N. meningitidis, for generating effective immunity against 
Men B disease. 
As natural carriage of N. meningitidis and related bacteria leads to the development of 
protective immunity both at the mucosal surface and in the circulation (Horton, Stuart et 
al. 2005), vaccine strategies that mimic this natural immunization process would better-
optimize vaccine-induced protective immunity have been proposed. Thus, mucosal 
immunization before a systemic booster vaccination could provide the solution and 
reduce the necessity for multiple injections to achieve immunity (Heyderman, Davenport 
et al. 2006). 
Other developments in meningococcal vaccine stretch towards research in the use of 
other bacteria within the Neisseria family in generating protection against the pathogenic 
N. meningitidis. Recently, studies have found that immunisation with killed N. lactamica 
whole cells and outer membrane proteins offers protection and cross reactivity with N. 
meningitides. These findings support the idea that successive colonisations with N. 
lactamica (in childhood) enhance the anti-meningococcal immune response (Oliver, 
Reddin et al. 2002; Sanchez, Troncoso et al. 2002), (Troncoso, Sanchez et al. 2002): 
confirming, thus, the idea for the potential of N. lactamica based vaccines, and providing 
evidence for commencing vaccine trials (Gorringe. Halliwell at al. 2005; Davenport. 
Groves et al. 2008). 
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2.7.2.b Hib vaccination 
Hib Conjugate vaccine has been used in Western countries for over 15 years, where it 
has resulted in dramatic decrease of incidence and mortality almost an elimination of HiS 
disease (Rushdy, Ramsay et al. 1999; Ladhani, Slack et al. 2008). Sut is still not widely 
used in the developing world where is most needed (Adegbola, Usen et al. 1999). This is 
despite evidence of its great success in developing countries, such as The Gambia, in 
West Africa, where Hib meningitis and severe pneumonia in young children have 
virtually been eliminated following implementation of routine infant vaccination against 
Hib. In Malawi and Gambia a large decline in HiB incidence since introduction of Hib 
Conjugate vaccine, from around 60 to about 5 in 100,000 per year (Adegbola, Secka et 
al. 2005; Daza, Banda et al. 2006). 
2.7.2.c Pneumococcal vaccine 
A type of Streptococcus pneumoniae vaccine is already in routine use in most of the 
Western countries, and that the conjugate vaccine is now used in children's 
immunisaiton programmes, e.g. in UK-Pneumovar; whilst a polysaccharide vaccine is 
generally used among at risk adults. 
Clinical trials conducted in South Africa and The Gambia has shown that a 9-valent 
vaccine is extremely effective in preventing pneumococcal disease in the less developed 
countries/populations. If used routinely, a pneumococcal conjugate vaccine could 
prevent hundreds of thousands of child deaths each year and contribute to achieving the 
United Nations 'Millennium Development Goal' to decrease childhood deaths by two-
thirds by 2015. The Global Alliance for Vaccines and Immunization (GAVI) works 
towards making these vaccines available for the developing countries. Some if the initial 
effect of the PCV in the population (in countries wehre introduced as a programme) have 
been: shift of the disease towards adults, change of serotypes (ie increase in non-
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vaccine type disease), heard immunity and reduction in anitbiotic resistance strains 
(Hsu, Shutt et al. 2009; Kaye, Malkani et al. 2008). 
2.7.2.d Bacillus Calmette-Guerin vaccine 
The Bacillus Cal mette-Guerin (BCG) vaccine is an attenuated strain of the M. 
tuberculosis that is used to prevent tuberculosis. The vaccine is used in national 
programmes of immunisation in many countries around the world, and where the 
incidence of TB is high. 
In the developed countries, including the UK, where the TB incidence is low, it is usually 
used for vaccination of high-risk groups, such as babies born of parents with origin from 
high risk countries. There has been debate around the effectiveness of the BCG vaccine 
(Murtagh 1980), but a recent meta-analysis provided evidence that vaccination is cost-
effective at preventing tuberculous and miliary meningitis rather then pulmonary, 
particularly so in southeast Asia, Africa, and the western Pacific region, where 
tuberculosis infection rates and BCG coverage are highest (Trunz, Fine et al. 2006) 
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2.8 A summary of the background 
Bacterial meningitis and meningococcal septicaemia are important causes of 
preventable morbidity and mortality in the UK and worldwide. 
Most of the information on the epidemiology, clinical picture and disease outcomes 
comes from studies on paediatric or teenagers population, which have different 
individual characteristics from adult population. Moreover, efforts to improve 
management have mainly concentrated on paediatric care. However mortality amongst 
young adults remains higher than amongst children and recent studies suggests 
deficiencies in health care delivery to adult cases. The introduction of the conjugate 
vaccination programmes has significantly changed the epidemiology of CABM and MS in 
children, and there are data to show a level of herd immunity, which might have affected 
the disease in adults as well. Under-reporting of infectious diseases is well-
acknowledged and determining its level for meningitis would be useful for planning 
control and prevention programmes. 
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Chapter Three 
Data and Methods 
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3.1 Introduction to data and methods 
To address the objectives of my research (see Chapter 1) I have used different 
methodologies and different data. These can broadly be classified as: 
1) Data and methods for the Epidemiological research; and 
2) Data and methods for the Clinical management research. 
Therefore, in this Chapter I will follow this broad classification, to describe the different 
data and methods as follows. 
Firstly, I will describe the case definitions I use, which are common to both aspects of my 
research (epidemiology and clinical management). I will then describe the 
methodological approaches specific to each aspect. Within these 2 broad categories I 
will describe the study design, data, data collection and management. The last part of 
the chapter describes the statistical methods used. 
3.2 Case definition 
Cases included in this research were defined as: any adult (age 16 years or older) with 
CABM and MS diagnosed between 1991 and 2002 in England and Wales. Below I will 
give the details of each main aspects of the case definition, which will apply to both 
incidence and deaths. 
3.2.1 Causative organism 
The following causative organisms were included in the definition of the CABM: 
Neisseria meningitidis (N. meningitidis), Streptococcus pneumoniae (S. pneumoniae), 
Haemophilus influenzae (H. influenzae) , Listeria monocytogenes (L. monocytogenes), 
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Mycobacterium tuberculosis (M. tuberculosis), Group B Streptococcus (GBS) and 
Escherichia coli (E. coli). 
The rationale for including the above listed causative organisms as CABM was based on 
the relevant literature showing the most common community acquired causative 
organisms of bacterial meningitis. This was complemented with advice from experts on 
the subject (K. Cartwright, R. George and J. Stuart) to include causative organisms that, 
based on literature review are likely to be community acquired, and for which there are at 
least 50 reports each during the ten year period (1990 to 2000). 
3.2.2 Time 
Overall the study included cases of CABM and MS in the years 1991 to 2002. Different 
parts of the study used slightly different time boundaries for cases, but all are within the 
period mentioned above. Table 3.1 sets out the time period relevant to each part of the 
research. The death data based on notifications to the ONS were available by different 
causative organisms only from 1993. 
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Table 3.1 - Time period relevant to research objectives. 
Research objective Date period Chapter with results 
Current epidemiology 1 January 1991 to 31 Chapter 4 December 2002 
Incidence: 1 April 1996 to 
Improving estimates of disease 31 December 1999 
measure: capture-recapture Chapter 5 
analysis Mortality: 1 April 1996 to 
31 March 2000 
Review of clinical management 1 January 2001 to 31 Chapter 6 December 2002 
Association of clinical 1 January 2001 to 31 Chapter 7 
management with outcome December 2002 
3.2.3 Place 
Cases included in this research are from England and Wales. Within the examination of 
the epidemiology (Chapter 4) there is a part which examines the trend of the lumbar 
punctures (LP), and uses data from the NHS Administrative Region of the South West 
(SW region), only. The capture-recapture analysis (Chapter 5) uses data from England, 
only. A part of this analysis, the verification of the analysis uses data from the SW 
region, only. 
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3.3 The epidemiological research 
This part of the research addressed two of the main objectives of this thesis, objectives 1 
and 2 (results presented in Chapters 4 and 5). 
3.3.1 Examination of the current epidemiology 
I analysed the available routinely collected data on CABM and MS on adults in England 
and Wales, for the period 1991 - 2002 using appropriate statistical regression methods, 
detailed below. I performed a thorough analysis of the epidemiology of CABM and MS 
with particular focus on the distribution of disease by years and the causative bacteria 
among age-groups, gender. The population data from ONS (mid year estimates) for 
each corresponding year was used to calculate incidence and mortality rates. 
3.3.2 Improving estimates - a capture-recapture analysis 
I undertook a capture-recapture analysis to obtain a better estimate of the 'true' burden 
(incidence and mortality) of CABM, using 2 data sources, than available from single 
sources owing to under-reporting. Pneumococcal meningitis was used as an indicator for 
other causative forms of CABM, as well. The rationale behind this was that: 
• A specific case-definition provides more reliable surveillance data than a loose 
definition, so if all forms of CABM had been included the quality of the data would 
have been lower; 
• Pneumococcal meningitis is one of the two most common forms of CABM 
• Clinically pneumococcal meningitis is one of the distinctly defined forms of CABM 
• A similar study into meningococcal meningitis was being undertaken by others at the 
time. Therefore by using pneumococcal meningitis I was able to make a useful 
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contribution to the literature, and have a valid comparison to the available estimates 
for the disease burden. 
3.4 Data and research methods for the epidemiology research 
Here I describe the data sources used for the all of the epidemiological research, 
including examination of the current epidemiology and the capture-recapture analysis. 
3.4.1 Incidence data 
These were derived from: Laboratory reports (including routine, enhanced or reconciled 
surveillance), HES and ONS. 
a) Health Protection Agency (previously Public Health Laboratory Servlce)2 
Surveillance is described as the ongoing systematic collection, analysis, interpretation, 
and dissemination of data for public health action (Buehler 1998.). In England and Wales 
the surveillance for CABM and MS is based on laboratory reports and clinicians' 
notifications. 
• Laboratory reports 
All samples taken for laboratory investigations upon suspected diagnoses of CABM and 
MS are tested by the local NHS and HPA (formerly PHLS) laboratories. Results from 
these tests are forwarded to the Center for Infection (CfI) (formerly CDSC), in Colindale 
London. For some causative organisms of particular public health relevance, such are 
N.Meningitidis, S.Pneumoniae, HiS, there are enhanced surveillance systems in place, 
and reference laboratory units. The laboratory data that are produced by and managed 
at the Reference Unit laboratories is referred to as Reconciled Laboratory Reports 
(RLR). This usually means that the surveillance is more sensitive (because of enhanced 
2 This organisation as from April 2003 has become part of the Health Protection Agency (HPA). 
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reporting and more advanced testing methods) and contains additional information, as 
compared to the routine laboratory reports. I will briefly describe the laboratory 
surveillance for the most common causative organisms of CABM in England and Wales. 
Neisseria meningitidis 
All requests, from the local clinicians or local laboratories, for laboratory testing of blood 
and CSF samples on meningococcal infections are sent to the Meningococcal Reference 
Unit (MenRU) in Manchester. There testing is performed for culture and polymerase 
chain reaction (PCR) of N.meningitidis and, amongst other services, includes: 
serodiagnosis of meningococcal disease; meningococcal isolate confirmation and 
characterization; molecular characterisation of meningococci. From the MenRU, the 
reports on isolates/PCR are regularly sent to the Cfl There, the data are maintained, 
collated analysed and published as annual reports, until recently in the Communicable 
Disease Report (CDR) and now available on the HPA website 
(http://www.hpa.org.uklwebw/HPAweb&Page&HPAwebAutoListName/Page/120300886 
3952?p=1203008863952). 
Streptococcus pneumoniae 
The local NHS and HPA laboratories will perform the laboratory testing, including culture 
growth, for S. pneumoniae, on either blood or CSF in suspected cases of bacterial 
meningitis requested from clinicians. Further, all submissions for reference laboratory 
testing on S. pneumoniae from the laboratories across England and Wales are sent to 
the Reference Unit for streptococci, part of the Respiratory and Systemic Infection 
Laboratory (RSIL), which is based in the Cfl, London. Similar to the laboratory 
surveillance of N.Meningitidis, the reports on isolates are then collated, analysed and 
reported annually. 
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• HPA reconciled laboratory reports (RLR) on pneumococcal disease: 
Data from laboratory isolates from HPA laboratories, NHS microbiology laboratories, and 
the RSIL in England. The RSIL has actively collected pneumococcal isolates from 
patients with invasive pneumococcal disease since 1996. More details on reporting to 
and recording of laboratory reports is given in the previous Chapter, section 2.6. 
Haemophy/us influenzae type B 
Laboratory surveillance for HiS is done through the routine reporting from the HPA labs 
and the RSIL, as above for S. Pneumoniae. 
Listeria Monocytogenes 
Local NHS I HPA microbiology laboratories report any confirmed cases of listeriosis to 
the national HPA CfI. The Food Safety Microbiology Laboratory (FSML) provides the 
national reference facility for the epidemiological typing and/or toxin testing of L. 
Monocytogenes along with a number of other organisms and other agents associated 
with food borne infection and intoxication. 
Mycobacterium Tuberculosis 
Laboratory surveillance for M. Tuberculosis is done through the HPA Mycobacterium 
Reference Unit. The system and principles of reporting and surveillance there are similar 
to as described for S. Pneumoniae at RSIL. 
Escherichia Coli 
The HPA Laboratory of Enteric Pathogens (LEP) is the national Reference Centre for 
England and Wales for pathogenic enteric bacteria. The LEP receives bacterial isolates, 
and clinical specimens, as faeces and sera, from HPA, National Health Service and 
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other laboratories throughout the UK. The LEP provides reference services for 
Escherichia coli, amongst other entheric pathogens. 
• Enhanced laboratory surveillance data 
Enhanced surveillance data from reconciled reports (routine laboratory and reference 
unit) on pneumococcal meningitis (ESPM) for the period 1996 to 2000 in cases aged 
over 15 years and individual information on causative organism, specimen type, date of 
birth, age, sex, earliest specimen date, reporting laboratory, region, outcome. 
Enhanced surveillance data from reconciled reports (routine laboratory and reference 
unit) to efl of meningococcal disease (ESMD) for the period 1996 to 2001 in cases aged 
over 15 years with individual information on causative organism, specimen type, earliest 
specimen date, age, sex, reporting laboratory, region and outcome. 
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b) Clinical notifications - ONS data 
All clinicians are required by statute to notify the Proper Officer of suspected case of 
bacterial meningitis 3. In most Local Authorities in the UK (Primary Care Trusts, PCTs), 
the proper officer is the local Consultant in Communicable Disease Control (CCDC). Up 
to 1968 all cases of meningitis were notified as one disease. From 1968 meningococcal 
meningitis was introduced as a distinct classification and became required to be notified 
separately. From 1989 meningococcal septicaemia was introduced as a distinct 
classification and became required to be notified separately. 
The Proper Officers, then, are required every week to inform the HPAs CfI of details of 
each case that has been notified; and the data then is collated, analysed and published, 
as local and national trends by the CfI. Following the establishment of the CDSC these 
data started to be reported there, whilst previously these data were reported to the Office 
for National Statistics data (ONS), and still often are referred to as ONS notifications. 
Information on the cause of disease was recorded using the ICD 9 coding system based 
on the diagnosis made by the medical officer in charge of patient (or the coroner in case 
of death). 
The ONS notification (and death registration data, described below in the Mortality data 
section in this chapter) were only available for meningitis caused by H. influenzae, S. 
pneumoniae, and all N. meningltidis. Death registration data were available only from 1 
January 1993 (see above 'Case Definition I Time'). 
I used the ONS reports (clinical notifications) of cases (and deaths) from bacterial 
meningitis and meningococcal septicaemia in those aged over 15 years 1993 - 2002, 
with information on ICD code, date of birth, age, sex, date of death, place of death, 
3 Public Health (Control of Disease) Act 1984. HMSO. 
2. The Public Health (Infectious Diseases) Regulations 
1988. HMSO. 
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Health Authority, NHS trust, Region. Data from this source, through separate 
extractions, were used in analyses in Chapter 4 and Chapter 5. 
c) Hospital Episode Statistics (HES) 
Medical information on all patients treated in or admitted to NHS Hospitals in England. 
Diagnoses are recorded using the International Classification of Diseases 10 (ICD 10) 
coding system based on the clinical diagnosis from the patient case notes, which may 
include local laboratory diagnostic data. An 'episode' is identified as an admission at a 
time under the care of a consultant. If the patient moves under the care of another 
consultant, or is transferred to another hospital unit/department, even though for the 
same condition for which s/he was admitted, then each of these events is entered as a 
separate episode in the HES. 
3.4.1. Mortality data 
These were derived from: HES, ONS, or Laboratory reports . 
• HES 
The reporting system is described above. The death data from HES are used in the 
application of capture-recapture analysis; the method is described further in this 
Chapter, and the results are presented in Chapter 5 . 
• ONS 
The reporting system is described above. The death data from ONS are used for 
estimates of mortality and case-fatality in: i) the review of epidemiology, and ii) in the 
application of capture-recapture analysis; the method is described further in this 
Chapter, and the results are presented in Chapter 4 and Chapter 5, respectively. 
• Laboratory reports 
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The reporting system is described above. The death data from laboratory reports are 
used in estimates of case fatality rates in the review of epidemiology (results in Chapter 
4). though generally the main estimates of the case-fatality rates are obtained from the 
ONS data for deaths, whilst using deaths from lab data to serve as comparison (unless 
otherwise stated). 
a) Population Data 
The population data for England and Wales is available from the census data. I used the 
mid year population estimates. by age, sex, region. 
Data on age were available in 5 year age-group bands, e.g. 15-19; 20-24; 25-29, and so 
on to 85+. To retrieve the data for my study population, i.e. 16 years old and older, I 
divided the 15 to 19 age-group data by 5 and then multiplied this figure by 4 to get the 
population for the age-group 16 to 19. This assumes that the population in the age-group 
15 to 19 is uniformly distributed. I deemed this to be a reasonable assumption. 
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c) Original data 
Examining trends of lumbar punctures (LP) performed 
In order to examine the extent of reliability of the data-sources, in particular the 
laboratory testing of the CSFs for CABM, I conducted a survey of the microbiology 
laboratories in the South West region. The objective of the survey was to collect the 
annual numbers of CSF specimens received by the laboratories for testing between 
1991 and 2000 for 0 to 15 year olds and for those aged over 15 years and to compare 
this with the laboratory reports nationally. This was aimed as a validation exercise for the 
number of CSFs tested, to be compared against the national reports from the Laboratory 
surveillance on the CSFs. I wanted to compare the trends of the reports from the 
national surveillance for the SW region with the data collected from this survey. This was 
a postal I email survey and I followed up the returns I non-returns with telephone calls, 
as appropriate. This was part of the research done for Chapter 4. 
Validation of data sources 
To validate the diagnosis and matching in the data extracts, I sent the relevant data 
extracts, line listings of HPA RLR and HES, to the consultant microbiologists in 17 
laboratories providing clinical microbiology services to all acute hospital trusts in the 
South West Region of England. I asked them to verify the correctness of diagnosis and 
matching according to their own laboratory records. They also obtained details from their 
local NHS Trust of hospital episode diagnoses of pneumococcal meningitis for cross 
checking against HPA RLR and HES records. This was done as part of the research for 
Chapter 5. 
96 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
3.4.2 Data collection and management 
3.4.2.1 Extraction of data 
Laboratory reports 
Laboratory confirmed cases were identified from the HPA laboratory reports database 
for England and Wales. Methods of confirmation included microscopy, culture, DNA or 
antigen detection from cerebro-spinal fluid (CSF) for meningitis, and culture or DNA 
detection from blood for septicaemia). 
I requested and used the data on laboratory reports for cases of all forms of CABM (as 
specified above, 'Case definition / causative organism'). This specified the request for 
"laboratory reports from England and Wales on all specified forms of bacterial meningitis 
(CSF PCR andlor culture positive, all causes) and Neisseria meningitidis (blood PCR 
and/or culture positive) with dates of specimen between 1st January 1991 and 31 st 
December 2002 for ages 16+. The data listed also specimen type, organism 
serotype/group, agelDOB, sex, laboratory, region and outcome." 
ONS data 
I requested the data on clinical notifications and deaths from England and Wales on 
CABM and MS classified by the ICD 9 codes as 320.0, 320.1 and 036 and any digit after 
with date of reporting between 1't January 1991 and 31 st December 2002 for ages 16+. 
Data was listed for causative bacteria (serotype/group), age/DOB, sex, laboratory, 
region, outcome (died or not). Data was provided by the Information Officers at the Cfl 
as an Excel spreadsheet. 
All adults in England 16 years and older with a diagnosis of pneumococcal meningitis 
were identified in HES and HPA RLR for England for the incidence analysis, and HES 
and ONS for England for the mortality analysis. HPA RLR data for the year 2000 were 
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not available at the time of the study and the HES data were recorded as financial years 
1996 -1999. Therefore the incidence analysis was restricted to the period between April 
1996 to December 1999. The mortality analysis was conducted using records from April 
1996 to March 2000. For the case-fatality rate estimates, the mortality analysis was 
restricted to December 1999, to be comparable with the incidence analysis. 
Cases were extracted from the PHLS RLR data where S. pneumoniae was isolated from 
CSF or when the clinical diagnosis recorded was pneumococcal meningitis. 
Cases from HES were extracted when ICD 10: G001 was recorded in the main 
diagnostic field. 
Cases were extracted from the ONS data were pneumococcal meningitis (ICD 9: 3021) 
was the primary cause of death. 
HES data 
HES data were available from the Department of Social Medicine, University of Bristol. I 
requested "All episodes with A170. A39(A39.0 toA39.9). GOO(GOO.O to GOO.9) in main 
diagnosis field for HES years 1996 to 2000. for adults aged 16 years and older. with 
information on HES year. NHS Region. Ward. Sex. Age. Date of birth. diagnosis code 
(ICD10) • date of start of episode. date of discharge. Trust name. All data was provided 
as encrypted Excel spreadsheet. 
I used the HES data for the period 1996 to 2000 in cases aged over 16 years and 
individual information on causative organism. primary diagnosis (ICD 10). date of birth. 
age. sex, date of admission, date of episode start, episode end. discharge date. 
reporting NHS Trust, Health Authority. Region, date of start of episode (proxy for date of 
onset of disease), outcome. The HES data are used in Chapter 5. 
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3.4.2.2 Identification of Duplicates 
laboratory reports 
The laboratory reports, including the RLR for pneumococcal meningitis may contain 
duplicates owing to multiple sampling for diagnosis. 2 or more PHLS RLR records were 
considered to be duplicates if they had same 'Date of Birth' and 'Sex', same 'Laboratory' 
and the laboratory specimen (CSF, blood, etc) had been collected within 3 months of 
each other. The earliest specimen was retained in further analysis. 
HES 
As mentioned above the HES contains data that often consists of many episodes of 
treatment of a patient for the same condition during the same admission at hospital. It is 
therefore clear that in order to use this data for estimating the incidence of a condition, in 
this case pneumococcal meningitis, much of the entries in the data-set would actually be 
multiple entries of the same incident case. 
Duplicates were identified as follows: 2 or more HES records that had the same 'Date of 
birth' and same 'Sex', and that were within 3 months of each other. 'Hospital NHS 
Trusts' were considered as a unique place identifier. However infectious diseases can 
reoccur (i.e. the same infection occurring at multiple episodes), though recurrent 
meningitis is not common. Therefore clear definitions of duplicate cases needed to be 
decided a priori when using these data. Records with different place identifiers but with 
the same 'Date of birth', same 'Sex' and within 3 months of each other were considered 
duplicates where a referral pattern between NHS Trusts (i.e. in the same or adjacent 
regions) could be identified. The record with the earliest 'Date of start of episode' was 
retained from each duplicate set for analYSis. 
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For reports with same 'Date of birth', 'Sex', 'Date of start of episode' within 3 months but 
for whom there was no clear referral pattern I did two sets of analyses, as follows: 
i) The main analysis, in which I included these reports as separate cases -
these results are presented as the primary analysis (Chapter 5) 
ii) A sensitivity analysis, using more stringent criteria, in which I entered these 
reports as just one case, retaining the report with the earliest date of hospital 
admission in the analysis. 
ONS 
The ONS data had the least amount of duplicates. These may occur due to reporting by 
different sources, or as artefact, e.g. errors in data reporting or entry. Two or more ONS 
records were considered to be duplicates if they had same 'Date of Birth', 'Sex', 'Date of 
Death' and 'Place of Death'. 
3.4.2.3 Exclusions 
Causative organisms 
Meningitis caused by other bacteria that are more rare and are probably hospital 
acquired infections, such as forms of Staphilocuccus, Gram Neg bacilli / Enterococci, are 
not included. 
From the ONS data I excluded ICD 9 320.8 and 320.9 (meningitis due to other specified 
bacteria and meningitis due to unspecified bacteria, respectively), as it is more likely that 
these would be hospital acquired rather than community acquired infections. These data 
were also available from the data officers at the COSC, Colindale. 
3.4.3 Data Confidentiality 
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All the data sets that contained identifiable information were provided and saved as 
encrypted or password protected files. 
Ethical approval was not required for this part opf the study as the data were supplied 
under strict procedures of ensuring confidentiality, specifying the protection of the data 
and the purpose for the use of the data. The person identifiers were restricted to date of 
birth, sex and the unique identifier (HES , laboratory data). 
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3.5 The clinical management research 
This part of the research addressed 2 of the main objectives of this thesis, objectives 3 
and 4, and these methods relate to the results presented in Chapter 6 and Chapter 7. 
The 2 parts of this section are the review of clinical notes clinical management and the 
examination of the association of clinical practice with the outcome of CABM and MS. 
The latter uses largely epidemiological methods of measuring associations. However, as 
the data used and the aim for this objective, both result from the review of clinical notes 
study, it seemed appropriate to follow a common structure. 
Data and research methods for the review of clinical management 
3.5.1 Ethical Approval 
The study was approved by the South West Multi-Centre Research Ethics Committee, 
reference MREC/01/6/70. 
3.5.2 Study design 
A retrospective review of clinical records of patients with CABM and MS in randomly 
selected hospitals in England and Wales. 
Sampling frame: All acute NHS trusts in England and Wales. 
3.5.3 Stages of the research 
This part of the research was undertaken in three stages: 
i) the pilot study 
ii) the main national clinical records review 
iii) the examination of association of management with outcome 
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3.5.4 The pilot study 
I undertook a pilot study with the aim of testing the reliability and validity of the case-
report form used for data collection in the main study. The pilot study was aimed, also, 
to test the feasibility of conducting the national review. The results and the experience 
from the pilot study were fed into the design of the main study. Results of the pilot study 
and how these informed the main study are shown in Chapter 6. 
Pilot study· sample and data 
The Hospital Trusts in the pilot study were enrolled as a convenience sample. The 
sample aimed to cover a range of geographical and clinical variation, including the 
following criteria: 
• To include hospital trusts from at least two NHS administrative English regions; 
• To include at least one NHS teaching hospital trusts; 
• To include at least one big hospital, i.e. >= 600 hospital beds. 
Case notes of all the cases identified in the enrolled hospitals were reviewed. 
3.5.5 The main - national study 
3.5.5.1 Sample and data 
The first stage in the study was enrolment of hospitals, and then enrolment of cases 
within these hospitals (these cases constituted the study unit). 
Enrolment of hospitals 
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There were a total of 188 Acute NHS Trusts across E&W of which 126 were general 
hospitals and 62 were specialty hospitals. Only the 126 general hospitals were eligible 
for inclusion. 
Step 1: The sample was stratified by the 9 health regions of England and Wales. The 
primary sampling unit was the NHS healthcare trust and two trusts were randomly 
selected within each region. 
Step 2: Hospital trusts usually consist of several different hospitals. Of all hospital trusts 
enrolled in the study, I selected the acute general hospital of the Trust for inclusion in the 
study since this would be where the patients with CABM and MS in adults would largely 
be treated. 
Step 3: If there was more than one acute general hospital within a trust, one hospital 
was randomly selected. 
Step 4: After the random selection a letter was sent to both, if different, the Medical 
Director for the Trust and to the Caldicott Guardian for the trust. The letter explained the 
purpose of the study and asked if they would be prepared to participate. 
Enrolment of cases 
• Retrieving the case-notes 
After approval was obtained from the Medical Director I Caldicott Guardian, I contacted 
the Medical Records Managers to agree the dates for the site visit to review the case 
notes. I instructed the Medical Records Managers on the case definition (including the 
ICD10 codes and time period) for which they were to identify and retrieve the case-notes 
and make them available for my visit. A copy of the check-list for the process of 
enrolment, of both, hospitals and cases is shown in Appendix 4 (Trust sampled check 
list). 
104 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
• Case definition 
The case definition for the overall research is given earlier in this Chapter, section 3.2. 
However, there are some specific aspects for this part of the research. The inclusion of 
the cases was dependent on the final clinical diagnosis, with or without laboratory 
confirmation and on the study period for this part of the research covered slightly 
different years to those used for the epidemiology study (see Table 3.1). The cases 
included were: 
or 
Confirmed: meningitis septicaemia AND at least 1 of the following: i) Isolation of N. 
meningitidis or other bacteria from blood, CSF or skin rash; ii) bacteria seen in CSF, 
iii) N. meningitidis DNA in blood, CSF or rash; iv) N. meningitidis specific antigen in 
blood, CSF or urine. 
Probable: meningitis, septicaemia in the absence of laboratory confirmation where 
bacterial meningitis and/or meningococcal septicaemia is thought to be the most 
likely diagnosis by the clinician managing the case and/or CCDC. 
Cases were identified by discharge diagnoses with ICD 10 codes. Diagnoses reviewed 
included any of the following ICD-10: A39 (all. meningococcal infection), GOO (all 
bacterial meningitis). 
All cases admitted to the hospital between 18t January 2000 to 31 st December 2001 
were included. 
• Plan for enrolling cases within the Hospital 
Following the arrangement with the medical records manager I visited the Hospital Trust 
and reviewed the medical notes using the standard case-form on-site, following these 
steps: 
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• Retrieve all cases (corresponding ICD codes) between January 2000 to 
December 2001 
• If more than 16 cases available then randomly select 16 of them. The sample 
size will be discussed below, in section 3.6.11 
Exclusion criteria 
The exclusion criteria for cases were: 
• if transferred from another hospital 
• if died before admission 
• if onset of illness was 2 weeks or more after hospital admission 
• any past neurosurgery 
• immunocompromised individuals (HIV, chemotherapy, organ transplantation, 
chronic high doses of steroid therapy). 
For the assessment of association of clinical practice with the outcome an additional 
exclusion criteria was cases that died within 6 hours of arrival at hospital. 
3.5.6 Data collection 
I collected the data using a standardised case-report form (questionnaire) developed for 
this study. The questionnaire was approved by the Expert Panel. 
3.5.6.1 The case-report form (see Appendix 5) 
The questionnaire was designed to incorporate all main areas of clinical management of 
CABM and MS cases including: 
• Personal identifiers and demographic data 
• Prehosptial management 
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• Admission to hospital 
• First assessment 
• Further diagnostic and treatment procedures 
• Measures of disease severity such as Glasgow coma score (GCS), blood 
pressure, white blood count 
• Specialist Vs non-specialist care 
• Chronic cardiac, pulmonary, liver and renal disease 
• Outcome (death, long-term sequelae) 
The case-form was designed to record the times of the management procedures and 
allow for calculation of times between arrival! admission to management, length of stay, 
etc. 
The questions on the above items included information on whether the indicators and 
procedures were performed (Y IN! NK ) and the date & time; the outcome I result, as 
appropriate. 
For conSistency and reliability of data recording, I categorised and coded some of the 
text answers, such as the types of the antibiotics administered (e.g. Benzyl penicillin = 1, 
... , vancomycin = 8, other =9), the grade of the clinician (JHO = 1, ... , Consultant = 4), 
the type of the sequelae (deafness =1, ... , amputation of limb = 7), etc. 
Data on the size of the hospital and population coverage 
I also developed a brief form to collect data on the size of the hospitals and the NHS 
Trust, the population coverage, and whether the hospital was a teaching hospital. These 
data were then merged with the data collected on clinical management for the 
respective hospitals I trusts and used in analysis for examination of clinical 
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management, e.g. classification of hospitals as big or not. The definition used was: a 
trust is considered to be large if it has more then 600 beds. 
3.5.7 Data management 
The data were entered by a data entry clerk based at the CfI, Colindale, London. The 
data were double entered to check for consistency and identify errors in the entry. 
provided support, as needed, for the data entry. 
Data was entered into a Stata v 6 data-base. 
As the research fellow for the study I had the responsibility of data management, 
including maintenance, editing, clearing, standardising; with the approval of the Lead 
Investigator. Specific issues of data management were: 
• In some cases a specific diagnosis was missing, and a general diagnosis of 
meningococcal disease (MO) was given. In these cases, for the purpose of the 
study (e.g. the definition of severity) I assigned a classification of the case as 
primarily meningitis or septicaemia based on the clinical picture. The features 
that I used to define the classification as either primarily meningitis or 
septicaemia were based on: the CSF results (indicative of meningitis), 
presence of rash (indicative of septicaemia), causative organisms (if other than 
N. Meningitidis would be meningitis). For classification of these cases I 
consulted with my external supervisors, Prof R. Heyderman and Prof J. Stuart. 
• The laboratory result values were recorded in different measurement units at 
different hospitals. I standardised these units to the recommended standard 
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units for the laboratory results (e.g. the blood glucose or urea levels where 
recorded either as mg/dl or mmolll , and I standardised them all to mmolll 4) 
3.5.8 Ensuring confidentiality 
Each hospital trust, hospital and patient was given a code (an encrypted unique 
identifier) to maintain anonymity but to enable record linkage. I, the research fellow, was 
the only one to be able to identify the coded subjects, though for the cases I made no 
record of their names. 
3.5.9 Assessment of standards of practice 
I formulated the standards of clinical practice based on the British Infection Society (BIS) 
guidelines (8egg, Cartwright et al. 1999) , with the support of the study investigators and 
finally with the approval of the expert panel. Standards included all relevant aspects of 
disease management process such as: first assessment, management in the first hour 
through to fOllow-up, disease severity assessment and recording of clinical data. The 
standards provide an analysis framework for the study (Figure 3.2) and the results are 
compared against these recommended standards. 
4 httj2:/len.wildpedja.or&!wikilGlucose meter 
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Figure 3.2 • Clinical management of CABM and MS 
._- _. 
Pre.Hospltal Treatment 
Primary Care benzylpenlclHln~ere diagnosis suspected First assessment 
----------------------'"~:~:"'-.:,,-,,:::~~;::.-.,~:.'''':~'"'--------------------]:---
Secondary Care: 
Emergency Department 
Medical Admissions Unit 
Hospital Ward 
First Hour 
1 
First 12 hours 
t 
110 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
Assessment of disease severity 
I assessed disease severity using parameters associated with an adverse outcome 
(Riordan, Marzouk et al. 2002), and likely to be recorded in the case-notes (based on the 
pilot study). Due to insufficient data recorded in the case-notes I was not able to 
determine severity scores such as the Glasgow Meningococcal Septicaemia Prognostic 
Score (Riordan, Marzouk et al. 2002). 
Definition of a severely ill patient 
The two clinical presentations, i.e. meningitis and septicaemia, have distinct clinical 
aspects. Therefore, I developed separate definitions for each. 
A case of meningitis was considered severely ill if on admission either of the following 
indicators were present: a marked depressed conscious level (GCS <10); focal seizures; 
papilloedema; bradycardia «60/min) AND hypertension (>140 mm Hg); or absence of 
neck stiffness accompanied by a WCC <1 x 109L and a platelet count <100 x 109L 
(definitions available in the Appendix .3 ). 
A case of meningococcal septicaemia was considered severely ill if either the 
admission systolic blood pressure was <90mmHg or Glasgow Coma Score was <10; or 
if three or more of the following were present - absence of neck stiffness, WCC <1 x 
109L, platelets <100 x 109/L or HC03 :5 15 mmol/L. 
I also noted the extent to which severity had been assessed according to the clinical 
records, dividing this as fully or partially assessed as follows: 
A case of meningitis cases was considered to have been assessed partially if an 
examination of pulse, blood pressure, conscious level (GCS) and focal signs was 
performed; and if in addition to the above the respiratory rate and papilloedema were 
also examined than this was considered as full assessment. 
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A case of septicaemia was considered to have been partially assessed if an examination 
of pulse, blood pressure, conscious level (GCS) was performed. If in addition to the 
above an examination of respiratory rate and peripheral perfusion (or signs of cyanosis) 
were also performed the case was considered fully assessed. 
Assessment of outcome 
I used the following endpoints to assess the clinical outcome of a case: death, length of 
hospital stay, and long-term sequelae (deafness, neurological deficit, major skin grafting 
or amputation). 
Assessment of data quality 
I determined the quality of data recording in the clinical notes, classifying as: 'good' if 
more than 75% of essential information (as specified in the Appendix .3) was recorded; 
'medium' if 50% to 75% was recorded; and 'poor' if less than 50% was recorded. 
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3.5.10 The examination of association of clinical management with outcome 
This part of the research was conducted following the review of the clinical management 
with the aim of examining whether aspects of clinical management were associated with 
the clinical outcomes. 
3.5.10.1 Definition of Outcome 
Length of stay: A 'long Hospital stay' was defined as over 16 days. This outcome was 
dropped from analysis as found to be strongly correlated with 'Long-term sequalae' and 
the latter was preferred as more robust. 
Good outcome: recovery; no long-term sequelae 
Adverse (bad) outcome: defined as either death or long term sequelae. 
3.5.10.2 Varlablesl Confounders to control 
The following variables are considered as confounders to the clinical management 
indicators in relation to outcome of the disease: 
a. Age 
b. Causative organism 
c. Underlying medical conditions 
d. Severity of illness signsl symptoms: 
• To identify predictive factors (clinical parameters associated with outcome) 
perform univariate analysis for all 'explanatory variables' (signs, symptoms, 
laboratory parameters) in data-set, report and control for those that are 
significant (95% CI). 
• Predictive factors were identified from the univariate analysis). 
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3.5.10.3 Measuring the association 
This examined the clinical management factors associated with outcome. I performed 
univariate analysis using logistic regression of the following variables with adverse 
outcome: 
a. First assessment within 1 hr of arrival 
b. Antibiotics administered at first assessment 
c. Diagnosis at first assessment 
d. Consultant assessment with 12 hours of arrival 
During the analysis for measuring these associations it became apparent that the 
missing data (Le. data not available on clinical management indicators performed, in 
particular their timings) renders this part of the research uninformative as it was planned. 
Methods that I used to deal with the missing data are presented below in section 
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3.6 Statistical analysis 
3.6.1 Calculation of rates 
Incidence and mortality: Both incidence and mortality were calculated as number of 
events per 100,000 relevant population using mid-year population estimates for each 
corresponding year of the study (ONS: population Estimates Unit). The analysis was 
stratified by age, or age-group and year as appropriate. Incidence of the disease is 
relatively low and the immunity after infection is not long lasting. Therefore the number of 
prevalent cases was not deducted from the population at risk, but overall population was 
used. Calculations were performed using either Excel for Windows or Stata, as 
appropriate. 
Case fatality: The case fatality rate was calculated as the ratio of number of deaths per 
relevant cases. 
For the review of the epidemiology (results presented in Chapter 4), the case fatality 
rate is generally calculated using laboratory reports as source for cases and ONS as 
sources for deaths (see above 'Data sources), unless otherwise specified. 
For the capture-recapture analysis (results presented in Chapter 5,), it is calculated 
using cases and deaths from the estimated numbers yielded from the capture-recapture 
for each data sources. 
For the review of clinical records the case fatality rate was calculated using cases and 
deaths from the cohort of hospital cases included in the study. 
Calculations were generally performed in Excel. 
3.6.3 Poisson regression models 
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I used Poisson regression to examine changes in the incidence rate over time and also to study 
differences in rates by age-groups, gender and region. The Poisson regression formula can be 
written as: 
Y - Poisson(R) (3 .1 ) 
Log(R) = betaO+beta1.X1 +log(N) 
Where Y is the number of events in a population of size N units, R is the rate ; 13 is the baseline, 
o 
i.e. the log of the rate in unexposed ; 13
1 
is the log rate ratio associated with exposu re; and X
1 
is 
the exposure. This can be simplified to: 
Log (Rate) = Baseline + Exposure log rate ratio (3.2) 
This model(Kirkwood and Sterne 2003) assumes that, given the exposure variables, events 
arise in a Poisson process over time, and hence that numbers of events in successive time 
intervals are independent. 
3.6.4 The likelihood ratio test (LRT) 
I used the LRT to choose between 2 nested models, i.e. to compare 2 models to see if one of 
them fits a particular dataset significantly better, and in particular to test for any statistical 
interactions (McCullagh and Neider 1983; Shoukri and Pause 1999). 
The LRT is only valid if used to compare models that differ only by the addition of one or more 
variables (i.e. nested). The LRT is based on the likelihood ratio statistics, namely: 
LR = 2*(logL 1-logL2) 
(3.3) 
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Where Li is the maximised likelihood for model i, and model 1 is nested in model 2, that is, 
extends model 2. Under the null hypothesis that the additional parameters in model 1 are zero, 
this statistic follows approximately a chi-square distribution, with degrees of freedom equal to 
the number of additional parameters in model 1 (McCullagh and Neider 1983; Shoukri and 
Pause 1999) 
I have presented the results for, and used in subsequent analyses, the better fitting models 
where the evidence from LRT suggests a better fit for the data. 
I also used the LRT to test for the presence of s~atistical interactions when examining the recent 
epidemiology of CABM and MS (results presented in Chapter 4). For example when examining 
the changes over time I used the LRT to measure the interaction with age. Similarly, for 
interactions between age and causative organisms. 
3.6.5 Adjusting for over-dispersion 
Over-dispersion is common when using Poisson regression models in analysis of population 
based surveillance data (Collett 1999). Over-dispersion occurs when the variance is greater 
than the mean of the Poisson model. A consequence of this is that the p-values will be too small 
and confidence intervals too narrow (McCullagh and Neider 1983). 
I initially checked for over-dispersion using Pearson's Chi-squared statistic and residual degrees 
of freedom in the Poisson model. These did not indicate a large degree of over-dispersion (i.e. 
they did not differ substantially), nonetheless, I also considered the following models to account 
for over-dispersed data. 
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3.6.5.1 Negative binomial regression models 
I applied negative binomial regression (NBReg). The NBReg combines the Poisson distribution 
for the outcome within clusters (as surveillance data on CABM and MS might contain clusters) 
and the gamma distribution of the random variation between cluster means (McCullagh and 
Neider 1983; Kirkwood and Sterne 2003). I used Stata ™ version 7 software to fit these models. I 
then compared these analyses with the results from Poisson regression models . 
The 95% Cis around the estimates retrieved from the two models, i.e . Poisson and NBReg, 
varied very slightly, in that NBReg resulted in slightly wider Cis. 
I also familiarised myself with and considered in some analyses some other methods to control 
for possible over-dispersion, including: 
• 
Zero-inflated Poisson regression 
• 
Zero-inflated negative binomial regression 
These models are useful if we suspect that zero counts are in some way special, eg reporting 
inertia, that is when low counts tend to be reported as null. 
3.6.6 Logistic regression models 
Logistic regression models are used for binary outcome data . The logistic regression model 
defines the probability of the binary outcome Y, P(y=1), in terms of exposure variables x, as : 
P(y = 1) = exp(pO + Pix) 
1 + exp(pO + PI x) 
(3.4) 
I used logistic regression models to predict the binary category of outcome for individual cases. 
For example I employed logistic regression models in examining the association of clinical 
predictors with the outcome and the effect of clinical management indicators in the outcome 
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over and above clinical predictors (Le. evidence of association of clinical management indicators 
adjusted for confounding by clinical predictors). 
Examining the association of clinical predictors I used a backward stepwise regression, i.e. by 
beginning the analysis with a full model (all clinical predictor variables) and eliminating variables 
from the model in an iterative process, Le. those not statistically significant dropping from the 
model in a step-wise sequence. 
3.6.7 Multilevel modelling 
In the analysis of the review of hospital management one issue which I considered addressing 
was allowing for multilevel analysis (H. Goldstein. 1995). This was because the data structure is 
complex, with cases clustered (nested) within hospitals that are stratified by region. This gives 
rise to a hierarchical data structure. In addition, some management policies apply at the hospital 
level. 
I compared the standards errors (s.e.) from the multilevel modelling with the s.e. from logistic 
regression models allowing for hospital cluster (svyset command in Statal. However, in general, 
the s.e. between the 2 models did not very greatly, hence I preferred to continue using the latter, 
especially since data are sparse: 18 trusts, 207 cases Le. about 12 cases per trust. 
So generally, in the analysis I employed the clustering technique in logistic regression models, 
which allows for the specification of multiple strata and primary sampling unit identifiers, in this 
case the hospital trusts (Carolina population centre 2009). 
3.6.8 Test for trend analysis 
Generaly I used the Poisson and Logistic regression models to test for trends, e.g. age, year, 
the results of anlaysis presentedi n Chapter 4. In a few instances, I used the Chi-squared tests 
for measuring trends over time and age; e.g. capture recapture analysis, Chapter 5. 
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I used either the Epi Info 2002 software, or Stata, as appropriate for test for trend analysis. 
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3.6.9 Capture-recapture analysis 
The capture-recapture method quantifies the degree of overlap between two or more sources to 
estimate the number of unobserved subjects by any source examined. The method consists of 
matching the records between two or more sources to determine the 'best estimated number' of 
cases / deaths in the population. I shall only use the method for 2 data sources (see Figure 5.1) . 
The number of unreported cases and the total number of cases in the population, for both 
incidence and mortality is estimated according to the following expression , and the actual 
estimateor is derived from Petersen (Hook and Regal 1995), 
A (ac) NA I A X= b; =a+ )+c+x (3.5) 
where a-number of cases reported to source A only, b-is number of matched cases, and c-
number of cases reported to source B only, x is number of unreported cases by any source and 
N is estimated total number of cases in the population . 
For each source, i.e. RSIL, HES, ONS, the sensitivity of the reporting systems was calculated 
as the number of cases/ deaths of pneumococcal meningitis reported to one source over the 
total number of cases estimated from the capture-recapture analysis. 
3.6.10 Matching of cases between the data sources 
HES and PHLS reconciled laboratory reports on pneumococcal disease (RLR) data for England 
were compared for the incidence analysis; and HES and ONS data for England were compared 
for the mortality analysis. HES data were available only for hospitals in England , this prevented 
an analysis based on a larger UK data set (see above , section 3.4.1). 
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For incidence estimates data from the ESPD and HES were matched to estimate the 'real 
number' of cases in the population and estimate the sensitivity of each system for incidence. 
Data sources were matched on date of birth, sex and date of first specimen with date of episode 
start (+1-30 days), further matched on reporting region. For mortality estimations data from HES 
and ONS were matched on date of birth, sex, and date of death, and further matching on 
reporting Health Authority. 
3.6.11 Underlying assumptions for capture-recapture method 
The underlying assumptions to be met for the capture-recapture method applied to two data 
sources to be valid are as follows (Faustini, Fano et al. 2000) : 
b. Independence of sources: the probability of notification of one event of pneumococcal 
meningitis in one data source is not dependent on its probability of notification in the 
other data source. 
c. Equal catchability: for each data source, all the subjects in the population have the 
same likelihood to be captured by that source. This means that the probability of 
notification of a case is not influenced by its characteristics (age, gender, circumstances 
of diagnosis) in each source. 
d. The population is closed, or at least changes in population are not large over the study 
period. 
e. Cases in each data source are true cases (Le. the specificity of each surveillance 
system is high) and the matching method should identify true and only true matches 
between the 2 sources. 
The validity of these assumptions, in our present application, will be discussed in Chapter 5. 
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3.6.10.1 Sensitivity analysis 
In order to test the validity and reliability of the method used, I performed a series of sensitivity 
analyses. 
I carried out the first sensitivity analysis using more or less stringent criteria for identification of 
duplicates, matching on the records using age and region instead of 'Date of birth' and 'Hospital 
NHS Trusts' as identifiers. 
I also performed analysis based on all diagnostic fields, as opposed to the first diagnostic field 
for identifying the cases. The inclusion criteria for HES was all cases where pneumococcal 
meningitiS (ICD 10: G001) was recorded in any of the diagnostic fields in the HES data-base, 
and not just the main dg field. The rest of the criteria, including the selection of duplicates 
remained the same as for the main analysis. 
3.6.11 Sample size calculations for the review of clinical management 
The sample size calculations have been done separately for two main outcomes partly based 
on the pilot study (48 cases in total): 
I. the proportion of cases with a suspected diagnosis at first assessment (within 6 hours of 
arrival); and 
II. the proportion of with a suspected diagnosis at admission who are given parenteral 
antibiotics within 1 hour of admission. 
For outcome I, 75% of cases had known outcome (37 out of 48) 
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Table 3.2 - Review of clinical management - outcome I: proportion of cases with a suspected 
diagnosis at first assessment 
Differential diagnosisS6hrs 
NHS Trust No Yes Total Proportion 
Jd1h 0 3 3 1.00 
Jb1f 4 7 11 0.64 
Jc1g 4 6 10 0.60 
Ja1e 4 9 13 0.69 
Total 12 25 37 0.68 
An estimate of the variance of the proportion between trusts can be taken from the variation 
between the 3 trusts: Jb1f, Jc1g, Ja1e (as the first trust had unusually small number of cases) 
(sd=0.045). 
An estimate of the overall proportion was taken as the average of the 3 trusts: Jb1 f, Jc1g, Ja1 e 
(mean=0.643). 
Assuming these results, from the full study of n trusts , the 95% confidence interval for the 
overall proportion can be estimated as: 
(3.9) 
then the 95% CI of the proportion of cases: 
If n=18 trusts: 0.64 [0.62, 0.67) If n=27 trusts: 0.64 [0.63, 0.66] 
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If I apply a sensitive analysis of an underestimation of the standard deviation between trusts by 
50%, so that the true standard deviation is 0.09, then if n=18 trusts then the 95% CI of the 
proportion of cases: 0.64 [0 .60, 0.69] 
For outcome II , incompleteness is partly due to incompleteness in outcome 1: 
Table 3.3 - Review of clinical management - outcome II : proportion of with a suspected 
diagnosis at admission who are given parenteral antibiotics within 1 hour of admission. 
Parenteral If suspected 
antibioticsS1 hr diagnosis=Yes . 
NHS Trust No Yes Total Proportion 
Jd1h 1 2 3 0.67 
Jb1f 0 6 6 1.00 
Jc1g 1 3 4 0.75 
Ja1e 2 5 7 0.71 
Total 4 16 20 0.79 
An estimate of the variance of the proportion between trusts can be taken from the variation 
between the 4 trusts (sd=0.149). 
An estimate of the overall proportion can be taken as the average of the 4 trusts: (mean=0.78). 
Assuming these results, from the full study of n trusts, the 95% confidence interval for the 
overall proportion was estimated as: 
(3.10) 
then the 95% CI of the proportion of cases: 
If n=18 trusts 0.78 [0.71 , 0.86] If n=27 trusts: 0.78 [0.72, 0.84] 
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If for some reason there's been and underestimated standard deviation between trusts by 50%, 
so that the true standard deviation is 0.09, then if n=18 trusts then the 95% CI of the proportion 
of cases: 0.78 [0.63, 0.93]. 
As the primary aim of this study was to review the extent to which the BIS guidelines are met, a 
surrogate for the sample size was to accurratley estimate the proportion of cases with a quick 
(in 1 hour) diagnosis and treatment , hence a sample of 18 trusts was a sufficient sample. I 
should note that at this stage of study desing I had not developed the idea for investigating 
factors that might influence the outcome of the disease (CABM and MS in adults). 
3.6.12 Measurement of clinical management 
I measured clinical practice against the study standards, adjusted to allow for: 
o stratification by region; 
o the clustering of the sample within hospitals; 
o within hospital correlation. 
I included a weighting for the total number of cases reported in England and Wales in 2000; and 
the results in comparison of unweighted and weighted analysis are presented in Chapter 6, 
Table 6.6. As the distribution of the sample was close to the distribution of the national data 
(presented in Chapter 6, Figure 6.1), there was little difference between the weighted and 
unweighted numbers. Hence, the results following Table 6.6 are therefore reported unweighted, 
unless otherwise specified. Unrecorded data were omitted from the calculations unless 
otherwise stated. 
I used the Standard Error (SE) of the estimate to determine the fitness of models with weighting 
and allowing for clustering effect asopposed to straight logistic regression model; sp that if these 
adjustments (i.e. wighting and lor clustering effect) resulted in the mode provducign a larger SE 
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- then these results are presented. Clinical practice was measured in terms of percentage of the 
standards met and its 95% confidence intervals. The associations between adverse clinical 
outcome and the recommended management practices were assessed using multiple 
regression models to calculate the risk ratios, controlling for severity of illness and age. 
I used the median to summarise time differences between events and clinical measurements 
(the chronology of clinical practice) and the middle 50% of observations ("the interquartile 
range") to summarise variability. The times to clinical practice were calculated either from arrival 
or admission, as clinically relevant and were calculated in both times in minutes ('time to') and 
days ('days to') as per recommended standards. Where exact times were not available for much 
of the data (missing data on exact times of clinical practice) I made a judgment on the clinical 
and statistical relevance, and presented the results accordingly (i.e. either models with more 
subjects included - in 'days to' or the models with fewer subject, but more precision, - in 'time 
to'. The analyses was performed using Stata (v 6 to v 8) . 
3.6.12.1 Calculation of 95% confidence intervals 
95% confidence intervals (CI) were calculated and presented to validate the precision of the 
estimates. 
For the review of the epidemiology the 95% Cis were retrieved from the Poisson! Binomial 
regression models. 
For the capture recapture analysis a parametric bootstrapping method was used to calculate 
95% Cis for the estimated unreported number of cases, the estimated total number of cases in 
the population and the estimated sensitivities of the two data sources. 10,000 simulated results 
were derived assuming independent random variables for the number of records in the first data 
source but not In the second; the number of records in the second but not in the first; and for the 
number of records found in both data sources. These were assumed to follOW Poisson 
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distributions with means equal to the observed counts. The 95% Cis were derived from the 
2.5% and 97.5% percentiles of the simulated values. For the case-fatality rate in capture-
recapture analysis the Cis are derived from the Poisson model. 
For the review of hospital management the 95% Cis were usually derived from the regression 
models and were adjusted to allow for the clustering of the sample within trusts. 
Similarly, for the examination of association of clinical management with the outcome the 95% 
Cis were derived from regression models employed. 
3.6.13 Dealing with missing data 
Due to incomplete recording of clinical practice in the clinical notes the missing data was an 
important determinant in my research methods. I used different approaches to dealing with 
missing data, and that: 
i) using continuous variables (per hour; rather than binary Yes / No) time to first assessment 
for the following variables: 
• time to first assessment 
• time to antibiotics 
• time to diagnosis 
• time to consultant assessment 
• time to ICU assessment 
II) Assuming best and worst scenario for the subject with no data regarding the performance 
of the clinical management indicator (Bridewell, Langley et al.; Collaboration 2002; Gamble and 
Hollis 2005). I treated the missing data in two subsequent approaches: 
Best scenario: assumed that subject that had no data on whether a clinical indicator was 
performed and its time interval when performed had actually undergone that clinical 
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management indicator within the recommended time. e.g. for missing data on whether diagnosis 
made in the first hour from arrival in this scenario I assumed this as a positive entry. I then 
employed logistic regression models to examine the association of these indicators, in turn, with 
the outcome of CABM and MS. 
Worst scenario: I assumed that subject that had no data on whether a clinical indicator was 
performed and its time interval when performed had not undergone that clinical management 
indicator within the recommended time. E.g. for missing data on whether diagnosis made in the 
first hour from arrival in this scenario I assumed this as a negative entry. I then employed 
logistic regression models to examine the association of these indicators, in turn, with the 
outcome of CABM and MS. 
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Chapter Four 
The recent epidemiology of community acquired bacterial 
meningitis and meningococcal septicaemia amongst adults in 
England and Wales, 1991- 2002 
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4.1 Introduction to Chapter 4 
This chapter examines the epidemiology of community acquired bacterial meningitis (CABM) 
and meningococcal septicaemia (MS) amongst adults in England and Wales, for the period 
1991 to 2002. 
I have used data that is routinely available through the different surveillance systems in England 
and Wales for the major causes of bacterial meningitis. There are several different surveillance 
systems in place for these conditions, such as: the clinicians' notifications; laboratory reports, 
which include enhanced surveillance and the reconciled laboratory reports for Neisseria 
meningitidis (NM), Streptococcus pneumoniae (pneumococcus). 
As usual with surveillance data, I have encountered difficulties, primarily with the timeliness, but 
also the completeness and other data quality issues. I will address these issues in the 
discussion section of this Chapter. 
I performed the initial analysis of the epidemiology data during 2003, including the data for the 
period January 1990 to December 2000. In 2005 I undertook an update of the analysis, which 
includes data up to December 2002. 
In this Chapter I firstly give a brief background of the epidemiological examination of bacterial 
meningitis. The data and methods applied are described in Chapter 3, section 3.4. I then 
present the results of this study, followed by a discussion of the study limitations. 
In the first part of the results I have presented the examining the epidemiology of bacterial 
meningitis in a greater detail - by causative organisms, age, sex, and season. I also present 
some results of the analysis using methods to account for over dispersion and compare these to 
the Poisson regression methods. 
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This part of my research was published as a peer-reviewed article, reference: Gjini, A. B., J. M. 
Stuart, et al. (2006). "Changing epidemiology of bacterial meningitis among adults in England 
and Wales 1991-2002." Epidemiollnfect 134(3): 567-9. 
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4.2 Background: the rationale for examining the epidemiology of CABM and 
MS in adults 
Understanding the epidemiology of CABM and MS is essential to appropriate clinical 
management and vaccine implementation. In order to begin to understand the burden of a 
disease it is usual to start by examining and describing its epidemiology. Therefore the 
information resulting from this Chapter has been essential to the further work I have undertaken 
through out my PhD research, which is presented in the following chapters. 
Amongst children, CABM and MS are important infectious causes of death and disability 
worldwide (Noah 1987; Bedford, de Louvois et al. 2001; Fellick and Thomson 2002). As 
mentioned in the Background, during the 90s, new protein-conjugate vaccines against 
Haemophilus influenzae type b (Hib) and Neisseria meningitidis serogroup C (MenC) have had 
a dramatic effect on the epidemiology of childhood meningitis in several industrialised countries, 
including the United Kingdom (Ramsay, McVernon et al. 2003).'(Ramsay, Andrews et al. 2003). 
Also, more recently, improvements in clinical management to paediatric meningococcal sepsis 
in particular, have been associated with a reduced mortality (Booy, Habibi et al. 2001). 
The epidemiology of CABM and MS amongst adults. however, over this time period has been 
less well documented. It is uncertain whether an increasingly ageing population, a paediatric 
population with a vaccine reduced carriage of common causative pathogens and the resurgence 
of infections such as tuberculosis, have modified the spectrum of disease (Mohle-Boetani, Ajello 
et al. 1993; Barbour, Mayon-White et al. 1995; Sigurdardottir. Bjornsson et al. 1997; Wenger 
1998; Rose, Watson et al. 2001; Grange and Zumla 2002). Also, as the incidence of bacterial 
meningitis in children declines, the relative public health importance of bacterial meningitis in 
adults increases (Durand. Calderwood et al. 1993; Butler, Shapiro et al. 1999). Recognition of 
these changes is important to inform clinical management and vaccination strategies. I have 
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therefore set out to examine the recent epidemiology of bacterial meningitis and meningococcal 
septicaemia amongst adults in England and Wales between 1991 and 2002. 
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4.3 Data and Methods 
For full details of the data and methods see Chapter 3. Here I will just mention briefly the data 
sources and the statistical methods used. I have used the surveillance data from the laboratory 
reports and clinical notifications 
Incidence - The primary source of data for incidence calculations was the laboratory reports. 
Clinical notifications are presented in one section as a comparison to laboratory reports. 
Case-fatality - The primary sources for case-fatality calculations were: laboratory reports for 
cases and clinical notifications (ONS) for deaths. Case-fatality using clinical notifications for both 
sources of cases and deaths is presented in one section as comparison. 
population Data - The population data for England and Wales is available from the census 
data. I used the mid year population estimates, by age, sex, region. 
Statistical analysis - I used the Poisson regression to calculate the incidence rates and the 
Negative binomial regression to account for the possible over-dispersion. The details of the 
methods used are presented in Chapter 3, sections 3.6.3 and 3.6.4. 
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4.4 Results 
4.4.1 Incidence 
Laboratory reports - There were a total of 3169 laboratory reports of CABM and 3118 (49.6%) 
of MS between 1991 and 2002 among adults in England and Wales. 
The pathogen most commonly associated with community acquired bacterial meningitis among 
adults overall was N. meningitidis (70.7% of cases), followed by S. pneumoniae (19.2%), E. coli 
(2.7%), M. tuberculosis (2.8%), H. influenzae (1.9%), L. monocytogenes (1.9%), and GBS 
(0.7%). 
Table 4.1 shows the number of reports by causative organism over the years. 
vd 
Year 
Grand 
Causative organism 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Total 
E.coll 14 22 9 13 10 13 15 13 16 19 31 10 185 
H. Influenzae 13 23 6 13 19 10 12 4 8 6 8 10 132 
L. monocytogene. 19 15 9 7 13 16 11 10 8 4 8 7 127 
M. tuberculosis 10 10 14 10 5 19 18 12 19 19 28 28 192 
SGS 6 4 6 4 6 3 2 2 4 4 2 6 49 
S. pneumonl.e 147 156 138 112 113 116 112 76 112 78 71 76 1307 
N.menlngltldl. 
(blood) 291 263 266 214 304 345 404 380 404 375 310 251 3807 
N.men/ng/tldl. 
(CSF) 110 107 81 70 93 103 83 101 82 67 61 45 1003 
CABM and MS 610 600 529 443 563 625 657 598 653 572 519 433 6802 
""'" 4.4.1.1 Incidence 
During the twelve year period the overall incidence for CABM and MS was 16.9/100,000. For 
the twelve year period, the reports for N. meningitidls, both CSFs and blood isolates, showed 
the highest Incidence, of 16.4/100,000 (with a peak of 1.81100,000 in 1997), and within this the 
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incidence for meningococcal meningitis alone was 2.5/100,000. S. pneumoniae followed with a 
total cumulative incidence of 3.2/100,000 and the rest of the causative organisms all had an 
overall cumulative incidence of 0.48/100 ,000 (M. Tuberculosis) to 0.12/100 ,000 (GBS). 
Changes over time 
Overall the incidence CABM and MS in England and Wales has increased during the period 
1991 to 2002. However, the trends differ for the CABM and MS in that decreasing for the former 
and increasing for the latter. 
Overall there was a statistically significant decease in the incidence rate of bacterial meningitis. 
Decreases in meningitis due to individual organisms were seen for N. meningitidis , H. 
influenzae , L. monocytogenes and S. pneumoniae (Figure 4.1.a,1 b). There was a mean 
annual increase of 11% in meningitis caused by M.tuberculosis. The decreasing trend in 
incidence of meningococcal meningitis contrasted with an increasing trend in meningococcal 
septicaemia (mean annual change -3% and 7%, respectively). 
Figure 4.1.a) - Incidence of CABM and MS over time. 
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Figure 4.1.b) - Incidence of CABM and MS over time. - the less common organisms 
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Comparing trends in incidence with notifications of meningococcal meningitis and septicaemia, 
no significant trend in incidence of meningococcal meningitis was seen (RR 1.02, 95% CI 0.99 
to 1.01 , P = 0.2), but incidence of septicaemia also increased. Mean annual incidence rate was 
over three times higher for notifications of meningococcal meningitis than for laboratory reports 
(0.92/100,000 vs 0.24/100,000), but were similar for meningococcal septicaemia (0.63/100,000 
vs 0.54/100,000) , and for meningitis due to S.pneumoniae (0.26/100,000 vs 0.28/100 ,000) and 
H.influenzae (0.03/100 ,000 vs 0.04/100,000). 
Table 4.2 present the three-yearly averages, to account for the annual fluctuations in incidence. 
For the period 1991 - 2002, the annual incidence of CABM from laboratory reports was 
0.6/100,000. S. pneumoniae and N. meningitidis together accounted for 78% of all cases. 
Meningococcal disease (meningitis and septicaemia due to N. meningitidis combined) rose to a 
peak in 1997-99 and then declined. TB meningitis rose throughout the period ; this way doubling 
over the study period (from 0.03 to 0.06/100,000). Whereas the incidence of meningitis caused 
by S. pneumoniae, H. influenzae and L. monocytogenes showed an overall decreasing trend 
over the study period . 
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Mean annual incidence rates were over three times higher for notifications of meningococcal 
meningitis than for laboratory reports (0.92/100,000 vs. 0.241100,000) but were similar for other 
infections. 
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4.4.1.2 Causative organisms 
The causative organism most commonly associated with bacterial meningitis was 
S.pneumoniae (41% of all cases of CABM), followed by N. meningitidis (37%), 
M.tubercu/osis (6%), E.coli (6%), H.influenzae (4%), L.monocytogenes (4%) and 
Group B streptococci (2%). 
The predominant pathogen associated with CABM varied according to age-group. 
The main pathogen responsible for meningitis in young adults remained N. 
meningitidis, comprising 84% (652/780) of cases in 16 - 24 year olds (Figure 4.2). 
This proportion decreased with increasing age to 10% (31/322) in over 75 year olds 
(p<0.0001). By contrast, the equivalent proportions for S. pneumoniae increased 
from 8% (63/780) to 59% (190/322, p<0.0001), and for E. coli from 2% (16/780) to 
13% (43/322, p<0.0001). Analysis of age-specific incidence revealed a significant 
increasing trend with age for E. coli, L. monocytogenes and S. pneumoniae and 
Group B streptococci (all p values <0.001). 
Figure 4.2 - Proportionate distribution of causative organism of bacterial meningitis 
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Incidence of CABM and MS by age 
The median age of adult patients with CABM and MS in England and Wales shifted 
from 31 years in 1991 to 40 years in 2002. In 1991 1.4% of cases occurred among 
those aged 85 years and older compared to 4.1 % in 2002 (p<0.0001) whereas 
amongst 16-24 year olds there was a decrease from 44% of cases in 1991 to 32% in 
2002 (p=0.002). 
The highest incidence of meningocoocal meningitis and septicaemias occurred in 
young adults. Both laboratory reports and clinical notification data showed a sharp 
drop in incidence from the 16 - 24 to 25 - 34 years age groups (2.9 to 0.7/100,000 
and 5.0 to 1.4/100,000 respectively) then subsequently little change with increasing 
age. There was a significant increasing trend with age for E.co/i, L.monocytogenes, 
S.pneumoniae (p<0.0001) or Group B streptococci (p = 0.001). No significant trend 
with age was observed for H.influenzae and M.tuberculosis. 
Comparing the results using Poisson with Negative Binomial regression 
models 
To check and adjust for over dispersion I used the Negative Binomial Regression 
(NBReg) model and compared the results with the Poisson model. The rate ratios 
(RR)for the annual Incidence by age group, compared to the youngest (16 to 24) as a 
baseline seemed to remain much the same when employing NBReg as compared to 
the Poisson model, whilst the 95 % CI generally were a little wider. Table 4.3 below 
presents results for RR increase by age group in incidence of CABM and MS 
comparing these two models. Conclusions about differences in time trends between 
different organisms are similar whichever model is used. 
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Table 4.3 - Rate Ratio for age group incidence comparing the Poisson and NBReg 
models. The youngest age group, 16 to 24 years old , is used as baseline. 
Poisson model Negative Binomial Regression model 
Age group RR 95%CI RR 95%CI 
16-24 1.000 1.000 1.000 1.000 
25-34 0.271 0.253 to 0.290 0.271 0.220 to 0.333 
35-44 0.234 0.218 to 0.251 0.234 0.190 to 0.288 
45-54 0.287 0.269 to 0.307 0.287 0.232 to 0.353 
55-64 0.228 0.212 to 0.245 0.228 0.185 to 0.281 
65-74 0.218 0.203 to 0.235 0.218 0.177 to 0.269 
75-84 0.163 0.150 to 0.177 0.163 0.132 to 0.202 
85+ 0.062 0.055 to 0.071 0.062 0.049 to 0.079 
Incidence of CABM and MS by sex 
Male/female status by age was available for 6182 (98.3%) of cases. Overall men 
were at a lower risk of acquiring the disease than women (rate ratio =0.94; 95% CI 
0.89 to 0.99, p= 0.01). The sex difference in incidence rates changed with age such 
that in younger age -groups incidence was greater for men, but in older age-groups 
the incidence was greater for women (p for interaction <0.0001) 
4.4.1.3 Case-fatality 
The case-fatality rates were calculated as the proportion of deaths within the number 
of cases in the appropriate group, i.e. causative organism, year of reporting , age, etc. 
As stated in Chapter 3, Data and Methods, generally the data sources are: cases 
from the laboratory reports, and deaths from the ONS notifications, unless stated 
otherwise (this was done with the aim of comparing data sources). 
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Pneumococcal meningitis had the highest case-fatality during the study period 
whether laboratory reports or notifications were used as the denominator (Table 4.4). 
Estimated case-fatality rates for pneumococcal meningitis during the 10 year period 
fell from 69% in 1993/94 to 52% in 2001/02 (172/250 to 76/147, p<0.0001) . Mortality 
rates showed a similar downward trend to that for case fatality, falling from 
0.21/100,000 to 0.09/100,000 in the same period (p<0.0001). 
Case-fatality rates for meningococcal septicaemia also decreased over the same 
period (48% to 27%, p<0.0001) but the case fatality rate for meningococcal 
meningitis remained at about the same level (22%). Overall mortality rates for 
pneumococcal and meningococcal meningitis (including meningococcal septicaemia) 
fell from 0.45 to 0.31/100,000 (p=0.0001) during a time when the combined incidence 
rates were not falling. 
Case-fatality rates for T8 meningitis also fell, from 83% (20/24) in 1993/94 to 34% 
(19/56) in 2001/02 (p<0.0001), mainly due to falling mortality in under 65 year olds. 
Figure 4.3 Case fatality rates over the years 
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Case fatality by age 
Case-fatality rates increased with age, whether derived using the laboratory reports 
as a source for cases, or when using the clinical notifications (X2 7 OF, p=0.03 and 
p<0.001, respectively) . 
Among the older age-groups case-fatality rates decreased over time, but not so for 
the younger ages. The annual rate ratio of case-fatality rate for those aged 55 years 
and older as compared to 16-54 was 0.7 (p for interaction between age and time 
=0.018). 
Figure 4.4 Case fatality rates by age group 
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4.4.1.4 The case fatality rate using different data sources 
Whether using clinical notifications or laboratory reports as a source of data, for 
either cases or deaths, the case-fatality rates vary. As described in Chapter 3 the 
primary source of data in this study has been laboratory reports for incidence data 
and ONS notifications for mortality data. Below I will show some key variations in 
case-fatality rates estimated when using ONS data as source for incidence. 
Using clinical notifications for both deaths and cases 
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Using the number of cases reported through the clinical notifications (ONS) (as 
opposed to laboratory reports previously) there are two differing features and that: 
• The case-fatality for MS in the early 1992 and 1993 is over 100% - suggesting 
more deaths are reported as caused by MS than there are cases. 
• the apparent drop in the case-fatality for those aged 85 years and older 
(Figure 4.8.b) . 
Figure 4.5 - Age-specific case-fatality rates. Source clinical notification cases and 
deaths. 
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Similar to the case-fatality rate when using laboratory reports for cases, the case-
fatality rate for meningococcal meningitis/ septicaemia and pneumococcal meningitis 
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increased with increasing age from 21% in 16 - 24 year olds to 74% in the 75+ age 
group (p<0.0001). 
Overall the largest difference in the case-fatality calculated when using clinical 
notifications as source for cases as opposed to laboratory reports was for 
meningococcal meningitis and that being lower (Table 4.4). 
Table 4.4 Comparing case-fatality rates laboratory vs ONS reports. 
Case fatality rates based on laboratory reports for the period 1993 - 2002 
(numbers in brackets) 
Organism 
Total Laboratory Notification CFR Deaths ReportCFR 
iMeningococcal meningitis 172 0.18 (954) 0.04 (3918) 
Meningococcal septicaemia 973 0.35 (2776) 0.38 (2581) 
Stre tococcus nuemoniae 725 0.72 (1004) 0.60 (1217) 
TOTAL 1870 0.4 (4734) 0.24 (77 16} 
4.4.2 Trends of number of lumbar punctures performed 
The exercise to examine trends in LPs performed in the South West region of 
England derived data from 6 of 18 laboratories. A total of 35,671 (14,192 among 15+ 
year olds) CSF specimens were received by these labs, with a median of 271 CSFs 
(range 24 to 756) per laboratory per year. Due to the incompleteness of the available 
data, i.e. a number of CSFs received for analysis by the HPA (at the time PHLS) 
laboratories, (2 laboratories had data for the entire study period; 2 only from 1994 to 
2000; and the other 2 had data from 1995 and 1996, respectively to 2000) it is 
appropriate to be cautious when drawing conclusions about the trends of LPs. 
Nevertheless, the number of CSF specimens received by the laboratories did 
increase year on year, from 2544 specimens in 1991 to 4115 specimens in 2000. 
The increase was steeper for adults, Poisson regression coefficient for adults was 
y=98 per year, compared to y=23 per year for children. 
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4.4.3 Conclusion 
This study provides evidence that bacterial meningitis is an important public health 
problem in England & Wales insofar as much of the disease is vaccine preventable 
and it poses a large burden in terms of high fatality. This study shows that the 
epidemiology of bacterial meningitis is changing among adults in the England and 
Wales. Vaccination programmes in children and the re-emergence of TB appear to 
be making impacts in opposing directions. 
The falling mortality rate is encouraging and suggests that standards of clinical 
management may be improving. Nonetheless, bacterial meningitis still results in 
considerable morbidity and mortality, and with the advances in the vaccine 
development, but also the potential changes in the causative bacteria, both, a 
detailed epidemiological monitoring and a high index of clinical suspicion for 
meningitis among adult patients should be maintained. 
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4.5 Discussion 
An overall discussion of the findings is deferred till Chapter 8; here I will address 
specifically the limitations and strengths of this particular aspect of the study. 
4.5.1 Limitations of the study 
4.5.1.a Limitations ofthe data 
The main limitation of this study was the completeness and the sensitivities of the 
reporting systems used. Under-reporting in routine surveillance systems is we" 
recognised (Goldacre and Miller 1976; Davies 1989; MacLehose, Brand et al. 2001) 
so that reported incidence provide an underestimate of the true rates (see Chapter 
5). The trends in the epidemiology of meningococcal disease observed may have 
been influenced by the introduction of non-culture diagnostic techniques during the 
study period, such as PCR testing (Ni, Knight et al. 1992). However, this trend has 
continued long after these techniques became introduced into routine use, i.e. 
changing to a decreasing trend only in the early 2000, probably due to the impact of 
Men C vaccination. 
A reporting bias from variation in the use of diagnostic LPs, as reported from other 
studies (Ramsay, Kaczmarski et al. 1997; Wylie, Stevens et al. 1997), may have 
influenced the observed differences in trends for meningococcal meningitis and 
meningococcal septicaemia. However, I was unable to confirm a decreasing trend on 
LPs performed from the South West laboratory data. The observed differences in 
trends for meningococcal meningitis between laboratory and Clinically notified data as 
well as the low fatality among those aged 85 years and older using clinical notified 
cases (as compared to cases reported by laboratory testing) may, also, be explained 
by differences if diagnostic practices, such as Clinically recognising meningitis but not 
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examining the CSF, instead the testing / confirmation is done from the blood 
samples. 
These data did not examine incidence by ethnicity, as the data was not available. 
Thus I was not able to demonstrate whether ethnic minorities are at higher risk of 
acquiring disease and of dying, as it has been reported in other studies (Rosenstein, 
Perkins et al. 1999). Despite these limitations, this data should be generalisable to 
the rest of the UK and to other European with similar population structures. 
4.S.1.b Differences between the surveillance data 
As noted in Chapter 3 the surveillance for CABM and MS is carried out by the 
clinical notification system (ONS) and the laboratory reports, by different causative 
organism. The source of reporting for both systems is different, i.e. clinicians for the 
ONS surveillance and microbiologists for the laboratory surveillance. These are both 
dependent on diagnostic practices and to some extent dependent on each other. 
Issues with reliability of data sources and the actual reporting, in particular following 
introduction of new surveillance systems or new public health initiatives (as it was the 
case during the period of my study with inrocduction of ESMD) has been reported 
(Olowokure, Hawker et al. 2000) (Freed, Green et al. 2008).The clinical notifications 
though are less sensitive for identifications of cases, whilst laboratory reports are less 
sensitive for identification of deaths. This was highlighted with the case-fatality rate 
estimates where the rates would exceed 100% in some occasions. 
Realising the issues of underreporting with the routine data-sources and, as noted 
earlier, in order to improve the estimates of incidence and mortality form the routine 
surveillance data, I undertook a capture-recapture analysis, which is reported in the 
next Chapter (Chapter 5). 
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4.S.1.c Limitations with statistical methods 
I have used Poisson Regression models, mostly, to calculate the incidence rates of 
the disease. There might be several limitations with this method, given the data used, 
and that because of the assumptions in Poisson Regression, mainly that: 
1. The disease rate changes linearly on the log scale (and hence exponentially 
in terms of actual rates) with equal increment increases in the exposure 
variable - as with most infectious disease the disease is not usually linearly 
associated with exposure; there are complicated models of transmission, 
including host, environmental, and causative agent interactions, that 
determine whether one will get ill upon exposure or not. However, the 
Poisson regression framework provides a convenient empirical representation 
in which to test for exposure effects, without involving detailed modelling of 
processes on which data is seldom available. 
2. At each level of the covariates the number of cases has variance equal to the 
mean - results suggesting that the data did not vary greatly from this 
assumption; and where there was some variation I have presented results 
from the Negative Binomial Regression models, rather then Poisson 
regression. These gave comparable results. 
3. Observations are independent - only about 2% of cases of MD (meningitis 
and septicaemia) are linked, i.e. are dependent on other cases; and less so 
for meningitis caused by other causative agent. Therefore, the independence 
assumption is unlikely to be violated in any major way. 
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4.5.2 Strengths of this study 
In Chapter 8 I will discuss in more detail the strengths of this study as well as the 
interpretation of the results in context of other published research; here I will briefly 
discuss the key strengths of this study. 
This is the first study to examine the national (England and Wales) epidemiology of 
CABM and MS amongst adults. Around the same time a similar study was 
undertaken for Scotland, and most of the aspects of the epidemiology are similar 
(Kyaw, Christie et al. 2002). I will present a brief comparison between this and my 
study in the section below. 
The interpretation of the results should be generalisable to other countries with a 
similar epidemiology, similar demographics, public health and surveillance systems. 
I undertook comprehensive analysis, examining age, sex, time, regional 
epidemiology for the causative organisms. 
The statistical analyses are robust; I employed appropriate methods and applied 
them robustly, compared and got reassuringly similar results between Poisson 
regression and NBreg models. 
I presented results from both the available data sources, i.e. clinical notifications and 
laboratory reports, and discussed discrepancies (where they occurred) between the 
both. 
4.5.2.a Comparing the two studies examining the epidemiology of bacterial 
meningitis: one In Scotland (Kyaw et al) and the other in England and Wales 
(my study) 
Kyaw et al used laboratory reports of invasive meningococcal, pneumococcal, 
Haemophllus Influenzae, Group B Streptococcus (GBS) and Listeria monocytogenes 
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isolates and examined the epidemiology of meningitis and invasive non-meningitic 
disease (INMO) caused by these 5 pathogens. They compared the data for two time 
periods, and that before (1983-91) and after (1992-99) the introduction of the H. 
influenzae type B conjugate vaccine (Hib) in the childhood immunisation programme 
in Scotland. 
I used the laboratory reports, as well as clinical notifications for meningitis, based on 
the respective ICD 10 codes (see Data and Methods), for all CSF isolates of the 
seven pathogens (see Data and Methods) and the blood isolates for N. meningitidis. 
I examined these data for the period 1991 to 2002. In this section I will compare the 
results by Kyaw et al for their second period of the study, ie 1992-99. 
There were a few differences between the two studies, including: 
1. The study population: 
a. The study by Kyaw et al (the Scottish study) examined the disease in 
all ages whilst I examined the adult population only (main results 
presented in Chapter 4 in this thesis). 
b. My study population was England and Wales, whilst Kyaw et al 
examined the disease in the population of Scotland. 
2. The study period (as noted above) the Scottish study was between 1983 to 
1999 whilst for my study was 1991 to 2001. 
3. The Scottish study examined only 5 causative pathogens (as opposed to 7 in 
my study) 
4. The disease examined - I only examined meningitis except for N. meningitidis 
for which I examined septicaemia as well (that is the only other form of 
invasive disease caused by N. meningitidis), whilst in the Scottish study the 
authors examined a wider range of invasive disease, including meningitis and 
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invasive non-meningitis disease (INMD), in most cases this includes 
septicaemia and pneumonia (eg due to HiB and S. Pneumoniae are amongst 
the more common ones, see Chapter 2 Background) 
5. In the Scottish study N. meningitidis was the most common cause of 
meningitis. accounting for 47% of cases in 1992-99, whilst in my study, data 
for England and Wales, S. pneumoniae with 43.6% of meningitis cases was 
the most common cause, and N.meningitidis was the second most common 
cause of meningitis (CSF isolates) accounting for 33.5% of all CSF isolates. 
The potential reasons for this difference are: 
• I had a wider list of causative organisms of CABM, 7 as opposed to 5 in the 
Scottish study, hence a possible dilution of the overall proportion accountable 
to each organism, in this case N. meningitidis. 
• I examined the data for a longer period, that is up to and including 2002 for 
difference from the Scottish study (up to 1999) therefore the impact of the 
Men C conjugate vaccine would have been reflected in my data but not in the 
Kyaw et al study .. 
• There seems to be a grater proportion of cases of suspected meningitis that 
are not diagnosed through the CSF (a lumbar puncture not performed) in 
England and Wales as compared to Scotland, and the proportion of 
meningitis cases caused by to N. meningitidis in the clinical notifications is 
grater than In the laboratory reports. Also, similar to the Scottish study, clinical 
notifications in m ysutdy did not show a decreasing trend for meningococcal 
meningitis (whilst this was Significant in the laboratory reports). 
6. A major difference in the findings was in the epidemiology of meningitis 
caused by HIB and that: 
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a. Hib was the second most common cause of meningitis in the Scottish 
study (31%), whilst in my study HiB was only accountable for 4.4% of 
cases of meningitis in the entire study period. 
b. The incidence of HiS in the Scottish study remained unchanged in the 
adult population in the post-vaccination period (ie 1992 to 1999) whilst 
in my study I found a decreasing incidence. 
The main explanations for these differences are: 
c. HiB is a major cause of meningitis in childhood but not adulthood (and 
my study was restricted to adult population) therefore a grater 
proportion of cases is accountable to HiS in the overall population (all 
ages as opposed to adults only). 
d. Another potential explanation is that up to 1996 Hib vaccine was 
given as a separate injection, but in 1996 a combined DTP-Hib 
vaccine was introduced which has consequently shown to have a 
better effectiveness in long term immunity as well as heard immunity. 
Therefore as my study extended further beyond the 1996 cut-off (from 
single vaccine to vaccine containing whole cell pertusis) the impact of 
heard immunity was probably grater than up to 1999 (Heath and 
Ramsay 2003) 
However, the most of the main findings between the two studies are similar, and 
these include: 
1. In both studies a significant increasing incidence of meningococcal 
septicaemia is reported, in the Kyaw et al study it is referred to as invasive 
non-meningitis disease (INMD) caused by N. meningitidis. 
1) In both studies a decreasing incidence of bacterial meningitis caused by L. 
monocytogenes is reported. 
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2) Also, similar to the Scottish study I found a significant decreasing incidence of 
meningitis caused by HiB in a non-vaccinating population (my study 
population is adults). 
It is therefore, reassuring for my study that the majority of the main findings are 
similar between both studies, and my study provides additional evidence of the 
changing epidemiology of CABM and MS in England and Wales in similar directions 
with the studies in populations with a similar demographical background and context. 
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Chapter Five 
Improving estimates of community acquired bacterial 
meningitis: an application of a capture-recapture analysis 
of pneumococcal meningitis in England 
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5.1 Introduction 
Not everything that can be counted counts, and not 
everything that counts can be counted! 
A. Einstein 
Pneumococcal meningitis is one of the three most common forms of bacterial 
meningitis overall, and the most common form of meningitis amongst adults 
(Kragsbjerg, Kallman et al. 1994) (Urwin, Yuan et al. 1996; Weisfelt, van de Beek et 
al. 2006). 
The uncertainty and the underreporting of infectious diseases in general, and 
meningitis in particular, are commonly acknowledged (MacLehose, McKee et al. 
2002). The analysis of the routine surveillance data to examine the recent 
epidemiology of CABM and MS, which is presented in the previous chapter, further 
highlighted these concerns (see Chapter 4). The discrepancies between the routine 
sources that record the same conditions but from different sources, i.e. laboratory 
reports and clinical notifications, were apparent at many levels of analysis. For 
instance the regional analysis by gender seemed not to correspond with what was 
expected (data not shown); the case-fatality analysis in some instances produced 
estimates of over 100%. 
These limitations prompted me to explore ways of measuring the underreporting in 
these routine data-sources, and of improving the estimates of bacterial meningitis 
incidence in England. Hence I undertook a capture-recapture analysis using the 
routine data sources for CABM and MS, including laboratory reports, clinical 
notifications IONS death data, and Hospital Episode Statistics (HES). 
I examined the surveillance of pneumococcal meningitis, one of the causative forms 
of CABM. I did not examine the surveillance for all forms of CABM as it would have 
been an impractical undertaking and because, for a correct application of the capture 
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recapture analysis, a well-defined condition is recommended, to ensure high 
specificity of the case definition. Hence, if I were to have included all forms of CABM, 
including those for which the case definition is less specific, the methodology would 
most likely have produced less reliable results. Meningococcal and pneumococcal 
meningitis, as seen in the previous Chapter, are the two most common forms of 
CABM amongst adults. At the time another researcher at the HPA / LSHTM, was 
undertaking a capture recapture study into meningococcal meningitis (Trotter). 
Therefore I decided to examine pneumococcal meningitis for the degree of under-
ascertainment by the routine data-sources. 
As showed in the previous Chapter, the routine data sources are useful in following 
trends of the disease and identifying changes in the occurrence of CABM and MS, for 
example those caused by outbreaks, or by changes in the underlying epidemiology. 
However, good estimates of incidence are needed to inform the population, clinicians 
and policy makers and to improve detection of disease. Planning of service provision 
and improvement of the clinical management, including early recognition of the 
disease and treatment, also requires accurate, reliable and timely epidemiological 
data. Policy making for prevention strategies, in this case vaccination policies are 
relevant, also requires accurate and reliable data on the burden of the disease. 
I have measured the sensitivities of reporting of the incidence of and mortality (fatal 
Incidence, from now on I will refer to it as 'Mortality') from pneumococcal meningitis 
using a two-source capture-recapture analysis (PHLS RLR and HES for Incidence 
and HES and ONS data for Mortality) for each of the occurrences. I have calculated 
the case-fatality from the data yielded by the capture recapture and I have done 
simple costing calculations for the vaccination of the adult population. In this chapter 
I present a brief background to pneumococcal meningitis and the capture-recapture 
method, state the data and methods used, and describe the results of this work. At 
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the end I discuss the limitations and strengths of the research and its implications. 
This part of the research is published as peer-review article, reference: 
Gjini, A., Stuart, J. M., et al. (2004). "Capture-recapture analysis and pneumococcal 
meningitis estimates in England." Emerg Infect Dis 10(1): 87-93. 
163 
Dr A Gjini. Oacterial meningitis amongst adults. PhD thesis 
5.2 Background 
5.2.1 Clinical manifestation of pneumococcal infections 
Streptococcus pneumoniae is a leading cause of pneumonia, bacteraemia, 
meningitis and otitis media in children and adults (Robbins 1978) (Weisfelt, van de 
Beek et al. 2006) (Soisier, Mainassara et al. 2007; Chanteau, Rose et al. 2007) 
(Melegaro, Edmunds et al. 2006). Pneumococcal infections occur at a number of 
different sites (e.g. upper and lower respiratory tract, cerebrospinal fluid) causing 
different disease manifestations. Pneumococcal infections can be divided into: i) 
invasive infections, such as: pneumonia, meningitis, and febrile bacteraemia; and ii) 
the non-invasive infections such as: otitis media, sinusitis, and bronchitis. 
5.2.2 Epidemiology of pneumococcal meningitis 
World-wide more than one million children die of pneumococcal disease every year, 
most of these being young children in developing countries (1999). In the developed 
world, including the UK, elderly persons carry the major disease burden. Long term 
effects of both invasive and non-invasive disease and the rapid emergence of drug 
resistant pneumococcus emphasize the need for effective public health prevention 
strategies. 
Changes in the epidemiology of pneumococcal meningitis have been reported from 
most of the industrialized countries. For example a study during the 1990's in the 
Netherlands reported an increase in annual incidence from 1 to 1.5 per 100,000 
between 1990 and 1996 (Spanjaard, van der Ende et al. 2000). An increased 
incidence, but also increased fatality amongst the elderly has been reported in the 
US (Butler and Schuchat 1999). 
5.2.3 Public Health Importance 
Pneumococcal infections are spread from person to person by droplets, through 
coughing and sneezing, as is the case with most of the causative forms of CABM. It 
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is estimated that in the UK, respiratory infections account for 55% of all antibiotic 
prescriptions (Frischer, Heatlie et al. 2001). The emergence of pneumococci resistant 
to single or multiple antibiotics (Johnson, Speller et al. 1996; Cartwright 2002) and 
their association with outbreaks in child care centers and nursing homes underscores 
the urgent need for new preventive strategies (Nuorti, Butler et al. 1998). 
Pneumococcal meningitis represents a small but important component of the total 
burden of pneumococcal disease, with a mortality of 25% and sequelae in excess of 
50% of affected cases (Kragsbjerg, Kallman et al. 1994; Kornelisse, Westerbeek et 
al. 1995). 
5.2.4 Prevention strategies 
Some of these reports have noted that pneumococcal meningitis is now one of the 
most common forms of bacterial meningitis (Short and Tunkel 2000) and that it is 
predominantly a disease of adults, rather than of infants and children (Tsai, Griffin et 
al. 2008). These findings have led to suggestions that we need to change the 
management of bacterial meningitis (Short and TunkeI2000). 
There is an increasing public health emphasis on the prevention of pneumococcal 
meningitis and pneumococcal disease in general (QUick, Hoge et al. 1993; Schuchat, 
Robinson et al. 1997; Black, Shinefield et al. 2000). This follows the great success of 
prevention of two other common forms of CABM: HiB and Men C meningitis (see 
Chapter 2). There Is compelling data to support the provision of pneumococcal 
conjugate vaccine for children (Sims, Steinmann et al. 1988) and considerable 
although arguably less robust evidence to support pneumococcal vaccination with 
polysaccharide vaccine in the elderly (Abeni, Brancato et al. 1994; 1995; Fedson 
1999; MacLehose, McKee et al. 2002). If pneumococcal vaccination is to be 
introduced into the general adult population accurate estimates of the burden of 
Invasive pneumococcal disease are needed. 
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5.2.5 Uncertainty of routine data sources 
Geographical differences in the distribution of invasive pneumococcal disease may 
render small surveillance data-sets poorly generalisable and it is widely accepted that 
infectious diseases are commonly underreported (Reintjes, Termorshuizen et al. 
1999). Population based surveys and active surveillance systems, the ideal methods 
for estimating prevalence and incidence of disease, are resource intensive. To 
overcome these problems, methods such as capture-recapture (Smith, Stuart et al. 
1998) have been used effectively for both chronic disease and infectious disease 
epidemiology (Hook and Regal 1995; Faustini, Fano et al. 2000). 
5.2.6 Capture recapture method 
The capture-recapture method originated in fisheries and wildlife biology, and is 
widely used for assessing the abundance of wildlife populations. It is also commonly 
used in epidemiology and in various public health surveillance projects with aim of 
improving estimates of health occurrences (International Working Group for Disease 
Monitoring and Forecasting. 1995; International Working Group for Disease 
Monitoring and Forecasting). It has successfully been used in cancer epidemiology to 
improve the data that supports planning and provision of health services (Crocetti, 
Miccinesi et al. 2001). It has been identified as a useful tool in identifying different 
sub-groups in the surveillance populations, e.g. risk groups in patients with traumatic 
brain injury (Schootman, Harlan et al. 2000), and has found multiple use in infectious 
disease epidemiology (Reintjes, Termorshuizen et al. 1999) (Devine, Bellis et al. 
1998; Tocque, Bellis et al. 2001) (Faustini, Fano et al. 2000), (Ferrer Evangelista, 
Ballester Diez et al. 1997); and has been widely used to estimate the population size 
of injecting drug users (Larson, Stevens et al. 1994; Hickman, Sutcliffe et al. 1999). 
166 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
5.3 Methods 
5.3.1 Data sources 
HES and PHLS reconciled laboratory reports on pneumococcal disease (RLR) data 
for England were compared for the incidence analysis; and HES and ONS data for 
England were compared for the mortality analysis. HES were available only for 
hospitals in England; this prevented an analysis based on a larger UK data set. The 
details of these data sources and the data extracted for this research are given in 
Chapter 3. 
5.3.2 Extraction of data 
All adults in England 16 years and older with a diagnosis of pneumococcal meningitis 
were identified in HES and PHLS RLR for England for the incidence analysis, and 
HES and ONS for England for the mortality analysis. PHLS RLR data for the year 
2000 were not available at the time of the study and the HES data was recorded as 
financial years 1996 - 1999. Therefore the incidence analysis was restricted to the 
period between April 1996 to December 1999. The mortality analysis was conducted 
using records from April 1996 to March 2000. For the case-fatality estimates, 
mortality analysis was restricted to December 1999, to be comparable with incidence 
analYSis. 
5.3.3 Validation of data sources 
To validate the diagnosis and matching in the data extracts, consultant 
microbiologists in 17 laboratories providing clinical microbiology services to all acute 
hospital trusts in the South West Region of England were sent line listings of PHLS 
RLR and HES extracts relating to their laboratory and acute NHS Trust respectively. 
They then verified the correctness of diagnosis and matching according to their own 
laboratory, and they were able to use further personal identifiers. They also obtained 
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details from their local NHS Trust of hospital episode diagnoses of pneumococcal 
meningitis for cross checking against PHLS RLR and HES records. 
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5.3.5 Matching and capture-recapture analysis 
The capture-recapture method quantifies the degree of overlap between two or more 
sources to estimate the number of unobserved subjects by any source examined. 
Figure 4.1. The sensitivities of the data sources examined, was then estimated by 
using the number of cases yielded from the capture-recapture and the number of 
cases reported within each of the data sources. Further details of the capture-
recapture method and the assumptions it makes are presented in Chapter 3. 
5.3.5.a Sensitivity analysis 
In order to test the validity and reliability of the method used, I performed a series of 
sensitivity analyses. I carried out the first sensitivity analysis using more or less 
stringent criteria for identification of duplicates, matching on the records using age 
and region instead of 'Date of birth' and 'Hospital NHS Trusts' as identifiers. 
I also performed analysis based on all diagnostic fields, as opposed to the first 
diagnostic field for identifying the cases. The inclusion criteria for HES was all cases 
where pneumococcal meningitis (ICD 10: G001) was recorded in any of the 
diagnostic fields in the HES data-base, and not just the main diagnostic field. The 
rest of the criteria, including the selection of duplicates remained the same as for the 
main analysis. 
5.3.6 Statistical analysis 
For each source, the sensitivity of the reporting systems was calculated as the 
number of cases of pneumococcal meningitis reported to one source over the total 
number of cases estimated from the capture-recapture analysis. Case fatality 
percentages were calculated from the estimated total number of deaths and the 
estimated total number of cases in the population. The further details of statistical 
methods and analysis performed are presented in Chapter 3. 
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5.4 Results 
5.4.1 Incidence 
Between April 1996 and December 1999, 668 isolates of S. pneumoniae from 
patients with meningitis were documented in the RLR, and 1069 cases of 
pneumococcal meningitis were recorded in HES. After excluding multiple records (20 
from RLR and 332 from HES) and 2 records from the RLR in which date of birth and 
age were missing, 646 records in RLR and 737 in HES were retained for analysis. 
The mean age of the cases in the RLR (55.8 years [range 16 - 97]) and HES data 
sources (55.3 years [range 16 - 96]) was similar, as was their sex distribution (52% 
were male). 
Matching was achieved in only 296 of cases, demonstrating an overlap of less than 
half the records between the data sources. It was therefore estimated that an 
additional 521 (95% CI 477 to 568) cases were not captured by either source. The 
capture-recapture analysis thus revealed a total of 1608 (95% CI 1483 to 1747) 
cases of adult pneumococcal meningitis. The estimated sensitivities of the data 
collection systems for pneumococcal meningitis were therefore 40% (95% CI 37 to 
44) for RLR and 46% (95% CI 42 to 50) for HES (Table 4.2). Sensitivity estimates 
varied by year of reporting, but no evidence of a trend was shown across the years 
(p-value 0.30 for RLR and 0.67 for HES) (Table 5.2) or the age-groups (Table 5.3). 
The lowest sensitivities were observed in those aged 85 or more (16% and 19% for 
RLR and HES, respectively) and the sensitivities of both data sources were 
significantly lower in those aged 85 or more compared to those aged 84 or under 
(p=0.002 and p=0.03 for RLR and HES, respectively; Table 5.3). Incidence rates 
using capture-recapture estimates decreased from 1.36/100,000 p.a. in 1996/97 to 
0.78/100,000 p.a. in 1988/99. 
172 
D
r A
 G
jin
i. 
B
ac
te
ria
l m
e
n
in
gi
tis
 a
m
o
n
gs
t a
du
lts
. P
hD
 th
es
is
 
Ta
bl
e 
5.
2 
-
Ca
pt
ur
e 
-
re
ca
pt
ur
e 
a
n
a
ly
si
s 
fo
r t
he
 n
u
m
be
r o
f c
a
se
s 
o
f p
ne
um
oc
oc
ca
l m
en
ing
iti
s 
a
m
o
n
g 
a
du
lts
 (1
6 
ye
ar
s 
a
n
d 
ol
de
r) 
in 
En
gl
a
n
d,
 
Ap
ril
 1
99
6 
to
 D
ec
em
be
r 1
99
9,
 b
y 
tim
e 
pe
rio
d 
.
 
N
um
be
r o
f r
e
co
rd
s 
in
 th
e 
da
ta
 
so
u
rc
e
s 
Ca
pt
ur
e 
-
re
ca
pt
ur
e 
a
n
a
ly
si
s 
M
at
ch
ed
 
U
nr
ep
or
te
d 
To
ta
l 
n
u
m
be
r 
o
f S
en
sit
ivi
ty
 
Se
ns
iti
vit
y 
Ti
m
e 
Pe
rio
d 
R
LR
* 
H
ES
**
 
re
co
rd
s 
ca
se
s 
ca
se
s 
in 
po
pu
la
tio
n 
R
LR
%
 
H
ES
%
 
[95
% 
CI
] 
[95
% 
GI
] 
[95
% 
GI
] 
[95
% 
GI
] 
Ap
r 
19
96
 -
M
ar
 
19
97
 
19
5 
23
9 
82
 
21
6 
[15
6,
 
30
0] 
56
8 
[48
7, 
66
8] 
34
 [2
8,
 4
0] 
42
 [3
5,
49
] 
Ap
r 
19
97
 
-
M
ar
 
19
98
 
16
8 
19
4 
70
 
17
4 
[12
1, 
24
8] 
46
6 
[39
3,
 
55
6] 
36
 [2
9,
 4
3] 
42
 [3
4,
49
] 
Ap
r 
19
98
 -
M
ar
 
19
99
 
17
2 
19
0 
99
 
67
 [4
6,
96
] 
33
0 
[28
6,
 
37
9] 
52
 [4
5, 
59
] 
58
 [5
0,
 
65
] 
Ap
r 
19
99
 -
D
ec
 
19
99
# 
11
1 
11
4 
45
 
10
1 
[64
, 1
58
] 
28
1 
[22
8, 
35
0] 
39
 [3
1,
49
] 
40
 [3
1, 
50
] 
Al
l s
tu
dy
 p
er
io
d 
Ap
ril
 
19
96
 
-
64
6 
73
7 
29
6 
52
1 
[43
4, 
62
5] 
16
08
 [1
48
3,1
74
7] 
40
 [3
7,
 4
4] 
46
 [4
2,
 
50
] 
D
ec
 1
99
9 
*
 R
ec
on
ci
le
d 
La
bo
ra
to
ry
 R
ep
or
ts
; 
*
*
 H
os
pi
ta
l E
pi
so
de
 S
ta
tis
tic
s
; #
 R
LR
 D
at
a 
n
o
t a
va
ila
bl
e 
fo
r J
an
 -
M
ar
ch
 0
0 
17
3 
D
r A
 G
jin
i. 
B
ac
te
ria
l m
e
n
in
gi
tis
 a
m
o
n
gs
t a
du
lts
. P
hD
 th
es
is
 
Ta
bl
e 
5.
3 
-
Ca
pt
ur
e 
-
re
ca
pt
ur
e 
a
n
a
lys
is 
fo
r t
he
 n
u
m
be
r o
f c
a
se
s 
o
f p
ne
um
oc
oc
ca
l m
en
in
gi
tis
 a
m
on
g 
ad
ul
ts
 (1
6 y
ea
rs
 a
nd
 o
ld
er
) in
 E
ng
la
nd
, 
Ap
ril 
19
96
 to
 D
ec
em
be
r 1
99
9,
 b
y a
ge
 g
ro
up
 
N
um
be
r o
f r
e
c
o
rd
s 
in
 th
e 
da
ta
 s
o
u
rc
e
s
 
Ca
pt
ur
e 
-
re
ca
pt
ur
e 
a
n
a
ly
si
s 
Ag
e 
gr
ou
p 
R
LR
 
U
nr
ep
or
te
d 
To
ta
l n
u
m
be
r o
f 
Se
ns
iti
vi
ty
 
Se
ns
iti
vi
ty
 
M
at
ch
ed
 
ca
se
s 
in
 
H
ES
 
re
c
o
rd
s 
ca
se
s 
po
pu
la
tio
n 
R
LR
%
 
H
E
S%
 
[95
% 
[95
% 
CI
] 
[95
% 
CI
] 
CI
] 
[95
% 
CI
] 
1
6
-2
4
 
.
.
.
 2 
35
 
15
 
23
 [9
,5
2]
 
75
 [5
2,1
10
] 
43
 [2
6,6
0] 
47
 [2
9, 
65
] 
25
-4
4 
14
5 
17
5 
64
 
14
0 
[96
, 2
05
] 
39
6 
[33
3, 
47
6] 
37
 [2
9, 
44
] 
44
 [3
6, 
52
] 
45
-6
4 
23
8 
28
4 
12
6 
14
0 
[10
3, 
18
8] 
53
6 
[47
4, 
60
7] 
44
 [3
9,5
0] 
53
 [4
7, 
59
] 
65
-7
4 
13
5 
14
0 
57
 
11
4 
[75
, 1
70
] 
33
2 
[27
6, 
40
2] 
41
 [3
3,4
9] 
42
 [3
4, 
51
] 
7
5-
84
 
75
 
78
 
30
 
72
 [4
1,1
25
] 
19
5 
[15
1, 
25
7] 
38
 [2
8, 
49
] 
40
 [2
9, 
51
] 
85
+*
 
21
 
25
 
4 
89
 [ -
] 
13
1 
[ -
] 
16
 [ -
] 
19
 [ -
] 
-
-
-
-
-
*
du
e 
to
 s
m
a
ll 
n
u
m
be
rs
 in
 th
e 
m
a
tc
hi
ng
 re
co
rd
s 
ce
ll, 
it 
w
a
s 
n
o
t p
os
sib
le
 to
 c
a
lc
ul
at
e 
re
lia
bl
e 
Ci
s 
fo
r t
hi
s 
ag
e 
gr
ou
p 
(ca
lcu
lat
ion
s y
ie
ld
in
g 
an
 
in
fin
ite
 u
pp
er
 lim
it).
 
17
4 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
Matched cases did not vary significantly from unmatched cases, when examined by 
age, by gender or by year. The mean difference between the specimen date (RLR) 
and date of episode (HES) for the matched cases was 0.14 days (range -10 to 24), 
with 70% of cases having the same date recorded in both data sources. Information 
on other covariates was largely consistent within the matched records. 
5.4.2 Mortality 
Between April 1996 to March 2000, 197 deaths from pneumococcal meningitis in 
England were reported by ONS, whereas 195 deaths were recorded in HES. The 
mean age of the cases in the ONS (61.7 years [range 16 - 96]) and HES data 
sources (62.7 years [range 16 - 97]) was similar, as was their sex distribution (50% 
were male). 
Between the two data set 95 cases were matched. Capture-recapture matching 
analysis revealed 107 (95% CI 75 to 150) adult deaths from pneumococcal 
meningitis not reported by either source, resulting in an estimated total of 404 (95% 
CI 350 to 466) deaths. The estimated sensitivity of the ONS and HES data collection 
systems for death from pneumococcal meningitis was 49% (95% CI 42 to 56) and 
48% (95%CI 41 to 55), respectively. There was a significant decrease in the 
ascertainment of deaths over the years for HES but not for ONS (test-for-trend 
p=0.03 and p=O.51, respectively). Mortality rates, similarly to incidence, decreased 
over the study years from 0.30 to 0.15/100,000 p.a, hence the case-fatality rate did 
not change. The data from the capture-recapture analysis yields an estimated case-
fatality rate for pneumococcal meningitis of 24% (95% CI 21% to 26%) (Table 4.4). 
The case-fatality rates were calculated by dividing the number of deaths and number 
of cases derived from the capture-recapture analysis, in Excel. 
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5.4.3 Sensitivity analysis of the incidence data 
Using less stringent criteria for identification of duplicates 
Application of less stringent criteria , matching on 'Age' instead of 'Date of birth', 
yielded an additional 13 matched records. This gave an estimate for the total number 
of cases in the population of 1541 cases, yielding a sensitivity of 42% for HES and 
48% for RLR. Application of more stringent matching criteria including matching on 
region resulted in an increased estimated number of cases from 1608 to 2061 , giving 
a sensitivity for HES and RLR of 31.3% and 35.8%, respectively. 
Using all diagnostic fields for identification of cases in HES data 
Extracting the data from HES for subjects with a diagnosis of pneumococcal 
meningitis (ICD 10 G001) in any diagnostic field , identified an additional 76 records 
compared to the data extracted for the 15t diagnostic field only as in the main 
analysis. 
Matching HES and RLR data-sources identified a total of 318 matches (22 extra 
matches compared to the main analysis), giving an estimated total of 1652 cases in 
the population, and sensitivities of the surveillance systems as 49.2% and 39.1 % for 
HES and RLR, respectively (Table 5.5). 
Table 5.5 - Sensitivity analysis for the capture-recapture method all vs 1 st diagnostic 
field . 
Total records in the 
data sources Results of capture· recapture analysis 
Matched Unreported ~otal cases !sensitivity ~ensitivity 
1996 -1999 RLR HES records ~ases in population RLR% HES% 
HES all 09 
~ields ~46 ~13 ~18 ~11 1652 P9.1 149.2 
HES 1st 09 
~96 ~21 ~0 .2 145.8 ~ield, only ~46 737 1608 
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5.4.4 Validation of data sources using local regional data 
For protecting the cofidentiality of patients, the data is not available for research 
purposes with identified names of individuals. However the local laboratories and 
hospitals do possess and have access to such data for their quality assurance 
purposes. Hence I asked all the HPA (at the time PHLS) laboratries (17) in the South 
West region of England to identify from their records the data I possessed and check 
by using further personal identifiers, Le. names, along with DaB and other identifiers 
to match against hospital recods. Data were validated in 13 of the 17 laboratories 
approached, covering 76 (88%) of the 86 RLR records and 75 (86%) of the 87 HES 
records identified in the South West Region of England. 38 cases matched between 
the sources, yielding an estimated capture-recapture total of 150. 
Of the 38 original matches, 37 were confirmed as correct from laboratory records. 
Two additional matches were identified (one incorrect date of birth in HES, one in 
RLR). Of the remaining 35 records in HES but not in RLR, 17 had no laboratory 
record, 9 had laboratory evidence of pneumococcal meningitis, 8 had positive blood 
cultures for Streptococcus pneumoniae, and 1 had been incorrectly reported 
(meningitis due to Group B streptococci). Of the 36 records in RLR but not in HES, 
33 had positive CSF cultures for S. pneumoniae, 1 only had septic arthritis, and 2 
had no laboratory record. An additional 5 cases were identified (3 only in laboratory 
records and 2 only in hospital trust records) that were not in the main study. Taking 
account of the 2 additional matches, the 2 incorrect diagnoses and the 5 additional 
cases, the capture-recapture estimate for the South West Region was unchanged at 
150 cases. 
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5.5 Discussion 
5.5.1 Strengths and limitations 
Although the use of capture-recapture analysis to estimate the burden of disease has 
its drawbacks (Tilling 2001), in the absence of large population base surveys, this 
method can provide good estimates of disease incidence and associated deaths 
(Hickman, Cox et al. 1999) (Brenner 1995), or at least more realistic estimates than 
those based on single databases. This study of adult pneumococcal meningitis has 
made several assumptions relating to the data and its analysis which must first be 
considered before these estimates can be used in policy making nationally and 
elsewhere. 
Data sources 
I used the three national data sources (NOTE analysis for each, incidence and 
mortality, was based in a two-source analysis), which are assumed to be the most 
representative and complete for pneumococcal meningitis. The data was 
accumulated in each of the data sources used in parallel and in a non-selective 
manner. Based on the premise that the population did not change Significantly within 
the study period [ONS population data], I assume that the population under study 
varied Similarly across sources . I was not able to include the clinician notification 
data in the incidence analysis because of the lack of personal identifiers and a date 
of Infection. 
Independence of sources 
The assumption that sources are independent is rarely fully met in epidemiology 
(Hook and Regal 1995). It is likely that there is some positive dependence between 
the sources, in that the laboratory confirmation of a case (RLR) is likely to lead to a 
notification to HES and, if death occurs, notification to ONS. This dependence would 
have, if anything, lead to an underestimation of the total burden of disease (Brenner 
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1994) (Brenner 1995), as the number of matched cases is likely to be higher than it 
would have been under independence and therefore the estimated total population 
would have been smaller. 
As I used a two-source capture-recapture method it was not possible to quantify this 
possible dependency of sources. A third representative and comparable source 
would have possibly been the clinical notifications to ONS, but: 1) due to the lack of 
personal identifiers it was not possible to include it in the analysis; and 2) the clinical 
notifications would probably be supplementary (Le. a strong positive dependence, 
meaning a laboratory report would lead to a clinical notification) source to the lab 
reports, therefore the estimates yielded would be poorer, e.g. the 95% CI Of the 
estimates would be a lot wider due to the dependency (Chang, LaPorte et al. 1999). 
It is highly unlikely that there is any negative dependency (ascertainment in one data 
source leading to non-ascertainment in the other) between sources which would 
have lead to an overestimation of the total population of pneumococcal meningitis 
cases and deaths (Brenner 1995). 
The temporal trends 
The estimated decreasing incidence during the study period could be suspected to 
have impact on the validity of the capture-recapture method. It would have been 
better accounted for if I did a loglinear model for timetrends. However, the data 
presented in Table 5.2 showing the analysis stratified by time, the overall estimate of 
the number of unrecorded cases is 521 and adding up the estimates of unrecorded 
cases for the 4 periods, we get a total of 558. This is the best estimate of the 
unrecorded cases, after allowing for time trends, which is a only very Slightly different 
total number estimated. Temporal trends are often found in the stUdies measuring a 
condition by capture-recapture methods (Hook and Regal. 2000). Possible 
explanations for the decreasing incidence over the time may be found in the changes 
in diagnostic practices. It is hypothesized form the stUdies on meningococcal disease 
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that the decrease in CSF diagnostic samples is replaced with increased blood culture 
samples (Ramsay, Kaczmarski et al. 1997). Nonetheless, even if the validity of the 
capture-recapture method is not affected, still these diagnostic mis-practices do have 
an influence on the management of cases (Fuglsang-Oamgaard, Pedersen et al. 
2008), therefore better epidemiologic data, such as this study provides should help to 
improving the training and clinical practice. 
Changes in surveillance systems 
In 1996 the surveillance of Invasive Pneumococcal Disease (IPD) in England and 
Wales was enhanced by actively asking all labs to report IPO episodes and refer 
isolates for typing. This study covers the period from the beginning when the 
enhanced surveillance for IPO was introduced in England and Wales. A peak on 
reporting of blood isolates occurred in 1997 (probably when the changes in the 
surveillance achieved the highest impact) (George and Melegaro 2001). But, an 
increased reporting is not seen in this surveillance system for the CSF isolates. A 
similar divergent trend between meningitis and septicaemia has been observed with 
enhanced surveillance of meningococcal disease in the UK. These changes did not 
appear to affect the analysis, in as much as the estimates follow the trend of the 
routine data sources, nationally and internationally. 
Equal probability of capture-recapture 
I assumed that the probability of cases being captured by each source is not 
influenced by the characteristics of the case and that almost all cases recorded by 
the RLR and ONS were also hospitalised. As shown in Table 5.1 cases derived from 
the data sources were similar in terms of age, gender and outcome. Recaptured 
cases did not vary Significantly from cases not recaptured, when examined by 
gender, by year, or age with exception of the older age group, 85+ (Table 5.3), 
though this did not have a major impact on the estimates. This is seen if we add up 
the total number of unreported cases by age group in Table 5.3, we get 578, 
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compared to 521 cases from the overall analysis. The discrepancy is due to the fact 
that the capture probability does vary with age, and is lower in 85+. However, the the 
overall impact on estimates of total burden is not huge, probably boosting the total 
number of unrecorded cases by only about 10% probably, which in the overall 
estimates of the total population would have hada negligible impact towards an 
underestimate. Nonetheless, the public health message is important: diagnostic 
practice for 85+ year olds is worse. This suggests that cases captured in the either 
source had an equal probability to be matched between the two data sources 
because of their characteristics, except for the older people (Cormack 1999). 
Misc/assification of diagnosis 
It is possible that there was some diagnostic misclassification of pneumococcal 
meningitis during the recording of the HES and the ONS data (2000; Williams JG 
2002). However, it would seem more likely that misclassification of pneumococcal 
meningitis onto meningitis cause 'unspecified' or cause 'unknown' occurred; most 
likely because of missing laboratory confirmation. This misclassification, if occurring, 
is likely to be similar across the two data sources examined, i.e. lab-reports I HES I 
ONS deaths. However, even if misclassification occurs capture-recapture analysis 
normally provides more reliable estimates than routine surveillance systems (Brenner 
1996). 
I restricted the analysis to records of pneumococcal meningitis from the primary 
diagnosis field of HES records, to avoid diagnoses not related to the reason for 
hospitalisation. As meningitis is commonly a serious condition, it is normally recorded 
as primary diagnosis in the first diagnostic field. It is unusual for meningitis to be 
recorded in the other diagnostic fields where typically chronic diseases are recorded. 
Searching other diagnostic fields in the South-West region validation analysis did not 
identify any additional cases. The sensitivity analysis using all diagnostic fields in the 
matching process did not reveal materially different results. The results from the main 
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analysis are likely to more reliable, as entries in other diagnostic fields may reflect 
past rather than current diagnosis. 
Accuracy of diagnosis and matching 
The study matching strategy was supported by the validation study conducted in the 
South West Region. This showed that matching without names for these data 
sources had a high degree of accuracy. An acceptable level of accuracy of recording 
laboratory confirmed cases was also found in both PHLS RLR and HES data 
sources, with only two false positive diagnoses being identified. There was no big 
change in the capture-recapture estimate after validation. 
Meningitis represents about ten percent of invasive pneumococcal disease among 
adults (Laurichesse, Romaszko et al. 2001). If all invasive pneumococcal positive 
isolates from the HPA RLR had been included, this would have greatly increased the 
probability of including false cases in RLR, thus increasing the probability of false 
matches, leading to overestimated results of the matched cases, but an 
underestimate of the total number of cases in the population. 
The inclusion of "non-specified meningitis" (ICD 10=GOO.9) would have led to a 
similar increase in the probability of including false cases in HES, and a similar 
overestimate of the total number of cases. 
Statist/cal analysis 
The parametric bootstrapping method is not the best for calculating the confidence 
intervals for cells with small numbers as it sometimes produces unbounded results. 
However, this does not invalidate the method, it just reflects the uncertainty around 
the data. In such circumstances other methods, such as for example Cormack's 
approximate method (a profile likelihood method), provide an alternative. However I 
did not have the capacity to apply such methods. Nevertheless, problems of low 
counts only emerged In sub-analyses. The evaluation of incidence overall involved 
183 
Dr A Gjini. Bacterial meningitis amongst adults. PhD thesis 
sufficient numbers of cases that such problems did not arise. Several sensitivity 
analyses showed that the estimates and Cis were robust. 
Another weakness of the analysis is not the calculation of Cis for the elderly. This 
could have been done using a full regression analysis allowing for time trends, age 
groups, sex. However, the results of my analysis show that such adjustments would 
have had a minor effect on the estimates, boosting the total number of unrecorded 
cases by only about 10% (see above under 'Equal probability of capture-recapture'), 
hence with a negligible impact on the overall counts. (International Working Group for 
Disease Monitoring and Forecasting 1995) 
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Chapter Six 
A review of hospital management of community acquired 
bacterial meningitis and meningococcal septicaemia in 
adults 
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6.1 Introduction and Background 
In Chapter 4 I presented the epidemiologic burden of Bacterial meningitis and 
meningococcal septicaemia in adults in England and Wales, including the incidence 
and mortality rates; and in Chapter 5 I showed that these rates as estimated from the 
routine data sources, are in reality probably almost twice as high. Clinically these 
conditions are serious, indeed potentially devastating. They are more common in 
small children and teenagers; but their severity and fatality rates are just as high in 
adults, and even higher in the elderly. 
A detailed description of the pathology, clinical presentation, recommended 
management of CABM and MS has been given in Chapter 2. 
In children, the last decade has seen many advances in the control and management 
of these conditions. The very successful immunisation programmes for Hib and Men 
C have dramatically decreased the incidence of meningitis (Ramsay, Andrews et al. 
2003), (McVernon, Ramsay et al. 2008) also there have been advances in clinical 
practice, reporting a reduced mortality and prevalence of long-term sequelae 
(Thorburn, Baines et al. 2001). In 2001 a study in clinical management of children 
highlighted improvements in the outcome of the disease (Booy, Habibi et al. 2001). 
However, mortality amongst young adults has remained higher than amongst 
children. In June 1999 the British Infection Society (BIS) published the Guidelines for 
management of bacterial meningitis amongst adults (8e99. 1999). These guidelines 
were published in the BIS journal and recommended by the Chief Medical Officer for 
England. A national study reviewing the clinical management of meningococcal 
disease (MD) in children and young adults was undertaken in 2001 - 2. The 
preliminary reports from this study were concerning, reporting considerable 
deficiencies in the delivery of the health care to adult cases (Ninis, Phillips et al. 
2005). 
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It was with this background that the Department of Health (DH) funded a proposal to 
review the clinical management of CABM and MS in adults in England and Wales. I 
was the Research Fellow on this project, and developed the study as follows. 
I undertook a retrospective review of clinical management of adult cases at hospitals 
across England and Wales. I reviewed case-notes (including: Accident and & 
Emergency, medical and nursing) of patients admitted in the randomly selected 
hospitals and assessed the practices against the indicators and standards of clinical 
practice, which I had developed, based on the published BIS guidelines (Chapter 3). 
This chapter presents the results of this research, which was a national review of the 
hospital management of adults with CABM and MS. Following this introduction I give 
a brief description of the methods used, a detailed description of the data and 
methods was presented in Chapter 3. Then I present the results, including the results 
of the pilot study that I undertook before embarking into the main study; then follow 
the results of the main study. At the end I discuss briefly the main findings in context; 
strengths and limitations of the study. A more detailed discussion and policy 
implications of the findings of this research are presented in Chapter 9. 
This research has been published as a peer-reviewed article: Gjini, A. B., Stuart, J.M. 
at al. (2006). "Quality of in-hospital care for adults with acute bacterial meningitis: a 
national retrospective survey." Quarterly Journal of Medicine; 99( 11): 761-9. 
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6.2 Data and methods 
The detailed description of the Data and Methods used is given in Chapter 3. Here I 
will just recall them briefly. 
This study was a retrospective review of case notes of patients with CABM and MS 
admitted and managed at a sample of randomly selected NHS hospital trusts in 
England and Wales between January 2000 and December 2001. 
6.2.1 The pilot study 
Prior to finalising the design of the main study, I undertook a pilot study with the aim 
of testing the reliability, validity of the study instrument (the questionnaire for data 
collection) and the feasibility of conducting the national review. The findings and the 
experience from the pilot study were fed into the design of the main study. Results 
are presented as plain percentages. 
6.2.2 The main study - design and data collection 
This was a national study reviewing the clinical management of CABM and MS 
amongst adults in England and Wales. 
The study was designed and conducted as a retrospective review of case notes of 
patients admitted at the randomly selected hospitals. 
The data was collected using a standardized case report form, which was revised 
following a pilot study in four hospital trusts. 
6.2.2.1 Selection of hospitals 
The primary sampling unit was the NHS healthcare trust. NHS hospital trusts were 
randomly selected from the list of all NHS hospital trusts across England and Wales. 
Two trusts were randomly selected from each of nine regions: the eight NHS regions 
of England (as in 2000/2001) and the single region of Wales. In trusts with more than 
one acute hospital, one hospital was randomly selected. 
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6.2.2.2 Cases of bacterial meningitis and meningococcal septicaemia 
I reviewed the medical records of patients aged 16 years and older with a diagnosis 
of acute bacterial meningitis and/or meningococcal septicaemia presenting to 18 
acute NHS healthcare trusts in England and Wales, between 1 January 2000 and 31 
December 2001. Cases were identified by discharge diagnoses with ICD 10 codes. 
6.2.2.3 Assessment of clinical practice, disease severity and outcome 
As mentioned above, in the Background section of this chapter, standards of clinical 
practice were agreed by the expert panel convened for the study, based on the 
published BIS guidelines and the results of the plot study (see Appendix 3). These 
standards relate to multiple steps in the diagnosis and management process, as 
described in Chapter 2, Background. They provide an analysis framework for the 
study (Chapter 3, Figure 3.2) 
6.2.3 Record keeping 
The quality of data recording in the clinical notes was classified as: 'Good' if more 
than 75% of essential information (as specified in the Standards and Indicators, 
Appendix 3.) was recorded; 'Medium' if 50-75% was recorded and 'Poor' if less then 
50% of essential information was recorded. 
6.2.4 Outcome 
The outcome of a case of CABM and MS was assessed using the following 
endpoints: death, length of hospital stay, and long-term sequelae (deafness, 
neurological deficit, major skin lesions or amputation). 
6.2.5 Statistical analysis 
I assessed the clinical practice based on the Standards and Indicators (Appendix 3.), 
adjusted to allow for: 
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• the clustering of the sample within hospitals and the within hospital 
correlation, as well as 
• stratification by regions 
wherever it was possible. If allowing for clustering effect resulted in increased the SE, 
of the estimate (e.g. proportion of cases) then results with this adjustment are 
presented. 
6.3 The pilot study results 
Four hospitals were included in the pilot study, one university teaching hospital and 
three district hospitals. The total number of records (cases of meningitis and/or 
meningococcal septicaemia) examined was 48. Numbers of records examined in the 
teaching hospital was 6 (12%) and in the district hospitals 15 (29%), 12 (25%) and 15 
(31%) each. 
6.3.1 Reliability and validity of the study Instrument 
The questionnaire was not difficult to use. Items in the questionnaire could easily 
relate to the information on the case notes. For items in which the information is not 
commonly recorded if the procedure is not done, it was not possible to differentiate 
between Not done and Not known. 
6.3.2 Demographics of cases reviewed 
Of the 48 cases reviewed 26 (54%) were female. Most cases were in the 45 to 64 
age group (29%) whilst the elderly were the smallest proportions (Le. 65+, 21%). See 
table 6.1. 
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Table 6.1 - Age distribution of cases reviewed in the pilot study. 
Age group Freq Percent (%) 
-
16-24yrs 11 23 
25-44yrs 13 27 
45-64yrs 14 29 
65+ yrs 10 21 
Total 48 100 
6.3.3 Note recording 
The standard of record keeping in the medical notes was as follows: 7 (15%) of the 
48 case notes reviewed in the pilot study were classified as good (>= 75% of 
essential information recorded), 33 (68%) medium (50-75%) and 8 (17%) poor. 
6.3.4 Management of cases at hospital 
25 (51%) of the cases were managed initially in Accident and Emergency 
Departments of the NHS hospital trusts, and others were admitted straight to the 
wards. Most of the cases, 30 (62%) were managed in more than one department 
during their stay. 42 (88%) cases were managed in medical ward, 2 (4%) in 
infectious diseases wards, 3 (6%) in paediatric wards, and 19 (40%) in HDU/ICU. 
6.3.5 Clinical management 
6.3.5.1 Pre-Hospital management 
32 out of 37 (86%) cases where information available, were seen by the GP before 
admission to hospital. In 5 of 26 (19%) where information recorded, there was 
evidence for GP having observed rash. Table 6.2, below, presents further information 
on pre-hospital management. 
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Table 6.2 - Pre-hospital management of cases of meningitis / septicaemia as 
recorded in the medical notes. 
Info 
recorded 
Pre-hospital management (%*) Yes (%**) 
Seen by GP before admission 37 (77) 32 (86.5) 
GP observed rash 26 (54.2) 5(19.2) 
GP suspected dg 20 (41 .6) 6 (30) 
GP administered B Penicillin 1 (2.1) 1 (100) 
*denominator is the total number of study records (no.48) 
**denominator is the number of study records with info recordea 
#among cases in which diagnoses was suspected. 
In 6 of 20 records where information was available (30%) there was a record of GP 
diagnosing meningitis / meningococcal septicaemia. Among these 6 cases, Benzyl 
Penicillin was administered in only one, whereas in 5 cases (83%) it was not. In the 
32 cases seen by a GP, irrespective of a GP diagnosis, Benzyl Penicillin was 
administered in only 2 cases. 
6.3.5.2 Initial hospital management 
Severely ill patients 
25 of 40 (62%) cases where it was a recorded had neck stiffness present. 22 of 25 
(88%) having a stiffed neck were managed at ICU. 13 of 41 (32%) where it was 
recorded, had a rash and 7 of these 13 (54%) were managed at ICU. 36 of the 48 
cases (75%) had a GCS recorded. 6 of 7 cases with conscious level of GCS <=8 
were managed at ICU. 
3 of 29 (10%) cases in which neurological examination was recorded, had focal 
neurological signs. In 22 of 38 (58%) meningitis cases (the other 10 were 
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septicaemia), a neurologic examination was recorded to have had been done. Table 
6.3 sets out key indicators for clinical management as recorded in medical notes. 
Table 6.3 - Initial hospital management of cases of meningitis / septicaemia as 
recorded in the clinical notes. 
Initial hospital management Info recorded (%) Performed Yes (%*) 
Parenteral a.b. within 1 hr 30 (62) 24 (80) 
Differential diagnosis included 35 (73) 24 (69) 
meningitis / septicaemia 
Parenteral a.b. throughout treatment 39 (80) 31 (79) 
course 
Consultant visited within 24hrs 16 (33) 15 (94) 
Lumbar Puncture done 44 (92) 27 (61) 
CT before LP 25 (52) 17 (68) 
Was CCDC contacted 26 (54) 21 (81) 
Was CCDC contacted within 12hrs 12 (25) 6 (50) 
* of cases for which information was available . 
Lumbar Puncture (LP) 
In 27 of 48 cases (56%) it was recorded that a LP had been performed . 17 of 27 
cases where a LP was performed, had a Computerised Tomography (CT) before LP, 
and 5 cases not; while for 5 cases the information was missing. 6 cases had a 
record of not having a raised ICP. In 21 of 38 (55%) meningitiS cases it was recorded 
that an LP had been performed. 2 of 3 cases in which papilloedema was recorded 
as present, had a CT scan performed. In 24 (69%) of 35 cases for which information 
was available, differential diagnosis included meningitiS / meningococcal septicaemia 
at admission «6hrs). 
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6.3.5.3 Other diagnostic investigation 
Table 6.4 presents the information on the diagnostic investigations as recorded in the 
clinical notes. 
Table 6.4 - Diagnostic investigations recorded . 
Recorded as 
Investigations done (%) 
Urea 34/48 (79) 
Blood Sugar 34/48 (79) 
Chest X Ray 15/48(31) 
P02 14/48 (29) 
PC02 14/48 (29) 
PC03 7/48 (15) 
Clotting screen 32/48 (67) 
Platelet count 40/48 (84) 
Blood for Men. Culture 33/48 (69) 
Blood Men PCR 11/48 (23) 
CSF Men PCR 1/21 (4.8) 
CSF Men Culture 14/21 (66) 
Throat swab 10/48 (21) 
*Including cases treated with Ceftriaxone as well. 
Treatment 
Where diagnosis was made at admission, in 15 of 19 cases parenteral antibiotics 
were administered within 1 hr. In 31 of 39 cases intravenous antibiotics were 
administered throughout the treatment course. In 15 of 16 cases were information 
was recorded, a consultant visited the patient within the first 24hrs. 24 of 48 cases 
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received parenteral antibiotics within 1 hour of arrival at hospital. (Although exact 
time was missing in some cases, I made an assessment, based on other information 
available, on the approximate time between admission and antibiotic administration). 
6.3.6 Clinical outcomes 
6.3.6.1 Final diagnosis 
27 (56%) cases were diagnosed as meningitis alone,10 (21%) as meningococcal 
septicaemia alone, and 11( 23%) cases were diagnosed as meningitis and 
meningococcal septicaemia. The organisms involved are listed in Table 6.5. 
Table 6.5 - Causative organisms of meningitis cases 
Organism Number Percent (%) 
Haemophilus B Influenzae 1 2 
Mycobacterium tuberculosis 1 2 
Neisseria meningitidis 
5 10 
Unidentified 
Neisseria meningitidis B 2 4 
Neisseria meningitidis C 3 6 
Streptococcus pneumoniae 10 21 
No isolate 16 33 
Septicaemia, only 10 21 
Total 48 100 
6.3.6.2 Deaths 
There were 4 deaths recorded before discharge from hospital (9%). Among the 15 
cases managed at ICU there was 1 death (7%). 
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6.3.6.3 Sequelae 
Information on sequelae recognised before discharge and/or at follow up was as 
follows: 7 cases had Deafness recorded at discharge, 6 Neurological deficit, and 10 
cases had records for Other sequelae (these included: loss of sight, confusion, 
headache, loss of memory, intermittent tiredness, depression, diplopia, arthritis). 
6.3.7 Notification and prophylaxis 
In 21 cases it was recorded that the CeDe was contacted, and only in 6 cases was it 
recorded that the CeDe was contacted within 12 hours of diagnosis. 
6.3.8 Recommendations for the main study 
Based on the findings and the experience from this pilot study the following 
recommendations were made for the design and the conduct of the main study, 
including design of the study questionnaire and standards and indicators: 
6.3.8.1 Standards to be used for assessment of management 
The following indicators should be used to assess the standards of care: 
• Mean time of referral from admission to leu for severely ill patients. 
• % of all bacterial meningitis and meningococcal septicaemia cases assessed by 
an leu team during their hospitalisation. 
• % of differential diagnoses that include meningitis I meningococcal septicaemia 
at first assessment «=12 hrs). 
• % of cases reported to eeoc on the day of admission, where MD diagnosis 
suspected. 
6.3.8.2 Review of the study Instrument 
The following recommendations were set out for the study instrument (case report 
form, Appendix 5) and specifically relate to: 
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Item 5 Sequelae: to collect information whether recognised at discharge or at 
outpatient follow up. And to add a section to this item: 'Was a hearing test done? If 
yes, when (date). Result. 
Items 8, 9 and 10: Information on investigations requested to be accompanied with 
whether investigations performed. If Yes should record the result of the investigation. 
Add a new item to the study intrument: "Was the patient assessed by ICU team?" 
Also, add a new item on: "Existing pre-medical conditions (chronic heart, lung, liver, 
renal diseases}." 
6.3.9 Conclusion from the pilot study 
The experience from the pilot study was useful for the design and conduct of the 
main study to review the clinical management of adults with CABM and MS in 
England and Wales. 
Valuable information was obtained on the feasibility of the enrolment of hospital 
trusts and the cases; on the feasibility of data collection; on the validity, reliability and 
usefulness of the study questionnaire; and on key information about the 
recommended standards of practice on which to base indicators for assessing 
clinical management. 
I reported on the experience and findings from the pilot study to the expert panel that 
was overseeing the review of hospital management study. As mentioned above I 
took account of and incorporated the recommendations that came out of the review 
from the expert panel into the design and conduct of the main study, which is 
presented below. 
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6.4 The main study 
6.4.1 Characteristics of the patient population and NHS trusts 
The sampling method has been described in Chapter 3 (give precise ref). Eighteen 
Acute NHS Hospital Trusts across England and Wales were included in the study. Of 
these, 3 were university teaching hospitals. These hospitals accounted for 23% (43 
cases) of all cases included in the anlaysis for this study. 
The median number of beds per hospital trust was 600 (Lq.r 375 to 650). All hospital 
trusts had an ICU; while 25% (5/19) had, also, an infectious disease unit. All the 
medical records reviewed and included in the analysis had been coded correctly and 
no apparent alternative diagnoses were documented in any of the records. 
Within the 18 sampled hospitals, I identified a total of 212 cases that were diagnosed 
as bacterial meningitis or meningococcal septicaemia (ICD 10: A39; GOO) in adults. 
For 5 cases their case notes were not available at the time of review, so were not 
included in the study. I also excluded 17 cases following study exclusion criteria, and 
that listing: 6 for past neurosurgery, 5 as immunocompromised (steroids, 
chemotherapy, HIV, splenectomia), and in 2 cases meningitis occurred more than 2 
weeks after being admitted to hospital, 4 were referred from another hospital. The 
highest number of cases excluded from one trust was 4. Thus, a total 190 cases was 
included in the analysis. 
Of these, 153 (81 %) were recorded as having a diagnosis of suspected meningitis or 
septicaemia (and all of these would then contiue to have this as a final diagnosis, as 
otherwise they would have had been exclude from the study, see case definition, 
Chapter 3). Of the 190 cases; 107 (56%) had a recorded diagnosis of meningitis 
alone, 46 (24%) had a diagnosis of combined meningitis and septicaemia, and 37 
(20%) of them of them the diagnosis recorded was of solely septicaemia. 
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The median number of cases enrolled in the study per trust was 8 cases (ranging 
between 4 and 16 cases from each hospital). The highest proportion of cases that 
one trust accounted for in the total number of cases in the study was 9% and the 
lowest 2%. 
Table 6.6 - sets out the organisms involved and the main characteristics of the 
patients in the study cohort. 
Unweighted Weighted' 
n (%) 
n (%) 
Age group 16 - 24 71 (37) 69 (37) 
25 - 64 87 (46) 87 (46) 
65+ 32 (17) 34 (18) 
Sex female 94 (49) 98 (52) 
male 96 (51 ) 92 (48) 
Co-morbiditl No 165 (87) 164 (86) 
Yes 25 (13 ) 26 (14) 
Diagnosis N. meningitidis serogroup B 26 30 
serogroup C 9 9 
serogroup Y 0 0 
serogroup not 25 24 
recorded 
total 60 (32) 63 (33) 
S. pneumoniae 25 (13 ) 27 (14 ) 
other 3 (2) 3 (1 ) 
clinical diagnosis 102 
alone* 
(54) 98 (52) 
Total 190 (100) 190 100 
, = see methods 
~ = chronic heart, lung, kidney or liver disease 
• 15 (14%) of patients with meningitis alone did not have a laboratory confirmed 
diagnosis" Total number in the 3rd column adds up to 191 due to rounding error induced by the weightin 
For most of the cases (no.=102; 54%) the diagnosis was solely based on clinical 
picture, with no laboratory confirmation (no isolate, or other test: PCR, CSF/blood 
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smear). This percentage was lower in cases of meningitis alone (14%) than in cases 
diagnosed with septicaemia (solely or both). The most frequent causative organisms 
identified were N. meningitidis (32% of confirmed cases) followed by S. pneumoniae 
(13%) 
The age distribution of the study cohort was similar to the national surveillance data 
(Figure 6.1), as was the gender distribution (51 % of the cases were male). 
Figure 6.1 - Age distributions of the hospital review sample and national surveillance 
data. 
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For 67 cases there was a record of patients' occupation . Of these, the most 
frequently recorded occupations were 'student' (n = 35, 52% of records); 'housewife' 
(n =10; 15%); 'retired' (n =5; 7%). 7 (10%) cases were classified as professionals and 
10 (15%) as manual skilled & non- skilled workers. 
6.4.2 Examination of the clinical parameters of the patient population 
Neck stiffness was present in 69% (100/144) of cases in which it was recorded as 
having been examined. whereas a fundus examination was done in 104 cases and 
papilloedema was positive in 13 cases (in 9 cases it was not possible to examine). A 
neurological examination was done in 133 cases, and a focal sign was recorded to 
be present in 13% (10/133) of these cases. GCS was measured in 144 cases and 
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the mean value was 13 (s.e. 0.97; median 14); the lowest value recorded was 3. 
Intravenous antibiotics. were given throughout the treatment course in 157 cases and 
the fluid management plan was recorded in a majority of cases (110/190). Table 6.7 
presents the frequency of diagnostic investigations performed in the study cohort. 
Table 6.7 - Diagnostic investigations in the cases of CABM and MS, England and 
Wales, 2000 - 2001 . 
I Investigation % 95%CI N l 
Pulse 92 88 to 96 190 
Temperature 85 79 to 97 190 
Systolic bl. pressure 93 90 to 97 190 
Rash 91 86 to 95 190 
Clinical Respiratory comprise 44 35 to 53 190 
sings Neck stiffness 76 67 to 86 190 
Papilloedoema 50 67 to 86 190 
Neurological examination 70 63 to 78 190 
GCS 73 66 to 80 190 
Capillary refill time 4 o to 8 190 
Opening pressure 62 50 to 73 62 
WCC 100 99 t0100 112 
WCC differential 98 94 to 100 85 
RBC 100 99 to 100 100 
LP G stain 98 95 to 100 84 
Protein 99 97 to 100 104 
Sugar 100 99 to 100 100 
CSF Culture 97 90 to 100 59 
CSF PCR 69 48 to 89 61 
Blood CRP 77 63 to 91 149 
Blood PCR 57 37 to 77 106 
Blood sugar 92 8 to 95 162 
FBCHb 100 99 to 100 181 
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FBCWCC 
Clotting 
Platelet 
100 
86 
99 
99 to 100 
80 to 91 
98 to 100 
183 
190 
179 
Mean pulse rate was 98.3/min (s.d. 1.3), temperature 37.8 Celsius (s.d. 0.74), mean 
systolic blood pressure measured 127.8 mmHg (s.d. 2.61); diastolic 71.6 mmHg (s.d. 
1.09); a rash was recorded in 31 cases; peripheral perfusion was measured as a 
capillary refill time only in 2 cases, and in 81 cases by other methods. 
6.4.3 Clinical practice 
Multiple elements of the diagnostic and management process from first assessment, 
early management through to prevention of secondary cases did not meet the 
recommended clinical practice standards. There was incomplete recording of clinical 
information across a range of parameters (Details of record keeping are presented 
further below in this section). 
6.4.3.1 Pre-hospital management 
48% of the patients (95% CI 39% to 56%) for which this information was recorded 
had seen a GP before hospital admission (Table 6.8). A suspected diagnosis of 
CABM or MS was recorded in 40% (95% CI 25% to 55%) and parenteral benzyl 
peniCillin was recorded as given in the community to 20% (95% CI 11 % to 29%) of 
these cases. Where bacterial meningitis or meningococcal septicaemia were 
diagnosed, benzyl penicillin was recorded as given to 84% (95% CI 56% to 96%). 
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Table 6.8 - Management of cases at GP practices, before admission to hospital. 
Pre-Hosoital management 
Seen by GP 
GP observed rash 
GP suspected diagnosis 
GP administered Benzyl 
Penicillin 
6.4.3.2 Hospital management 
First assessment in secondary care 
Yes (%) 
79/164 (48) 
16/79 (19) 
32/79 (40) 
17/85 (20) 
115 (71%, 95% CI 65% to 77%) of cases were seen in emergency departments, the 
remainder were admitted directly to medical assessment units or other wards. 
For most of the patients the first assessment was made by a Senior House Officer 
(SHO), followed by a Specialist Registrar (SpR), whilst a consultant made the first 
assessment in only 2 cases (see Table 6.9). 
Table 6.9 - First assessment by medical staff. 
No. (%) 
JHO 8 (4) 
SHO 93 (49) 
First assessment by SpR 50 (26) 
Consultant 2 (1) 
Not known 37 (20) 
The time to medical assessment, appropriate diagnosis and prompt administration of 
parenteral antibiotics varied considerably (Table 6.9). There was considerable 
variation in the speed and accuracy of the first assessment. For example, the median 
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time from arrival to first assessment was 45 min, but with Lq.r 10min to 1 h 50min. 
Similarly, the interquartile range for the time from arrival to receiving intravenous 
antibiotics was 15m to 3h. 
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A differential diagnosis including CABM or MS was recorded in 82 (56%, 95% CI 
45% to 67%) cases. Overall, parenteral antibiotics were administered to 56% (95% 
CI 46% to 66%) of cases within one hour of first assessment but when a diagnosis of 
CABM or MS had been made, were administered to 86% (95% CI 72% to 100%). 
Severity of illness assessment 
Of all cases of CABM and MS in this study (total 190) a full severity assessment was 
made in 18 (10%, 95% CI 5% to 15%) of them, whilst a partial assessment of 
severity (as defined in Chapter 3) was done in 63 cases (33%, 95% CI 25% to 39%). 
Although 68 (81 %, 95% CI 70% to 92%) severely ill cases underwent some form of 
severity assessment, only 27%, (43/162) underwent a full severity assessment. 
Amongst meningitis cases 34% (95% CI 22% to 46%) were assessed fully or partially 
for severity, whilst amongst the meningococcal septicaemia cases this was done in 
75% (95% CI 61%,89%) of cases. Overall, the time to assessment by an ICU team 
was highly variable (Lq.r between 35m to 8h 30m) but varied less for severely ill 
cases (35m to 2h 35m). 
Lumbar puncture and CT Brain Scan 
A lumbar puncture was performed in 65% (120/185; 95%CI 54 to 75) patients overall 
and in 79% (117/149; CI 70% to 85%) patients with bacterial meningitis, with or 
without septicaemia, whereas in patients with meningitis alone 11 (10%) of them did 
not undergo a LP. 
Among the 35 cases where all the relevant information was available, 14 underwent 
lumbar puncture in the presence of either papilloedema, a GCS of ~ 10, and/or focal 
neurology. Of the 126 cases for whom the information was available, 81 (64%, 
95%CI 55% to 82%) underwent CT brain scan before LP. The exact time when the 
CT was performed was not generally recorded and therefore it was not possible to 
assess whether CT contributed to the delay in administration of antibiotics. 
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6.4.3.3 Recording of clinical findings and investigations. 
There was incomplete recoding of clinical information across a range of parameters 
(Table 6.11). Record keeping was classified as good in 125 (68%) medical notes. 
Table 6.11 - Record keeping of clinical management in the case-notes of patients. 
Record keeping % 95%CI (N.185) 
Bad 2 o to 5 
Fair 30 23 to 37 
Good 67 60 to 75 
The quality of record keeping varied slightly and not significantly when the senior 
staff assessed patients. Table 6.12 presents the recording of the essential 
information (See Appendix 3) on clinical management of a case by the senior staff. 
Table 6.12 - Essential information recorded if assessed by senior staff. 
Essenitallnfo 
recorded % (95% el) 
Assessed by a 65 (50.1 to 82.8) consultant 
Assessed by a 76 (59.9 to 95.1) ."' ... - -
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6.4.3.4 Treatment with antibiotics 
In the 179 cases where the antibiotic administered was recorded, cefotaxime or 
ceftriaxone were the most common first-choice parenteral antibiotics (n=117, 65%), 
followed by a combination of Benzyl Penicillin and cefotaxime (n=44, 25%). None of 
the 4 cases with a recent history of travel to high-prevalence antibiotic-resistant 
countries, including Spain and USA, was prescribed vancomycin. 
6.4.3.5 Consultant's speciality 
The specialty of the consultant in charge was available for 153 cases, the majority 
were general physicians (82, 54%). Consultant geriatricians and neurologists were in 
charge of 16 (10%) cases each; followed by cardiologists in charge of 11 (7%). In 37 
cases it was not possible to retrieve this information. 
6.4.3.6 Notification and antibiotic prophylaxis 
In total 111 cases where reported to a consultant for communicable disease control 
(CCDC - a medical consultant responsible for the surveillance, prevention and control 
of communicable disease) at some stage. However, this notification was done within 
24 hours of diagnosis (as per recommendation) in 64 cases of 72 where information 
on the time of reporting was available (86%,95% CI 76% to 93%).58 cases received 
rifampiCin and an additional 23 cases received ceftriaxone as part of treatment alone, 
so that in total 81 (43%, 95% CI 35% to 50%) of all 190 cases reviewed, and 76% 
(95% CI 62% to 87%) of the 106 meningococcal meningitis or meningococcal 
septicaemia cases received recommended antibiotics to eradicate carriage before 
discharge. 
6.4.4 Variation In clinical practice between hospitals 
Numerous differences in the clinical management of CABM and MNS between NHS 
trusts were observed. Figure 6.2 highlights the variation between the 18 hospitals in 
four indicators, namely: 'First assessment within 1 hour of arrival', 'Consultant review 
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within 12 hours of arrival', 'Fully or partially assessed for severity for CABM cases' 
and 'Good record keeping of essential investigations'. This variation was most 
marked for 'review by a consultant within 12 hours of arrival' (p<0.005), the 
proportions meeting this criterion ranging from 0 % of patients reviewed to 100%. For 
the other clinical indicators, though the variation was large in terms of clinical 
significance, this was not statistically significant. For example, the proportions 
meeting the standard ranged from 0% to 100% for 'First assessment within one 
hour', and from 45% to 95% for 'Good record keeping' (see Figure 6.2). 
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6.4.5 Outcomes 
6.4.5.1 Length of stay 
The median length of stay in hospital was 10 days (Lq.r. 7 to 16 days). 
6.4.5.2 Case-fatality 
In total there were 21 deaths in the cohort, constituting an overall fatality rate of 11 % 
(95% CI 7% to 17%). 
Diagnosis 
For meningitis only cases, the fatality rate was 14%, (X out of Y, 95% CI 9% to 19%); 
whilst for MS it was 13%, (X out of Y, 95% CI 6% to 21%). Among the 79 cases 
managed at HDUIICU there were 14 deaths (CFR 18%; 95% C111% to 28%). 
Causative organism 
The highest fatality rate by causative organisms was recorded for the cases with no 
isolate 25%, (95% CI 15% to 37%). However, where a organism was isolated S. 
pneumoniae was the commonest cause of death with a case fatality rate of 18% 
(95% C111% to 28%). 
Age 
Case fatality rates were highest among individuals 75 or more years old (38%, 95% 
C17% to 71%) compared with 6% for those aged 55 - 64 years old (see Table 6.12) 
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Table 6.13 - Case fatality rate by age group 
Age group Fatality % 95%CI N 
16-24 9 3 to 15 71 
25 - 34 13 o to 31 19 
35-44 6 o to 17 27 
45 - 54 12 o to 28 22 
55 - 64 6 o to 18 19 
65 -74 10 o to 22 19 
75 - 64 39 7 to 71 11 
85+ 0 - to- 2 
16 + 11 7 to 17 190 
6.4.5.3 Long term sequelae 
Of the 190 patients, 65 (34%) had long-term sequelae at discharge (many had 
multiple sequealae), including: hearing impairment (n=30), other neurological 
impairment (34), severe scarring or plastic surgery (8), loss of digits or limbs (6) and 
other sequelae such as renal failure, behavioural change, chronic arthritis or 
peripheral ischaemia (16). 
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6.5 Discussion 
6.5.1 Strengths and limitations of the study 
This study was based on a randomly selected sample of national acute NHS trusts. I 
examined contemporaneous data, reviewing medical records of patients, including 
A&E, and nursing notes. The general characteristics and age distribution of this 
cohort was similar to that expected from national surveillance data (Chapter 4). 
CABM and MS are relatively uncommon in adults, therefore a prospective study 
would have not been feasible. My findings were limited by the quality of case note 
keeping. This was the main limitation which impaired the analysis. Some were 
particularly affected, such as: a) severity assessment was restricted to those 
parameters that were commonly documented; b) the assessment of timeliness of the 
management indicators. 
The study was retrospective, hence did not affect the quality of records kept in the 
medical notes. A prospective study would have most likely ensured that the essential 
medical indicators were more completely recorded. However, the study would then 
not have been representative of real management practices. 
The poor medical record keeping is also likely to both affect and reflect inadequacy in 
medical practice, and it is likely to increase the risk of error (Mann, 2003; Huston, 
2004). 
6.5.2 Conclusion 
This study revealed many areas of clinical practice where standards of care do not 
meet the recommended standards. The study also emphasized a need for 
improvement in several areas of clinical practice relating to CABM and MS, these will 
be discussed in more detail Chapter 8, Discussion and in Chapter 9 
Recommendations. 
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Chapter Seven 
Association of clinical management with the outcome of 
community acquired bacterial meningitis and 
meningococcal septicaemia in adults in England and 
Wales 
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7.1 Introduction 
In the previous chapter I showed that many of the key clinical management 
recommended standards are not met in current clinical practice. 
There is a current debate around the evidence on the benefit of early recognition of 
CABM and MS and, in particular, early antibiotic treatment (Harnden et al. 06). It is, 
though, recognised that much of this lack of evidence is due to inherent limitations of 
observational studies, including confounding and lack of prospective studies. These 
problems are compounded by the inappropriateness of randomised studies. 
Much effort in policy making and improvement of health-care services is put into 
agreeing standards of care (Shekelle and Schriger 1996). However for many of the 
recommendations the evidence on whether they do improve the outcome of the 
disease is not robust, or is unavailable. Unless randomised controlled trials are 
undertaken it is difficult to assess the effect of standards of care on outcomes. 
Observational studies assessing the effect of a treatment or exposure are often 
subject to bias and confounding which can be difficult to eliminate or control for using 
standard statistical methods, including multivariate models. These conventional 
statistical techniques may not adjust for the important prognostic characteristics 
between the treatment subjects, and the remaining bias may limit valid causal 
inference. Use of propensity scores models is considered to better adjust covariates 
between the groups and reduce bias, especially when there are many relevant 
covariates and data on outcomes are sparse. Retrospective studies, such as the 
review I undertook on the clinical management of CABM and MS also are subject to 
miSSing data. I attempted several approaches to dealing with miSSing data in this 
chapter. 
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The purpose of this chapter is to examine the association of clinical management 
indicators with the outcome of the disease and compare the statistical approaches in 
this context. 
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7.2 Data and Methods 
7.2.1 Data 
The data used in this part of the research are from the review of case-notes from 
randomly selected hospitals across England and Wales. These are described in 
details in Chapter 3 and are the same as the data used in Chapter 6. For the purpose 
of this investigation I had to generate a few new variables, such as: 
a) Clinical predictors: 
High glucose; high systolic pressure; high blood urea; - these variables were 
generated as a dichotomous variable based on the original continuous variable, 
using the recommended normal range of clinical parameters. 
b) Management Indicators: 
Continuous: time to first assessment; time to antibiotics; time to first diagnosis; time 
to consultant IICU review - these were derived from time of arrival to the time of the 
performed indicator (for details see Chapter 3); 
Dichotomous: first assessment within one hour; antibiotics within one hour; diagnosis 
within one hour; consultant I ICU review within 12 hours are based on the defined 
standards are generated from the original data as above. 
7.2.2 Methods 
For details of the data collection, see Chapter 3. 
I excluded cases where death occurred in less than 6 hours as it was considered that 
the impact of clinical management could not be examined in these cases. 
7.2.2.1 Outcome 
Outcome was defined as adverse if the patient died or survived with the defined (see 
previous chapter) long-term sequelae (McMillan, Lin et al. 2001). Outcome was good 
if the patient recovered and without the defined long-term sequelae. The Outcome 
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variable was coded 1 if outcome was adverse, 0 if outcome was good. Thus the odds 
ratios presented are for adverse outcomes. 
7.2.2.2 Severity of illness 
Illness was defined to be severe if cases met the following criteria. For the meningitis 
only cases: GCS of 10; low pulse rate «60) and high systolic pressure (>140); low 
platelet count >100/m3 • 
For the septicaemia cases: GCS of 10; low systolic pressure «90mmHg) and no 
neck-stiffness; low WCC « 1 Omm3) and low platelet count « 1 00/mm3 ). 
7.2.2.3 Clinical management indicators examined 
I identified four main clinical management indicators to be examined against the 
outcome. These were: early medical assessment; early suspected diagnosis; early 
antibiotic treatment; and review by a senior clinician including consultant and ICU 
team. 
7.2.3 Statistical methods 
These are described in full detail in Chapter 3. 
Odds ratios and 95% confidence intervals were derived from logistic regression 
models, adjusting for random hospital effect. Univariable analysis included only the 
exposure of interest, i.e. one of the clinical management indicators examined with the 
outcome. Multivariable analysis was used to adjust this association for possible 
confounders. The latter were identified from the analysis of clinical parameters 
associated with the outcome; all the relevant clinical parameters for which I collected 
data were examined using logistic regression analysis. 
7.2.3.1 Dealing with the missing data 
I used two different approaches to dealing with missing data, as follows: 
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Assuming best and worst scenario for subjects with no data on a clinical 
management indicator (Bridewell, Langley et al.; Collaboration 2002; Gamble and 
Hollis 2005). 
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7.3 Results 
A total of 187 cases where included in the analysis for this chapter (3 cases were 
excluded as they died within 6 hours of admission) . 
7.3.1 Prognostic factors associated with outcome 
Several clinical features were found to be associated with the outcome, namely: age, 
high systoliC blood pressure, GCS, high blood urea, high blood glucose, causative 
organism . These are referred to as 'the prognostic factors' (Table 7.1). 
Table 7.1- Prognostic factors associated with outcome, statistically significant in 
univariate analysis. 
Prognostic factors associated with outcome, statistically significant In univariate 
analysis 
N (n) OR (95%CI) 
continuous 187 (44) 1.04 (1.02 to 1.05) 
Age 
<65yrs 155 (61) 1 
>65yrs 32 (22) 3.39 (1.50 to 7.65) 
Neisseria meninqitidis 63 (19) 1 
Streptococcus 
Causative organism ipneumoniae 25 (18) 5.41 (1 .93 to 15.16) 
Other isolated 
organisms 4 (2) 2.10 (0.27 to 16.10) 
Clinical diagnosis only 95 (44) 1.00 (0.56 to 1.79) 
continuous 140 (49) 0.89 (0.79 to 0.99) 
GCS 
>=13 73 (30) 1 
<13 67 (39) 1.99 (1.02 to 3.91) 
Blood Pressure I Systolic 
continuous 187 (83) 1.01 (1 .00 to 1.02) 
<=90mmHg 118 (44) 1 
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>90mmHg 56 (36) 0.94 (0.82 to 1.08) 
continuous 140 (52) 1.13 (1.04 to 1.23) 
Blood Urea 
Low 107 (36) 1 
High 80 (47) 2.81 (1.54t05.11) 
continuous 14 (6~ 1.1611.03to 1.31) 
Blood sugar 
Low 118 (48) 1 
High 69J351 1.510.82 to 2.731 
Neuromuscular 
convulsions YIN 75 (8) 9.11 (1.04 to 79.96) 
N - number in analysis 
n - number with adverse 
outcome 
The reference level is No (entered as 0, lower entry, in the data). 
7.3.2 Clinical management factors associated with outcome 
The only clinical indicator that was associated with outcome was diagnosis within 1 
hour, as first assessment was defined. Of the 111 cases that had a diagnosis made 
in the first hour, 48 had an adverse outcome; the odds ratio of 0.45 (95% CI 0.22 to 
0.93 Table 7.2) indicated an increased benefit from early diagnosis. However in the 
multivariate analysis controlling for the clinical predictors listed above, this 
association weakened and was not statistically significant (Table 7.2). 
No other clinical indicator examined appeared to be associated with the outcome of 
the disease, in either univarlable or multivariable analysis. (see Table 7.2). 
While the odds ratios for the association between adverse outcome and clinical 
management indicators were generally not significant, most tended to indicate a 
protective effect (Table 7.2). 
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Table 7.2 - Uni and multi variable analysis of association between clinical 
management and outcome in bacterial meningitis amongst adults. 
Uni and multi variable analysis of association between clinical management and 
outcome in bacterial meningitis amongst adults. 
Clinical management OR (95%CI) 
indicator Yes (a) N (n)* OR (95% CI) adjusted" 
First assessment within 
1 hr (YIN) 58 (24) 187(118) 1.01 (0.94 to 1.07) 0.96 (0 .87 - 1.07) 
Diagnosis on first 
assessment (YIN) 111 (48) 154 (101) 0.45 (0 .22 to 0.93) 0.52 (0.17 - 1.56) 
Antibiotics on first 
assessment (YIN) 67 (26) 103 (73) 0.99 (0.43 to 2.29) 1.55 (0.41 - 5.85) 
Consultant review within 
12 hours (YIN) 28 (12) 118 (187) 1.001 (0.937 to 1.085) 0.979 (0.881 - 1.088) 
ICU review within 12 
hours (YIN) 330 0 0.988 (0.906 to 1.078) 1.016 (0.903 - 1.145) 
Specialist" review within 
12 hours 470 0 0.969 ( 0.893 to 1.051) 0.942 (0.842 - 1.053) 
Yes - number with the indicator performed NA: Not appropriate 
a - number with adverse outcome 
" Consultant or ICU 
N - number in unadjusted analysis team 
n - number in adjusted analysis " aQe, GCS, BP, Urea 
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7.3.3 Dealing with the missing data 
7.3.3.1 Assuming the best vs. worst scenario 
Assuming that subjects for which there was no relevant data did have the 
recommended clinical management indicator present (best scenario) generally 
resulted in more protective associations, though for none of the indicators examined 
did this result in a significant association (Table 7.3). 
The pattern was less consistent when it was assumed that subjects with missing data 
did not have the recommended clinical management indicator present (worst 
scenario); these associations were not significant either (Table 7.3). 
Table 7.3 - Multivariable analysis of association between clinical management and 
outcome in bacterial meningitis amongst adults - assuming the best or worst scenario 
for the missing data. (N=187) 
Multivariable analysis of association between clinical management and outcome in 
bacterial meningitis amongst adults - assuming the best or worst scenario for the 
missing data. (N=187) 
Clinical management indicator OR (95% CI) best OR (95% CI) worst 
Assessment within one hour from 0.77 (0.30 - 1.98) 0.96 (0.87 - 1.07) arrival 
Diagnosis within one hour from 0.41 (0 .14 - 1.21) 1.19 (0.48 - 2.92) arrival 
Antibiotics within one hour from 2.57 (0.77 - 8.54) 0.51 (0.22 -1 .18) arrival 
Consultant review within 12 hrs 0.98 (0.88 - 1.09) 0.98 (0.88 - 1.09) from arrival 
ICU review within 12 hours 1.03 (0.91 -1.16) 1.03 (0.91 -1.16) 
Specialist" review within 12 hours $ NA 1.58 (0 .65 - 3.83) 
$ . predicts failure perfectly! 
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7.4 Discussion 
Would the outcome of cases of CABM and MS actually improve if the recommended 
standards of care are met? In an initial analysis of the four key indicators as part of 
the review of the clinical management (presented in the previous Chapter) I found no 
significant association with the outcome. This led me to explore this question further. 
7.4.1 Strengths 
This part of my research dealt with a very important question - that of the effect of 
clinical factors and clinical management in the outcome of the disease (CABM and 
MS). 
The identification of clinical predictors is consistent with other studies in adults with 
CAB M and MS. I found that age, causative organism (and S pneumoniae in 
particular), blood pressure, conscious level and blood level of glucose and urea were 
associated significantly with a adverse outcome (van de Beek, de Gans et al. 2004). 
Much effort is directed to developing clinical guidelines and in implementing them in 
clinical practice (Shekelle and Schriger 1996; Shekelle, Woolf et al. 1999), hence it is 
important to have evidence that those efforts are appropriate, i.e. have the desired 
impact (Raine, Sanderson et al. 2005). The evidence for this is lacking, particularly 
so in the management of CABM and MS, where there is a recent debate about some 
of the recommended practice, i.e. early management with a.b (Hahne, Charlett et al. 
2006; Harnden, Ninis et al. 2006). For this reason, I sought to address this issue in 
this part of my thesis. 
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7.4.2 Limitations 
The major limitation of this part of the study was its low power, further reduced by 
missing data. Incomplete data is a common problem with regard to clinical management 
(Davenport, Dennis et al. 1995), as was shown in the previous chapter. However the 
extent of the missing data on variables of specific interest, such as the times to 
intervention in clinical management, was very high. This compromised even the methods 
used to dealing with the missing data. 
I attempted to assess the impact of missing data by carrying out a sensitivity analysis, 
assuming best and worst scenarios for the missing clinical management indicator. This 
showed the estimated odds ratios for the effect of the clinical management to lie in the 
direction that would be expected, though the 95% CI were wide and inclusive of the 
value of no effect, i.e. 1 (Collaboration 2002). The impact of missing data was also felt 
on the clinical indicators; a similar best/worst scenario could have been used for these 
(Personal communication, Prof D Lawlor, 2008) (Table 7.3). 
Another approach to dealing with missing data is (multiple) imputation. This method of 
dealing with missing data is widely recommended, and is based on the assumption that 
the subject with missing data are similar to their cohort of cases with respect to the 
variable in question (Schafer 1999; O'Rourke 2003). As noted above the extent of the 
missing in my study data was, particularly for some indicators, very high. There is no one 
acceptable amount of missing data, below which imputation will not be effective. It is 
generally considered that when the rate of the missing data is over 50% there is not 
much benefit In applying multiple imputation for dealing with missing data (Personal 
communication Prof J Sterne, Prof 0 Lawlor, 2008). An approach ot the impiutation of 
the missing data would have been to estimate the average value of the time to 
intervention for the subjects with missing data and impute this average where data were 
missing (Schafer 1999, Schafer and Graham 2002). 
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I consider application of the propensity scores analysis, which is considered as another 
appropriate approach to examinig risk associations in observational studies as it 
provides a simpler and robust way to control for multiple clinical variables that influence 
both treatment and outcome - i.e. confounders. Propensity scores can be described as 
the conditional probability that a subject will be treated, based on an observed group of 
underlying subjects' characteristics (prognostic factors) (Kurth, Walker et al. 2006). 
However, as the logistic regression analysis, and attempts to deal with the missing data 
were not indicative of any promising or sensible results in more complex analyses, I did 
not carry out the analysis of the propensity scores. The approach would have been to 
obtain the propensity score from the logistic regression model including the following 
pretreatment variables: age, causative agent, clinical- severity: low platelet count. Then 
match the subjects using a criterion e.g. +-0.05 (depending on results of propensity 
score form log regression model) of the propensity score and grouped as such 
(Heckman et al. 1997) for further analysis. 
Neither of these methods, i.e. imputation of the missing data or propensity scores 
analysis, would help overcome the essential problem with these analyses, which is that 
they are under-powered. This is essentially as the primary aim was not to investigate the 
impact of management on outcome, but to describe management (see Chapter 3, 
Calculation of study sample). Nonetheless my study suggests that management might 
influence outcome, but a larger study is needed to estanlish this conclusively. 
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Chapter 8 
Discussion 
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8.1 Introduction 
ltSeeking to know is only too often learning to doubt," 
Antoinette Deshoulieres 
In this chapter I will contextualise the findings from my research, compare them with 
other adequate published reports and discuss the implications for practice and policy. I 
will start with the main findings from the examination of the epidemiology of CABM and 
MS, to follow with the results and their application from the capture-recapture analysis. 
Once the epidemiology of the disease is addressed I will move to its clinical 
management. I will address the main findings from the review of clinical management, 
comparing them with other similar research and addressing their relevance in improving 
clinical standards. I will then discuss the possible association of clinical management 
with the outcome of the disease. I will then debate how this research fits with an 
improved understanding and hence improved outcome from CABM and MS. 
In the next part of this chapter I will review the strengths and weaknesses of this 
research. Lastly I will address how this research can be taken further. 
In the next chapter I will discuss the specific recommendations for policy, practice and 
further research . 
8.2 Overview of this research 
This study provides the first nationally representative examination of the epidemiology 
and clinical practice in relation to CABM and MS in adults in England and Wales. 
Previous work has been largely focused on meningitis in children and mostly reviewing 
their management in the community, i.e. general practice or describing the clinical 
picture in adults (Thompson, Ninis et al. 2006) (Noah 1987; Rosenstein, Perkins et al. 
1999). An examination of the epidemiology of CABM in adults was done for Scotland, 
showing many similar aspects of changing epidemiology to what my study showed, 
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however this did not include an assessment of clinical practice (Kyaw, Christie et al. 
2002). Generally the published literature about the disease in adults was scarce. 
Even though rare, the burden of CABM and MS in adults is relatively high: with an 
overall fatality from the disease of over 10%, but reaching nearly 40% in the older people 
(Cartwright, Reilly et al. 1992; Heyderman, Lambert et al. 2003). This was demonstrated 
with the analysis of the epidemiologic data, as well as through the hospital case-notes 
review. Another major burden of the disease is the long-term sequelae, and I was able 
to measure this through the hospital case-note reView, as well as compare it with other 
published reports, showing that over the third of the cases that survived had evidence of 
a form of long-term sequelae (Grimwood, Anderson et al. 1995; Erickson, De Wals et al. 
2001; van de Beek. Schmand et al. 2002). 
My research encompassed most of the aspects of the disease that are important when 
considering an overall approach to reduCing the burden of a disease - epidemiology. 
accuracy of the available data, clinical management practice and preventative strategies. 
The main findings of this research are: 
• A changing epidemiology over the years, with regard to both the causative organism 
and the population groups affected. 
• Routinely reported incidence and mortality is underestimated. 
• The recommended standards were not widely achieved in a number of key areas 
throughout the diagnostic and management process, compared to the guidelines. 
• The inconsistency and the lack of the record keeping in the hospital medical practice. 
• I did not find a significant association of clinical practice indicators with the outcome 
of CABM and MS. This, largely due to limitations with the medical record keeping. 
but also the lack of statistical power of the study to measure this association. 
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8.3 Is the epidemiology of CABM and MS changing and what are its 
implications? 
8.3.1 Overview 
Accurate ascertainment of a changing epidemiology requires surveillance of a large 
population over a long time-period. The 12 year analysis of national routine surveillance 
data, presented in Chapter 4, shows that overall the incidence rate of CABM and MS 
among adults has not changed much (95% CI for RR 0.99 to 1.03) annually in England 
and Wales between 1991 and 2002; there were, however, opposite trends for CABM 
(decreasing 4% annually, 95% CI for RR 0.94 to 0.98) and MS (increasing 7% annually, 
95% CI for RR 1.03 to 1.11). This increase in MS incidence is largely explained by an 
upsurge in meningococcal disease during the well-documented national epidemic in the 
late 1990s. The possible explanations for this are addressed further below. 
CABM is occurring in an increasingly older population and is associated with a case 
fatality, which remains unacceptably high overall, exceeding 23% in those over 55 years 
(Durand, Calderwood et al. 1993). 
During the second half of the last decade, meningococcal disease reached high 
incidence rates (epidemic levels according to some authors) in the UK alongside similar 
trends in several European countries (Connolly and Noah 1999; McVernon, Howard et 
al. 2004) The UK MenC vaccine programme was then introduced and has been highly 
effective (Ramsay, Andrews et al. 2003). In the year following completion of the 
introductory programme, confirmed cases of invasive group C disease fell by 85% 
overall and deaths in those aged less than 20 years fell by 90%. In contrast, the burden 
of serogroup B disease remains constant, with an apparent increasing in number of 
cases during late 1990s early 2000 (however, the number of cases in adults has been 
falling since, though this is outside the study period for this research) (HPA 2009). The 
data presented here demonstrates the impact of this epidemic on the adult population, 
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which although concentrated on 16-24 year olds remains prominent across all age 
groups. In line with previous studies, there has been a consistent shift of MD towards 
older ages (Harrison, Pass et al. 2001), with older women being at increased risk 
compared to men (Rosenstein, Perkins et al. 1999). 
8.3.2 The varying trends in incidence by causative organisms 
It is noteworthy that there are apparently contrasting trends in the laboratory reporting of 
meningococcal septicaemia and meningitis. These could be explained by a reduction in 
the number of diagnostic lumbar punctures performed (Ramsay, Kaczmarski et al. 1997; 
Jolly and Stewart 2001) leading to the under reporting of meningitis or by a real change 
in the clinical presentation of meningococcal disease with more septicaemia and fewer 
meningitis cases. The observation that the ONS notification rates, a clinician based 
reporting system, did not follow a significant decreasing trend for meningococcal 
meningitis (as seen for the laboratory reports) suggests that the trend in laboratory 
reports represents a change in diagnostic practice rather that a change in the biology of 
the disease (Ramsay, Kaczmarski et a\. 1997). 
With regard to the incidence by the causative organisms of CABM, during the same time 
period there has been a decrease in meningitis caused by H. influenzae and L. 
monocytogenes, whilst tuberculous meningitis has had a small but significant increase in 
the incidence. 
The decline in invasive H. influenzae infection after the introduction of routine Hib 
vaccination has been dramatic amongst paediatric populations (Teare, Fairley et al. 
1994; Heath and McVernon 2002). My data reveal a reduction in the incidence of H. 
influenzae CABM amongst an adult population who would not have received Hib 
vaccine. This supports the suggestion of a herd immunity effect observed in both US and 
UK populations (Barbour 1996; Wenger 1998; Sarangi, Cartwright et al. 2000), 
presumably resulting from a reduction in nasopharyngeal colonisation (Mohle-Boetani, 
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Ajello et al. 1993). During the early 2000s there was a small but constant rise in Hib 
cases; raising the possibility that the effect of the vaccine on the unimmunised 
population may also break down, again underlining the importance of continued 
surveillance (Ramsay, McVernon et al. 2003). Following this increase in number of 
cases a Hib booster campaign was undertaken in 2003, which helped to re-establish 
herd immunity in the UK, and provided evidence for the routine boosting for Hib at 12 
months of age (Ladhani, Slack et al. 2008; McVernon, Ramsay et al. 2008). 
Over the last two decades there has been a global resurgence of tuberculosis. The 9% 
annual increase in tuberculous meningitis revealed in this study is the tip of a T8 iceberg 
(Handysides 1997), in which there has been a reversal of previously falling incidence of 
the disease in the UK. This is a worrying trend: TB meningitis is more likely to be 
associated with HIV co-infection and, in those that survive, is associated with a very high 
morbidity (Rose, Sinka et al. 2002). Although multi-drug resistance T8 remains 
uncommon in the UK (Djuretic, Herbert et al. 2002), should this emerge amongst this 
enlarging population of meningitis cases, the results would be devastating. 
The risk of meningitis caused by L. monocytogenes amongst pregnant women, the 
elderly and the immunocompromised has led to the recommendation that antibiotics 
such as high dose ampicillin are added to empirical therapy for CA8M (8egg, Cartwright 
et al. 1999). The data I have presented here, mirror the reductions in invasive disease 
seen in Scotland and the US (Kyaw, Christie et al. 2002; 2003). I have presented a 
comparison between my study and the Scottish study (kyaw et al 2002) in Chapter 4, 
section 4.5.2.a Although current recommendations do not warrant modification at this 
stage it is reassuring that better regulation of contaminated foods and dietary 
recommendations for high-risk individuals issued by the UK Department of Health and 
the US Centres for Disease Control have been effective. 
S. pneumonise is the most prominent aetiological organism and is associated with a 
fatality of over 30%. The true burden may be significantly underestimated. Using 
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capture-recapture analysis, which was presented in Chapter 5, I demonstrated an almost 
2 fold under-ascertainment of both incidence and mortality from adult pneumococcal 
meningitis in England by the national laboratory and clinically-based reporting systems. 
In addition, the sensitivity of these systems to capture cases occurring in the over 85 
year olds had a tendency to be lower than in the younger population, though the 
numbers in analysis for this age group were small and no statistical significance was 
reached. These findings emphasise both the need for diagnostic vigilance and 
evaluation of vaccination programmes in this age group. 
There is a significant burden of co-morbidity in an increasingly elderly population in 
many industrialised countries, including the UK. The data presented in Chapter 4 
suggests a shift in the burden of bacterial meningitis to this population, with 
proportionately more cases occurring amongst older ages in the recent years. The case-
fatality rate, though, did not exhibit the same upwards trend with increased age, i.e. 
case-fatality rates decreased over time for the older ages, but not so for the younger 
ages. One of the obvious explanations is that of the aging population effect, i.e. there are 
proportionately more older people in the recent years of the 12 year study period. 
However the data is presented in rates per 100,000 people, which should account for the 
proportionate distribution of age-groups over the time, and the incidence is low to suffer 
from such an effect. Another explanation is that particularly meningococcal disease, 
which actually accounts for most of the cases, occurs in epidemic cycles and the 
epidemic of the mid nineties, which at time mostly affected children and young people, 
might have been tailing off amongst the older age groups. The recent conjugate 
vaccination programmes have resulted in long-term immunity and have had an effect in 
carriage and herd immunity, which could have had provided some protection of the 
younger age groups (e.g. 16 to 34 year olds) in the few years following the epidemic of 
the early 90s. A possible explanation accounting for the falling overall case-fatality over 
the years is that the meningococcal epidemic in the first half of the study period, was 
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primarily caused by N.meningitidis group C, which is associated with higher fatality. It is 
possible, though I did not analyse the data by serogroups, that proportionately more 
cases in the later part of the study period where caused by other serogroups, particularly 
serogroup B, with lower fatality then serogroup C, this was shown in an early review of 
MD following the introduction of Men C campaign in under 18s in 1999 (Ramsay, 
Andrews et al. 2001). The apparent decrease in case-fatality rate for older ages but not 
so for younger ages (16-24) has been reported by other studies (Harrison, Dwyer et al. 
1999), a possible explanation is that Meningitis C, which has a higher fatality, is more 
common in younger people (Gold 1999; Ramsay, Andrews et al. 2001). 
An additional factor that should be recognized in the epidemiology of infectious diseases 
in general, and hence in CABM and MS, is the effect of epidemics on disease estimates, 
namely incidence. Some, but not all of the causative organisms of CABM have a 
recognized potential for epidemics - these are mostly N. meningitidis, Hib and to a 
lesser extent S. pneumoniae, M. Tuberculosis and, though L. monocytogeness and E. 
coli can cause generally food-born outbreaks, the proportionate meningitis cases in 
these invasive diseases are almost not relevant for the epidemic transmission to have 
effect on the epidemiology of meningitis. Nonetheless, epidemiologic studies that have 
looked into the effect of epidemics in disease estimates have found only a marginal 
effect, and that standard methods that do not adjust for regular epidemics are valid 
(Whitaker and Farrington 2004). 
8.3.5 The trends of lumbar puncture (LP) in examination of the 
epidemiology of CABM and MS 
The exercise of validating the trends of LPs, that I undertook surveying the HPA 
laboratories in the SW, showed that the number of CSF specimens received by the 
laboratories (I.e. CSFs taken through LPs by the clinicians in patients with suspected 
diagnosis of meningitis) did not fall during the study period. This finding is also supported 
by the capture-recapture analysis, which did not show a trend of decreasing sensitivities 
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of the surveillance sources over time (Table 5.4). This exercise did not support possible 
suggestions that any fall in the incidence of CABM is due to the fall in LPs performed. 
8.2.6 Implications of the changing epidemiology for policy and 
practice 
This part of my research provided evidence for the changing epidemiology of CABM and 
MS among adults in England and Wales (though most aspects of the epidemiology are 
not significantly different in other parts of the UK) (Kyaw, Christie et al. 2002) . Vaccine 
programmes in children and young adults are likely to have a significant impact in the 
epidemiology of disease amongst adults, and other factors such as improved food 
hygiene, the re-emergence of TB and an aging population also all appear to be having 
an effect. This data emphasises the need for continuing enhanced surveillance and the 
need for constant re-evaluation of the age groups for which vaccination should be 
targeted. Vaccine programmes that take into account the continuing burden of disease 
throughout adulthood are required. 
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8.4 The under-ascertainment of CABM - what is its extent and 
how does it affect the sensitivities of surveillance sources? 
8.4.1 Results of the capture - recapture analysis in context 
The capture-recapture analysis provided evidence of under ascertainment of both 
incidence and mortality from adult pneumococcal meningitis amongst adults in England 
by the national laboratory and clinically-based reporting systems. All data sources 
compared in the study captured around half of the estimated cases and/or deaths in the 
population. It seems that, from the trend analysis for HES and ONS reported deaths, 
increasingly more deaths have been occurring at hospitals across the years. This might 
suggest that more cases are reaching hospitals, even though probably not early enough. 
My findings are similar to capture-recapture estimates of bacterial meningitis in Italy 
(Faustini, Fano et al. 2000), and the estimates of case-fatality rates (24%) are similar to 
those published elsewhere (16-31%) (Berg, Trollfors et al. 1996; Moberley, Holden et al. 
2008) and comparative with a European wide study on meningococcal meningitis 
(Trotter, Samuelsson et al. 2005). An additional feature to give support to my findings is 
that I focused on the disease in adults, which is a lot less recognized then the paediatric 
CABM and MS, and therefore the rate of clinical ascertainment and hence reporting is 
likely to be lower. Hence, this capture-recapture analysis should be generalisable to 
other industrialised countries, with a similar epidemiology of adult pneumococcal 
meningitis and other forms of CABM, and similar surveillance systems. 
Apart from incomplete reporting in the surveillance systems, under-ascertainment may 
arise from the absence of a specific diagnosis in the severely ill, particularly the elderly 
(Le Moal, Roblot et al. 2000; Davison, Crowcroft et al. 2002); the absence of a confirmed 
microbiological diagnosis (Newcombe, Cartwright et al. 1996); or misclassification of 
known pneumococcal meningitiS as meningitis cause 'unspecified' or cause ·unknown'. 
An active surveillance study conducted in the United States concluded that deaths due 
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to invasive pneumococcal disease may be underestimated by 15-45% and suggested 
that these missed cases could potentially be reported as 'unspecified' deaths (Moore 
MR 2001). 
This analysis did not show any trend of under-ascertainment associated with age. 
There seemed to be some decreasing sensitivity of surveillance sources from 16-24 to 
75-84 age groups, though the confidence intervals overlap widely, suggesting no effect 
of age in the sensitivities of the data sources, though other studies have suggested an 
lower index of suspicion of diagnosis of meningitis in older ages (Davison, Crowcroft et 
al. 2002). I choose not to compute the Cis for the 85+ age-group owing to the scarcity of 
the data. However, it is likely that these would be been wide and overlapping with the 
younger age-group. Clinically it is thought that diagnosis of meningitis in the elderly is 
more difficult, not solely because of the complicated comorbidities that these patients 
present with. Other studies using capture-recapture method have found an 
underreporting associated with age, and severity (Hickman, Sutcliffe et al. 1999; Jarvis, 
Lowe et al. 2000). Similarly, a recent review of the published literature on the usefulness 
of the routine data sources in epidemiology of infectious diseases found that the 
reporting of infectious disease was most strongly associated with the type of the disease 
being reported and that the feasibility of a early distinguished diagnosis (Doyle, Glynn et 
al. 2002). 
In support of the validity of my estimates of incidence and mortality is the estimated 
case-fatality rate from the capture-recapture method. The analYSis yielded an estimate of 
the case-fatality rate of over 20%, which is in line with reported fatalities from other 
studies (Aronin, Peduzzi et al. 1998) and it is similar with case-fatality calculated from 
the routine surveillance data, presented in Chapter 4. 
It is possible that some cases of pneumococcal meningitis might have been missed in 
the capture-recapture analysis as they might have had been confirmed through blood 
test rather then CSF (hence missed from the laboratory surveillance). However the aim 
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of my study was to examine the ascertainment of CABM in adults, which ultimately has 
an effect on the management of the disease. Hence, if clinicians have confirmed a 
pneumococcal infection with the blood test rather then CSF it is likely that this is 
reflected in the clinical management of the case (which might not be appropriate for 
meningitis). 
8.4.2. Validation of matching in the South West region 
This validation exercise, confirming the matching process of individuals' subjects 
between the data sources, validated my capture-recapture analysis. The individual 
laboratories were in position to cross check the records they had using further personal 
identifiers (then what I had) against the hospital records. They identified 2 additional 
matches, 2 incorrect diagnoses and 5 additional cases, and the capture-recapture 
estimate for the South West Region was unchanged as per my available data. 
8.4.3 Possible implications on vaccine prevention 
Pneumococcal meningitis, although rare in comparison to other forms of pneumococcal 
disease in adults, is associated with a high mortality and represents a reasonably robust 
indicator of the burden of invasive pneumococcal infection in the population (Aszkenasy, 
George et al. 1995). Therefore this analysis should inform decision makers when 
considering prevention and control poliCies of IPO but also other forms of CABM and 
further research. 
Is pneumococcal meningitis a good surrogate for assuming these results to other forms 
of CABM? Pneumococcal meningitis is one of the most common causative forms of 
CABM in adults, particularly so in countries with Hib and Men C conjugate vaccination 
programmes. Clinical features are not distinctly different from other causative forms of 
CABM, hence diagnosis I ascertainment should not be significantly different. It is 
possible as elaborated earlier that blood testing is used when a LP should have had 
been done, leading to a diagnosis of IPO rather then meningitiS specifically. However, 
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this - i.e. a decreasing trend of LPs performed was not shown in my validation exercise 
in the SW region. If it does happen, that is if blood tests are used over the CSF tests, it 
should be similarly extended to all forms of CABM, as it is shown with epidemiological 
data in the trends of meningococcal meningitis vs meningococcal septicaemia. Lastly 
there are no reasons why reporting of pneumococcal meningitis should be different from 
other forms of CABM. 
Modelling studies into Pneumococcal Conjugate Vaccine (Melegaro and Edmunds 2004; 
Melegaro and Edmunds 2004) reported that rather than targeting high risk groups, 
vaccination policies for adults are most cost-effective if implemented for all persons 
above 65 years. Evaluation of the pneumococcal conjugate vaccine (PCV) based on 
data from the Kaiser Permanente trial indicate that population based programmes for 
infants and children are cost-effective compared to PPV, or no vaccination (Black, Lieu 
et a\. 2000; Lieu, Ray et a\. 2000). Data from England and Wales show that the 7 valent 
PCV has about 77% of serotype coverage in adults aged 65 and over and 51% in 
younger adults (George and Melegaro 2001; Sleeman, Knox et a\. 2001). In the context 
of these revised estimates, the benefits of vaccination are likely to be greater then 
assumed, particularly in the over 85 year olds where the sensitivity of the data sources 
fell below 20%. 
Do these revised estimates of the burden of pneumococcal disease amongst younger 
adults suggest consideration for vaccination at an earlier age? Despite the apparent 
high cost of vaccination ( Ament, Baltussen et al. 2000), I suggest that a detailed cost-
benefit analysis of PCV vaccination of adults across a range of different ages is required 
0/Veycker, Richardson et al. 2000). This analysis should take into account my revised 
estimates for incidence and deaths, the efficacy of the new pneumococcal conjugate 
vaccine in a younger adult age group, the potential for immunological boosting by further 
vaccination in old age, the impact of herd immunity, and the potential for a decrease in 
the carriage of antibiotic resistant strains (Black, Lieu et al. 2000) (Dagan, Givon-Lavi et 
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al. 2002; Kyaw, Lynfield et al. 2006). Also, the costs saved due to averted cases should 
be taken into account, including indirect costs associated with reduced work loss, or 
averted future productivity loss due to disability or death caused by IPD. 
Whereas efficacy of Pneumococcal Polysaccharide Vaccine in the elderly has been 
reported to range between 45 to 68% (Foster, Knox et al. 2008), (Sankilampi H, Pekka 
Honkannen P et al. 1996),(Butler, Dowell et al. 1998), efficacy of the new Pneumococcal 
Conjugate Vaccine (PCV), as from its licensure (US 2000 and Europe 2001) in this 
population is still unknown (Parijs and Malinoski 2004). Data from the Kaiser 
Permanente Pneumococcal conjugate Efficacy Trial report an 78% efficacy of PCV in 
infants (Black, Shinefield et al. 2000). In the cost-effectiveness analysis from the trial the 
authors report that vaccination can be even cost-saving for the health care perspective 
at a reduced cost per vaccine dose or if incidence of disease is higher (Lieu, Ray et al. 
2000), (Hueston, Mainous et al. 2000), (Le 2000). Results from this study, reporting 
almost double of incidence and fatality then reported from routine data sources, and 
taking account that the cost of the vaccine has now dropped, show that the efficacy of 
the PCV is likely to be higher than previously thought. However, the use of the PCV in 
children seems to be resulting in a decreased carriage of pneumococci, and indirectly 
having an effect in reduced IPO amongst adults (George, Pauline Kaye et al. 2008). This 
effect has been shown with other conjugate vaccines, i.e. Hib and MenC (McVernon, 
Howard et al. 2004; Trotter, McVernon et al. 2008). 
The presented results (in Chapter 5) should inform policy making with regard to 
pneumococcal vaccination policies in adult but also to the management of meningitis 
amongst adults -as will provide information on the likelihood of a pneumoccoccal 
meningitis occurring, as opposed to another form of CABM (and the appropriate 
treatment, and specifically antibiotics, depend on the different causative organisms). 
When considering policies and strategies for prevention, such as vaccination, data 
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showing that the burden of the disease is likely to be twice as high, has a significant 
impact, eg on the cost-benefit analysis. 
8.4.4 The impact of the PCV 7 on the epidemiology of pneumococcal 
meningitis, and IPD, so far 
In 2002 PCV7 was recommended for use in at-risk children under 5 years of age in the 
UK. From September 2006 PCV7 was introduced into the routine childhood 
immunisation programme. PCV7 contains the serotypes 14 , 18C , 19F , 23F , 4, 6B , 
9V. 
The Health Protection Agency (HPA) monitors the impact of the programme through the 
enhanced surveillance for IPO and by actively following up every case of IPO in England, 
Wales and Northern Ireland, in children eligible for vaccination. 
Since the introduction of PCV7 in England and Wales there has been a marked 
reduction in the rate of cumulative increase of cases of disease caused by the vaccine 
serotypes some herd immunity in older age groups. Similar benefits are reported from 
elsewhere (Grijalva, Nuorti et al. 2007; Isaacman, Mcintosh, Reinert. 2009). However, 
the incidence of disease due to non-vaccine serotypes appears to have been increasing 
and serotype replacement is a concern (ref Kaye, ###). 
Higher valency vaccines, such as PCV10 and PCV13 appear to offer modest benefits in 
terms of costs saved and QAL Ys gained compared to PCV7. However, evidence of 
replacement disease caused by serotypes not in either of these two new conjugate 
vaccines is occurring. (ref: Kaye, Malkani et a/. 2009) 
Changing characteristics of IPO after the introduction of the PCV7 have been reported 
from other countries, as well. For eg in Atlanta, US the rates of non-PCV7 serotypes 
increased in both children and adults in the four year period following the introduction of 
the PCV7 (2000-2004) (ref Albrich, Baughman et a/. 2007). However, considerable and 
significant changes in the serogroup distribution of S. pneumoniae over time in the 
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period preceding the introduction of PCV7 we reported. (ref: Jefferies, Smith et al .2000; 
Foster, Knox, et aI.2008). 
A study using the inpatient data for US (the Nationwide Inpatient Sample) during a ten 
year period 1994 to 2004 estimated the national trends in the rates of hospitalization for 
pneumococcal meningitis before and after the introduction of the PCV7 in 2000. It 
reported a significant decrease in annual rates of hospitalisations of 50% among children 
2-4years and 33% amongst adults >=65 years. Other studies reported similar results 
(Ref Tsai, Griffin, et al. 2008; Albrich, Baughman et al. 2007). These findigs are further 
strengthened with a recent study that examined trends in pneumococcal meningitis in 
the US comparing the causation by PCV7 serotypes, and non-PCV7 serotypes. The 
authors examined changes in the incidence of pneumococcal meningitis from the 
introduction of the PCV7 in 2000 comparing to the baseline values from 1998-1999. 
They reported that rates of pneumococcal meningitis have decreased among children 
and adults since PCV7 was introduced. However, an associated increase in meningitis 
caused by non-PCV7 serotypes was also reported and highlighted as a concern. (Hsu, 
Shutt et al. 2009) 
Apart from a decreasing number of cases of the invasive disease, an indirect effect on 
the carriage of the vaccine serotypes amongst the household members of a PCV7 
vacinee is reported. (ref: Millar, Watt et al. 2008; Kaye, Andrews et al. 2008). 
Nonethelss, ultimately the most cost efficient prevention would be a vaccine that would 
have the ability to protect against invasive disease independent of serotype (Barocchi, 
Censini, Rappuoli 2007). 
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8.5 Does this review of clinical management provide opportunity 
for improving clinical practice? 
8.5.1 Overview 
The findings from the review of the medical notes emphasise a few important issues with 
regard to the potential for improved clinical management: 
• that these potentially devastating conditions are not commonly seen in a hospital 
setting (median 8 adult cases per year per NHS trust) 
• that suggested standards of care are not widely achieved, demonstrating a 
strikingly variation in medical practice between hospitals. 
This research showed that in the context of potentially critically ill patients with serious 
infections, clinical records frequently do not contain essential information required for 
optimal patient management. Recently, considerable concern was expressed that paper-
based patient record systems in the UK have no structure, are inconsistent and show no 
uniformity (Audit Commission 1995; Mann and Williams 2003; Huston 2004). As reaction 
to these concerns the Health Informatics Unit of the Royal College of Physicians (RCP) 
published in 2007 the "Generic medical record keeping standards" recommending use 
of a standardised proforma, with specific focus on most of the key standards which in my 
study were found to be of poor record keeping (Carpenter, Bridgelal et al. 2007). 
Importantly, this study showed an aparent variation between NHS healthcare trusts, 
where recommended standards of clinical practice in some areas were met in 0% of 
cases in some trusts and 100% in others. Although in most elements of management 
this variation did not reach statistical significance, the magnitude of the differences 
suggest the potential for improvement and indicates that several key steps in the 
management process should be amenable to interventions aiming to narrow this 
variation (Sterne JA, DaveySmith G 2001). 
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8.5.2 Making a diagnosis 
Previous reports have suggested that when faced with a febrile patient with no apparent 
focus of infection, general practitioners place less importance on making a definitive 
diagnosis than discriminating between self-limiting and potentially serious illness 
(Granier, Brennan). It was therefore not surprising that among those patients seen by a 
GP prior to hospital admission in my cohort, a differential diagnosis of CABM or MS was 
recorded in less than half of cases. However, once a patient reaches hospital, early 
recognition is essential to guide appropriate intervention (Heyderman, Lambert et al. 
2003). 
Diagnosis at arrival was recorded in just over the third of case-records, and the actual 
diagnosis ranged from 'fever' or 'confusion' to 'malaria', or even 'strange' in one case. 
Most of the records did not have a diagnosis specified at arrival at all (37%). 
In this retrospective review I found that only three-quarters of patients with CABM or MS 
were assessed within one hour of arrival and that there was (clinically large but 
statistically not Significant) variation between hospitals. More than a quarter of patients 
did not have an appropriate differential diagnosis at this assessment. The clinical 
features of CABM or MS in the early stages are often nonspecific and a high index of 
suspicion is needed to distinguish them from the many febrile illnesses observed in 
primary care and emergency departments (Heyderman and Klein 2000). Nonetheless, 
this data suggests that diagnostic awareness needs to be strengthened in adult practice. 
8.5.3 Initiating treatment 
As anticipated from previous studies (Cartwright K 1992; Strang and Pugh 1992) and 
the difficulties identified by GPs in implementing advice regarding pre-hospital penicillin 
(Brennan, Somerset et al. 2003), parenteral antibiotics were given to less than the 
quarter of patients seen by a GP. Patients with CABM or MS may appear relatively well 
at presentation but may deteriorate rapidly without warning. In hospital, therefore, 
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stabilisation and institution of specific therapeutic measures are crucial to patient 
management (Begg; Heyderman, 2003). I found that close to a quarter of the cases did 
not receive antibiotics within 1 hour of first assessment (range 0 to 2 days). In this review 
I did not specifically assess the reasons for this delay but I found that when a diagnosis 
of CABM or MS had been made, initiation of antibiotic treatment was more likely. 
Whether there were delays while awaiting investigations such as LP or CT brain is 
uncertain (Aronin, Peduzzi et al. 1998; Miner, Heegaard et al. 2001; van De Beek, de 
Gans et al. 2002). The role of LPs goes beyond management of individual patient; it 
contributes to the appropriate prophylaxis of contacts, possible outbreak detection, 
surveillance and programme evaluation (Clark, Duffell et al. 2005). 
8.5.4 Assessment of severity and review by a senior staff 
In any patient with CABM or MS a severity assessment should be made, documenting 
any warning signs of shock or raised intracranial pressure so that an appropriate 
continuous management can be sustained (Heyderman 2003). Senior input into the 
management of such patients is required early, in some of the specialties, such as 
respiratory medicine it is required that a consultant assesses the patient in no less then 
12 hours. In this review of clinical management, I found that a severity assessment was 
done for just over half of the cases in the entire cohort and significantly less CABM 
cases were assessed for severity as compared to MS cases. Although these findings 
may reflect poor record keeping, other studies have demonstrated that the standard of 
care received by acutely ill general medical inpatients in the UK is not optimal {Report of 
a Working Party of the Royal College of Physicians, 2002}. Indeed one confidential 
inquiry suggested that more than 50% of critically ill patients receive suboptimal 
treatment prior to admission to intensive care (McQuillan, 1998). The considerable 
variation in severity assessment observed between hospitals could be explained by 
unsuitable organisation, infrastructure or clinical leadership and governance, but also 
highly likely due to a lack of appropriate clinical training and supervision of junior staff. 
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Most patients were assessed first by junior medical staff, only half were reviewed by a 
supervising consultant within 12 hours and some patients were not seen for more than 2 
days. Also, I found that LP continues to be undertaken were there is clear evidence of 
raised intracranial pressure or cardiovascular compromise (Clark, Duffell et al. 2005). 
Conversely, despite an emerging consensus that brain CT does not rule raised 
intracranial pressure and should not be part of the initial routine management of CABM 
(Heyderman, Lambert et al. 2003), CT brain was undertaken in over half of the cases. A 
recent report of a working party of the Royal College of Physicians recommended that 
that every new patient admitted should be reviewed by a consultant physician within 24 
hours (Royal College Physicians 2004). Depending on whether MS or CABM 
predominates, the major clinical management problems may differ considerably. 
Decisions on which and when interventions should be performed can be extremely 
difficult and such decisions require early senior input and involvement of the critical care 
team. Amongst the severely ill patients in this review, the median time for assessment by 
a critical care team was more than 2 hours. These results show that in only one case a 
consultant was involved in first assessment of the patient and only half of cases were 
seen by an leu team at any stage, suggesting that there is a lack of senior or critical 
care assessment, which may be associated with a worse outcome (Booy, Habibi et al. 
2001; Ninis, Phillips et al. 2005), underlining the importance of such review. 
8.5.5 Prevention and public health management 
National guidance (PubliC Health Laboratory Service, Public Health Medicine 
Environmental Group et al. 2002) recommends that that prophylaxis should be initiated 
in all probable cases of MS or CABM, yet a significant number were not notified and 
prophylaxis to index case was not done for all cases. The severity of meningococcal 
disease and its tendency to occur in clusters, particularly among the household contacts 
of an index patient. necessitates notification of the consultant for disease control and 
antibiotic prophylaxis for close contacts and the index case (Purcell, Samuelsson et al. 
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2004). These findings underscore an inadequate interface between hospital and public 
health services. 
8.6 Can clinical management change the outcome of CABM and MS? 
There has been much debate in recent years around the importance and, effectively, the 
benefit of the recommendations for an early and prompt diagnosis and management of 
meningitis (Talan, Hoffman et al. 1988; Meadow, Lantos et al. 1993; Wilks and Lever 
1996; Hahne, Charlett et al. 2006). 
Some studies have found an association between the delay in initiation of antibiotics with 
an adverse clinical outcome. However, generally the authors of these studies have also 
reported that it has been difficult to be differentiate between the effect of antibiotics in the 
outcome of illness from the effect of severity of illness and other prognostic factors, such 
might be co-morbidities (Aronin, Peduzzi et a\. 1998). Surrogates of antibiotic delay (for 
example, duration of symptoms before admission to hospital and time to sterilization of 
cerebrospinal fluid) have been associated with adverse outcome in some studies, but no 
study has identified delay in initiation of antibiotic therapy as an independent risk factor 
after adjustment for other variables that affect clinical outcome (Kilpi, Anttila et al. 1993; 
Quagliarello and Scheid 1997). 
A study that examined whether antibiotic timing influences clinical outcome of patients 
with CABM concluded that for patients with the highest level of clinical severity, the risk 
for adverse outcome is influenced more by the severity of illness than the timing of initial 
antibiotic therapy (Aronin, Peduzzi et al. 1998). Another recent study focusing on 
children suggested that patients who were administrated parenteral antibiotics before 
hospital admission had more severe disease and poorer outcomes then those who were 
not given penicillin before admission (Thomspon, Ninis, 2006). However the authors did 
also recognise that the association with adverse outcome may have been because 
children who are more severely ill are being given penicillin before admission. 
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I did not find an association between clinical management and outcome of CABM and 
MS. The results of the univariate analysis, and then the multivariable logistic regression 
of those factors significant in the univariate analysis, indicated the association of 
adverse outcome with a few key outcome predictors, including demographics, clinical 
and laboratory features, very much in line with previous reports (Durand, Calderwood et 
al. 1993; Grimwood, Nolan et al. 1996; Laurichesse, Romaszko et al. 2001; Short and 
Tunkel 2001; Meyer, Samuelsson et al. 2004; van de Beek, de Gans et al. 2004). Uni or 
Multivariable analysis examining the key clinical indicators with the outcome (L adverse 
- including death or long-term sequelae; ii. good - recovery) and controlling for the effect 
of the clinical predictors that were significant in the multivariable logistic regression did 
not, reach statistical significance except for diagnosis witin one hour which showed a 
protective effect in univariable anaysis. I discussed the limitations for this part of the 
research and the alternative statistical methods that might have had been employed in 
the Discussion section of Chapter 7 and as a recap the main limitations were: 
i. Study was not designed to test such a hypothesis (Le. a null hypothesis that clinical 
management has no effect on the outcome of the disease); 
ii. The relatively small number In the study sample, particularly the number of patients 
with adverse outcome 
iii. The misSing data for both, the timing of the clinical indicators performed and 
indicators of severity of illness. 
I discussed in Chapter 7 the limitations of my study in examining the association of 
clinical management with the outcome of CABM and MS and approaches to overcoming 
them e.g. dealing with missing data. I attempted to stratify the patients based on their 
severity of illness on arrival before the administration of the antibiotics, in order to then 
examine the association per each group, however the data on severity were lacking. 
This was owing to Incomplete record keeping but also due to fact that they were not 
collected in a way to support examination of such associations, as I had not included this 
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examination when I designed the study (either the study power or the questionnaire for 
data collection. 
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8.7 Strengths and limitations of this research 
In the sections below (8.7.1 and 8.7.2) I will emphasize the overall strengths and the 
briefly the overall weaknesses of the research. I have discussed the specific limitations 
of each part of my research within the respective chapters (Chapter 4 to Chapter 7). 
8.7.1 Strengths 
This research provides the first nationally representative examination of the 
epidemiology and clinical practice in relation to CABM and MS in adults in England and 
Wales. I have used different, research approaches for the appropriate parts of this 
research. E.g. to examine the epidemiology I used the available routine surveillance 
data, that are nationally representative and accredited, undertook comprehensive and 
robust analysis for incidence, mortality and case-fatality rates. I compared the analysis 
employing Poisson regression models with Binomial regression models to account for 
overdispersion of surveillance data. Further I undertook a regional exercise, in which I 
was able to obtain straight from the source of reporting, i.e. the local microbiological 
laboratories, the number of CSFs tested during the study period. 
I then applied statistical approaches to examining their accuracy and providing improved 
estimates. The capture-recapture analysis is widely used and recognised as an 
improvement of disease estimates as compared to those from routine data. I applied a 
rigorous analysis for incidence and mortality, and also several approaches to sensitivity 
analysis, including: definition of matched cases, inclusion of all diagnostic fields, 
calendar year vs financial yea period, etc. 
The review of clinical management of CABM and MS is the first national study to review 
comprehensively pre-hospital and more thoroughly hospital diagnosis, first and 
continuous assessment and management, both clinical and public health, of adult cases. 
I reviewed over 20 cases (over 260 including the cases form the pilot study) and had a 
nationally representative sample of both hospital trust and actual cases. I myself 
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designed the questionnaire and collected the data throughout- ensuring this way a high 
reliability, validity and consistency in the data collected and the process. The study was 
overseen by a panel of national experts in various relevant fields, including: 
epidemiology, immunology, microbiology, general practice, paediatrics and geriatrics, 
intensive/critical care, statistics, etc. I undertook robust and comprehensive statistical 
analysis and in addition considered the benefit and appropriateness of more advanced 
analysis (e.g. multilevel modelling). Also the interpretation of the results is appropriately 
contextualised in view of other research. 
The examination of clinical practice with the outcome of disease (Le. CABM and MS in 
adults). Is a step further to expand the and explore the ways to reduce the burden - it 
aimed to provide information on the actual impact of clinical guidelines and the ultimate 
benefit to the patients outcome with an improved clinical practice. I examined the key 
indicators of clinical practice, developed appropriate techniques and steps to ensuring a 
robust statistical analysis, including definitions of inclusion criteria, patients 
characteristics demographics, causation, co-morbidities and clinical and 
microbiological components - to achieve an effective was of dealing with the 
confounding into the effect of actual clinical management in outcome. However, as 
discussed in the limitations in Chapter 7 and will be briefly addressed below - owing to 
two principal issues, i.e. the design of the study and non-availability of data in medical 
records, much of this analysis did not reveal statistically Significant results 
Weaknesess 
I have addressed in specific the weaknesess of each part of my research within the 
espective chapters (Chapter 4 to 7). The quality and scarseness of data overall showed 
to be the greatest weakness of this research, and that being either the routine 
epidemiological data or clinical mdecial records. 
A prospective clinical management review study would have had provided more 
information on the clinical practice and possibly overcome some of the issues with 
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missing data, however this design is known to introduce bias to the normal clinical 
practice - i.e. the awareness of clinicians that are part of the research in itself improves 
clinical practice. 
Limitations specific to the data and methods related to the Chapter presented are 
included in the Discussion sections within each relevant chapter (ie chapters 4 to 7). 
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Chapter 9 
Conclusion, recommendations and further work 
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9.1 Introduction 
In this last chapter of my thesis I will set out my conclusions from this research, drawing 
together all the aspects examined along with the results of the data and their 
interpretation. 
I will then present my recommendations resulting from this research, joining the aspects 
of the epidemiology and clinical management, then going into details of my 
recommendations for improving the clinical practice (that I had prepared for the DH 
when reporting the findings of the review of clinical management). 
Lastly I discuss how can this research be taken further and what are the further 
interesting avenues that my work warrants. 
9.2 Conclusion 
Knowing the epidemiology of a disease, in this case CABM and MS, is crucial for 
following trends, detecting changes, e.g. outbreaks, developing appropriate prevention 
strategies, and also for increasing the potential of improved knowledge and hence 
clinical management, as well. The data I presented in this thesis underlines the 
importance of maintaining a high index of clinical suspicion for CABM and MS, with a 
heightened focus amongst the elderly where the diagnosis has previously been 
considered unlikely in this age group. When a clinician has a better understanding 
regarding how likely it is that an adult presents with CABM or MS, what sort of causative 
organisms are common on which age groups, and what the variations are in the 
geography of distribution - they are more likely to instigate appropriate diagnostic 
procedures and treatment. My research has provided an understanding of the 
epidemiology, previously, until my findings were disseminated, relatively unknown and 
unrecognised. 
Measuring the extent of the underreporting also provided a contribution to the 
understanding of the epidemiology and opportunity for the prevention strategies to more 
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appropriately address the disease in adults. The results of my capture-recapture 
analysis showed that cases of and deaths from pneumococcal meningitis among adults 
are almost twice of those routinely reported, finding this largely in line with other studies 
in similar conditions countries (Faustini, Fano et al. 2000) (Trotter, Samuelsson et al. 
2005)., across Europe. This study adds to the evidence on bacterial meningitis in the 
adult population. Even though it is not disputed that attention should be in under 5s 
where most of disease occurs, these results suggest that more attention should be paid 
to diagnosing meningitis in adults. 
Underreporting of other forms of CABM has been reported by numerous studies and 
across different countries (Faustini, Fano et al. 2000) (Trotter, Samuelsson et al. 2005). 
The recording practices in HES, laboratory reports or ONS are not suspected to vary 
significantly between different forms of CABM. This will also was in part addressed in 
Chapter 7, reviewing the hospital records of patients with CABM I found that the 
information recorded in medical notes and the notification off cases (meningococcal 
disease in specific) to the CCDC was often and indiscriminative to the causative 
organism inappropriate. 
I further reviewed the clinical management of adult cases with CABM and MS in hospital 
setting across England and Wales. The sample was a random selection of hospitals and 
cases (where appropriate). Measuring the clinical practice against recommended 
standards provided the opportunity to identify the suboptimal practice and address -
both - the actual clinical practice and the ways of active dissemination of standards. 
However, once knowing the current standards of practice we need to show that clinical 
practice does actually, or at least has the potential, to improve the outcome of the cases. 
To address this I examined the association of clinical practice with the outcome, data 
presented in Chapter 7. Although preliminary results showed to be in the direction of a 
protective effect of the recommended standards of care (e.g. review within 1 hr), the 
study lacked the power to detect marginal changes with a statistical significance; and the 
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missing data added an obstacle to properly examining this association. This arose 
largely as the study was not designed to address this question - it was designed with 
power to only measure clinical practice against recommended standards, and the data 
collection was done with focus of measuring clinical standard, rather then providing 
opportunity for examining association. I.e. data collected needed to be as representative 
of the current practice at the time and not introduce a non-realistic situation, e.g. by 
going further to collect the data that was not available in the medical records of the 
patient. 
9.3 General recommendations and further research 
The examination of the epidemiology of CABM and MS in England and Wales during 
1991 to 2002 showed a changing epidemiology, with different changes occurring for the 
causative organisms, a shifting burden of the disease towards the older ages. It is likely 
that since when I carried out the study, i.e. up to 2002, the epidemiology has changed 
further, overall incidence probably decreasing significantly, due to the decrease in Hib 
and Men C meningitis I MS following the respective conjugate vaccination programmes. 
Bacterial meningitis (assuming CABM and MS) has become a more rare disease, 
however, as it is a predominantly a childhood disease, it will require caution to assume 
that the decrease in childhood has been mirrored into the adult disease, even though my 
data seemed to suggest that that might have been happening. E.g., the increase in 
incidence in Hib meningitis in the early 2000s calls for a cautions approach to assuming 
a decrease of the burden of the disease. The capture-recapture results showed that the 
actual burden of pneumococcal meningitis, and possibly similar results for other forms of 
CABM, is likely to be twice as high of what reported through routine surveillance. The 
data from the review of clinical management, though of different nature and objective, 
supported much of the revelations regarding the epidemiology, e.g. with regard to the 
causative factors, issues with ascertainment and reporting (late or no reporting of cases 
to the CCDCs) as well as the case-fatality rate of the disease. Hence - a continuous 
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examination of the epidemiology, accounting for the rate of under-ascertainment I under-
reporting, is necessary for an effective control of this vastly preventable condition. In the 
last few years the pneumococcal conjugate vaccine (PCV) has been also introduced to 
the childhood immunisation programme. I recommend that a detailed examination of the 
epidemiology of the disease in adults is carried out - now ten years since the 
introduction of the Men C vaccine; then, partially depending on the results of such a 
review - cost-effectiveness analysis for extending the conjugate vaccination programmes 
to adults at risk, e.g. the PCV to over 65s, should be carried out. The immunologic 
studies into mucosal immunity for Neisseria and pneumococcus could be linked to the 
examination of the epidemiology as potentially would provide data to validate I 
compliment the routine surveillance data. 
My review of clinical management of CABM and MS amongst adults in England and 
Wales demonstrates a need for improvement in several areas of clinical practice relating 
to CABM and MS. Central to an improvement in adult practice should be better 
recording of essential clinical information, further training in the diagnosis, severity 
assessment and management of acutely ill patients with serious infections and improved 
senior Ispecialist supervision. Specific guidance should be given on documentation of 
disease severity which could be incorporated into a standard generic clerking proforma. 
Patients with suspected CABM should be reviewed promptly on arrival and parenteral 
antibiotics should usually be given as part of the first assessment. Severely ill patients 
should be reviewed rapidly by a supervising consultant or critical care specialist. 
Competency in the necessary core skills should be assessed and become a mandatory 
requirement for progression through the new foundation training years in the UK. In 
addition, the management of critically ill patient with an infection should be included in 
the undergraduate curriculum. Consensus guidelines on management of these 
conditions should be promoted using Interventions that effectively improve compliance. 
A repeat review to complete the audit cycle is an essential element of clinical 
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governance in the NHS and should be undertaken to test the efficacy and uptake of the 
interventions put in place. To plan and facilitate change of the clinical practice the 
recommendations from NICE guidance on behaviour change published recently (NICE 
2007) should be taken into account. This guidance is aimed at helping people, NHS 
professionals, policy makers, to change their health-related knowledge, attitudes and 
behaviour. The above listed recommendations have been addressed in specific in my 
recommendations to the DH when reporting the findings from the review of clinical 
management, presented in Appendix 6. 
It is important to measure the effect of the clinical management into the outcome of the 
disease. Some of the above recommendation, particularly to do with the record keeping, 
should facilitate such an undertaking. However, a properly designed and conducted 
study that would be sufficiently powered to detect a potential association of the clinical 
management with outcome and appropriately accounting for potential confounders, the 
major one being the severity of the disease, should be considered. This study could be 
as part of a repeat cycle of review of the clinical management and cost-effectiveness 
studies for effective prevention strategies, i.e. vaccination. This research could be linked 
to my research presented here, and draw from the initiatives that have followed the 
research into management of childhood meningitis (MRF funded research) i.e. 
production of training materials or management of paediatric meningitis. The DH should 
consider funding a repeat review to complete the audit cycle and MRF might have 
funding to complement this study with provisions for training materials. I have been 
considering a proposal for a further research that draws from my findings presented in 
this thesis, which though in an embryonic form indicates some further avenues to 
improve our knowledge for more effective control - reduction of the burden, of CABM 
and MS in adults in England and Wales. A copy of this draft proposal is shown in 
Appendix 7. 
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Appendix 1 
The original proposal to the Department of Health, 2001: 
"Community Acquired Bacterial Meningitis and Meningococcal 
Septicaemia in Adults: A Review of Diagnosis and Management" 
Background 
Bacterial meningitis and meningococcal septicaemia are important causes of 
preventable morbidity and mortality in the UK. Around 900 cases of adult bacterial 
meningitis are reported each year, primarily caused by Neisseria meningitidis and 
Streptococcus pneumoniae. In addition, almost 500 adult cases of meningococcal 
septicaemia without meningitis are reported annually. The introduction of a 
meningococcal serogroup C vaccine to the national immunisation programme has had a 
dramatic impact on the number of cases of serogroup C disease N. meningitidis in the 
UK [1, 2]. However, serogroup B strains are the commonest cause of bacterial 
meningitis and the annual numbers serogroup B-related cases of meningococcal 
septicaemia have been rising recently (PHLS data). Serogroup C vaccines do not 
protect against serogroup B disease and a specific vaccine is unlikely to be widely 
available for at least five years. Although conjugate pneumococcal vaccines appear 
potent in children [3), their efficacy in preventing meningitis in older adults is unproven. 
Clinicians and public health physicians will therefore need to remain vigilant for the 
possibility of cases of meningitis and septicaemia. 
Potential improvements in the way we identify and manage patients who may have 
meningitis or septicaemia have been identified for all levels of healthcare [4]. These 
range from parental awareness through to the interface with primary care and 
emergency departments to the management by specialist paediatricians and physicians 
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[5-9]. Such studies have focused largely on meningitis and septicaemia in childhood (the 
majority of cases), have resulted in significant improvements in our approach to 
suspected paediatric cases and have been associated with a reduction in mortality, 
particularly amongst septicaemic cases in this age group [10]. 
Adult meningitis and septicaemia have been less well studied. The mortality amongst 
otherwise fit young adults remains higher than amongst younger children [4]. Clinical 
management varies considerably between centres. Data emerging from a recent 
prospective study conducted by the Royal College of Paediatrics and Child Health, 
suggests that there are marked deficiencies in health care delivery to adults with 
bacterial meningitis or meningococcal septicaemia (Dr N Nennis, personal 
communication). 
In paediatric practice, the formulation of widely accepted management algorithms, 
targeted postgraduate training and a greater willingness to refer critically ill patients to 
specialist centres has had a significant impact on the morbidity and mortality associated 
with bacterial meningitis and meningococcal septicaemia in this age group [11]. To 
address this issue the British Infection Society (BIS) published guidelines in 1999 for the 
management of acute bacterial meningitis in immunocompetent adults [12]. The failure 
to integrate such guidelines and the CMO's national recommendations into everyday 
clinical practice is of considerable concern. Before the barriers to implementing good 
practice in the management of adults with bacterial meningitis and meningococcal 
septicaemia can be identified and addressed, it is essential to establish the nature and 
the size of the problem. The proposed study will assess the extent to which current 
practice in the acute management of these conditions meets the standards set by the 
BIS guidelines, focusing specifically on delays in diagnosis and administration of 
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antibiotics, appropriate use of monitoring, investigations, intensive care facilities and 
management of the complications of the disease, primarily shock. 
This proposal will establish collaboration between academic microbiology, epidemiology, 
public health medicine, primary care, general internal medicine and infectious diseases. 
This will bring together the specific skills and experience necessary to generate outputs 
that will identify problem areas, inform policy, lead to specific recommendations and 
identify mechanisms that will enable clinicians to implement best practice. This study has 
the potential to lead to a significant reduction in the morbidity and mortality associated 
with bacterial meningitis and meningococcal septicaemia across the United Kingdom. 
Aims and Objectives 
This project will establish the extent to which current management of community 
acquired bacterial meningitis and meningococcal septicaemia amongst adults meets the 
standards set by the British Infection SOCiety and the CMO. We plan to address the 
following specific aims: 
1. To improve current estimates of the incidence and mortality associated with acute 
bacterial meningitis and meningococcal septicaemia. 
2. To conduct a retrospective review of current diagnosis and management of adults 
presenting to randomly selected acute healthcare trusts, focusing on BIS standards 
and recording other outcome measures including morbidity, mortality and length of 
hospital stay. 
3. To identify key areas of deficiency in current management of bacterial meningitis 
and meningococcal septicaemia in adults. 
4. To generate further specific recommendations to improve clinical management. 
Plan of Investigation and Methods. 
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1) EPIDEMIOLOGICAL REVIEW 
A further review of the literature will be conducted to establish historical estimates for the 
incidence and mortality associated with bacterial meningitis and septicaemia in adults. 
These estimates will then be compared with current data derived from the Public Health 
Laboratory Service, statutory notifications of infectious diseases, HES data, enhanced 
surveillance, data from conSUltants for communicable disease control (CCDC) and the 
RCPCH meningococcal study. 
2) STANDARDS FOR BEST PRACTICE 
The BIS and CMO's guidelines will be reviewed by an expert panel in the light of the 
current literature. The panel will consist of at least one of the following: a microbiologist, 
an infectious diseases physician, a public health physician, an epidemiologist, a general 
practitioner, a general physician and a physician specialising in care of the elderly (see 
appendix II). Standards will be identified relating to pre-hospital management, early in-
patient management and investigation, and completeness of recording of information. 
Specific emphasis will be placed on factors leading to delays in diagnosis and 
administration of antibiotics, early identification of at-risk individuals, appropriate use of 
investigations, use of intensive care, and management of the complications of the 
disease, primarily shock. Where possible, standards will be based on randomised trials 
or well-conducted clinical studies. These standards will also be reviewed by the 
research and development division of the DH. The standards will be further modified on 
the basis of the initial pilot phase of the study (see below). 
3) SAMPLING METHOD FOR THE CLINICAL MANAGEMENT REVIEW 
Data will be collected by a retrospective case-note review. Although a prospective study 
may yield more reliable and comprehensive data in some areas, there is insufficient time 
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to establish a research network for such a study, and the use of sentinel centres for such 
a study would inevitably introduce an acquisition bias. Approval from the PHLS research 
ethics committee and the multi-centre research ethics committee (MREC) will be 
obtained before commencing the sampling. Acute healthcare trusts wifl be surveyed 
using a random cluster sampling technique [13]. This should ensure that the sample 
includes patients admitted to a range of specialist, non-specialist and district general 
hospitals, and across a variety of regions. The data should therefore be generalisable. 
All potential cases of adult meningitis and meningococcal septicaemia presenting in the 
previous year to these trusts will be identified through hospital data, laboratory records 
and CCDC data. An on-site case note review will then be conducted of all cases ~16 
years of age with acute community acquired bacterial meningitis (either a compatible 
CSF or microbiologically proven) and/or meningococcal septicaemia (characteristic rash 
or microbiologically proven). Individuals who have undergone recent neurosurgery, with 
recurrent meningitis or who are significantly immunocompromised will be excluded. 
4) REVIEW OF CLINICAL MANAGEMENT 
The case note review will be carried out by a clinical research fellow who will compare 
management and investigation with the study standards, using a survey instrument 
developed by the expert panel (see appendix I for draft version). Disease severity for 
meningitis and meningococcal septicaemia will be recorded using standard parameters 
[4, 14-16]. Data will be collected to establish the specialist! non-specialist nature of the 
unit where management took place, the length of hospital stay, morbidity (deafness, 
neurological deficit, skin or limb loss) and mortality. The accuracy and completeness of 
the clinical note taking will be assessed by cross-referencing the charts, the medical and 
nursing records. The review will be conducted in two phases, firstly a pilot study (4 
healthcare trusts) to evaluate the utility of the study instrument, to assess the reliability 
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and completeness of the study data, and to refine the review process; and then 
secondly, using methodology modified on the basis of our initial findings, a full-scale 
survey (20 healthcare trusts). It is estimated that between 10-15 cases will be identified 
at each healthcare trust. Therefore, between 40-60 cases will be reviewed in the pilot 
study and 200-300 cases will be available for the full analysis. However, the sample 
frame for the full-scale survey will be adjusted on the basis of the data derived from the 
epidemiological review and pilot study. In paediatric practice, there is a strong 
impression, based on some preliminary data, that the move to refer critically ill patients 
to specialist centres or units has had a significant impact on the morbidity and mortality 
associated with bacterial meningitis and meningococcal septicaemia [11]. We propose 
to explore this possibility in adult patients using data derived from specialist vs non-
specialist units. Based on the observation that up to 70% of individuals receive sub-
optimal treatment in hospital [8], this study would be able to detect a 20% difference 
between specialist and non-specialist units with 85% power at a significance level of 
0.05. While it is appreciated that it is likely that more severe patients are admitted to 
specialist units, differences have been observed in the paediatric setting despite this 
confounder. 
5) DATA STORAGE 
Study patients will be assigned an anonymous study code and the data will then be 
entered onto a password-protected computer database for analysis. Information on each 
sample site will be retained but individual named hospital or trust data will not be 
disseminated without permission. 
6) DATA REVIEW, DISSEMINATION AND PUBLICATION 
The pilot study data will be reviewed by the expert panel and the study instrument then 
modified prior to the main survey. The full-scale study data will be analysed using the 
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Mann Whitney-U test for continuous variables and the chi-squared test or Fischer's 
exact test as appropriate for discrete variables. Using the data collected, incidence and 
mortality rates will be calculated. Differences between specialist and non-specialist units 
will be determined. The relationship between sub-optimal treatment and length of stay 
will be assessed. While mortality data will be collected, the sample size will be too small 
to make comparisons based on this end point. The analysed data will be reviewed by 
the expert panel and formulated for presentation and publication. 
A preliminary report based on the pilot data will be made to the Chief Medical Officer for 
dissemination in summary form rather than in detail. The details of the full-scale study 
will be made available to the Chief Medical Officer prior to submission for publication or 
disclosure. 
Research Outputs 
A number of specific outputs in relation to adult meningitis and meningococcal 
septicaemia will arise from this project. In addition to providing operational information 
that will enable us to optimise the main study, the pilot will generate a comprehensive 
epidemiological review and preliminary data on the use of existing guidelines and 
important departures from best clinical practice. The main study will establish a minimum 
data set describing current diagnostic and management practice; identify important 
departures from best clinical practice; and provide reliable data to inform policy and base 
practical guidelines to enable both primary and secondary care clinicians to achieve best 
practice. These outputs will take the form of a report to the CMO, presentation and 
publication in peer reviewed scientific journals. 
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Appendix 2 
List of Expert Panel members - for the review of clinical management 
~ 
Name Title I Affiliation to the study Address I Affiliation 
Dr James Stuart Regional Director Co-investigator HPA South West :\ 
Dr Henry Prempeh Consultant in Public Health Medicine Forth Valley NHS Board 
Professor of Infectious Diseases, Consultant Dept of Pathology & 
Dr Rob Heyderman Principal Investigator Microbiology, University 
of Bristol 
Michael Jacobs Infectious Disease Consultant 
University College 
Hospital 
Prof. Keith Cartwright Professor of Microbiology HPA South west Co-investigator 
Prof. John Cohen Professor of infections Disease (Consultant) 
Imperial College, from 
and Dean of Medical School. 1 Feb 2003 University of Brighton 
Dr Ardiana Gjini Clinical Research Fellow I (from 1 Jan 2004 
Department of Pathology 
Specialist Registrar in Public Health) . & Microbiology University of Bristol 
Specialist Registrar in Paediatrics (later on St Mary's Hospital, Dr Nelly Nenis Consultant Paediatrician) 
Research fellow for the children's study London. 
Andrew Whitehouse Consultant Physician, Geriatrics Birmingham NHS hospital trust 
I 
Tom Nichols Statistician PHLS Statistics Unit CDSC Colindale 
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Appendix 3 
Confidential 
"Community Acquired Acute Meningitis and Meningococcal Septicaemia 
in adults: An Audit of Diagnosis and Management II 
Standards and indicators for assessing diagnosis and management of 
acute meningitis & meningosepticaemia based on recommendations by 
the British Infection Society 
1. OUTSIDE HOSPITAL MANAGEMENT 
• Treatment: Parenteral benzylpenicillin (1200mg). Iv or im route 
Contraindication - anaphylaxis 
6/06/02 
1. a) % of those seen by GP and diagnosis suspected, who were given parenteral 
benzylpenicillin (1200mg) iv or im route*. 
* Excluding those with recorded anaphylaxis. 
2. EARLY HOSPITAL MANAGEMENT 
• Assessment of severity of illness: Severely ill patients managed in 
ICU/HDU 
2. a) % of all patients, where differential diagnosis includes 
meningitis/meningosepticaemia, assessed by ICU team. 
2. b) % of severity of illness assessed recorded. 
2. c) % of severely iII* patients managed or referred to ICUlHDU. 
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• Investigations: CT or MRI to all patients with papilloedema or focal 
neurological signs. 
2. e) % of patients with papilloedema or focal neurological signs who had CT or MRI 
scan. 
• Investigations: appropriate blood and CSF diagnostic investigations in all 
suspected cases. 
2. f) % Blood for Meningococcal culture 
*severely ill patient: patient presenting with signs of meningeal irritation and 
impaired conscious level and/or petechial rash. 
2. g) 
If predominantly septicaemia 
suspected 
• % of Heart rate 
• % of Respiratory rate 
• % of Peripheral perfusion 
• % of Blood pressure 
• % of Urine output 
• % of Mental status 
2. h) % Meningococcal PCR 
2. i) % Throat swab for Meningococcal culture, 
2. j) % Blood for Meningococcal serology. 
If predominantly meningitis 
suspected 
• % of Heart rate 
• % of Respiratory rate 
• % of Blood pressure 
• % of Mental status (coma scale) 
• % of Focal neurology 
• % of Frequent seizures 
% of Papilloedema 
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2. k) % CSF for Meningococcal culture, 
2. I) % CSF for Meningococcal PCR. 
• Lumbar puncture: to al\ adult meningitis patients except when a contraindication 
Contraindications: Clinical diagnosis of meningitis (Raised intracranial pressure)* 
(ICP), focal neurological signs, severe shock, impaired conscious level, coagulation 
disorder, respiratory comprise or clinical diagnosis of meningococcal sepsis. 
*includes if Computer Tomography (CT or MRI) performed, shows raised ICP. 
2. I) % of meningitis patients who had LP 
2.m) % who have LP in presence of contraindications. 
• Treatment/management: IV antibiotics in less than 1 hour of admission* at 
hospital 
* Time of the first assessment by medical staff (JHO, SHO, Registrar, .. )at the hospital 
• 2.n) % of patients given IV antibiotics in less than 1 hour of diagnosis*. 
* where diagnosis at arrival includes meningitis / meningococcal septicaemia. 
3. HOSPITAL MANAGEMENT: 
• Diagnosis: The differential diagnosis should include meningitis! meningococcal 
septicaemia at first assessment « 12hrs). 
• Management: Patient should be assessed by the consultant within 24 hours. 
3.a) % with differential diagnosis of meningitisl meningococcal septicaemia at first 
assessment « 12hrs). 
3.b) % of patients assessed by consultant within 24 hours. 
• Treatment of suspected meningitis or meningococcal septicaemia: 
Meningitis patients: Meningococcal patients: 
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3. c) % of cases with typical 
meningococcal (purpuric) rash given 
2,4g benzylpenicillin iv or ceftriaxone 
or cefotaxime 
3. d) % of cases without typical purpuric rash giv 
ceftriaxone or cefotaxime iv 
3.e) % of suspected penicillin resistant pneumococcal meningitis* given 2g 
ceftriaxone or cefotaxime regime + 19 vancomycin or, 600mg rifampicin iv. 
3. f) % of all case antibiotics administered intravenously throughout the treatment 
course. 
*if within two months have had visited a high prevalent penicillin resistant country. 
4. NOTIFICATION AND PROPHYLAXIS 
Notification: report to ceDe all clinically suspected cases 
4. a) % of cases- reported to CeDe 
4.b) % of cases reported within 24hrs of diagnosis, where diagnosis suspected. 
• Chemoprophylaxis to eliminate carriage: Index cases should be given 
chemoprophylaxis before discharge from hospital 
4.c) % of cases given chemoprophylaxis (rifampicin or ciprofloxacin orally), or 
ceftriaxone for eliminating carriage. 
5. RECORDS 
Records: All essential information* about the management of the case should be 
recorded. 
5.a) % of essential information recorded. 
5.b) % of results recorded from the Investigations required. 
*Essential information:: Assessment of vital signs (Pulse, Temp, Blood Pressure, 
Rash, Respiratory comprise); Assessment of meningeal signs (Neck stiffness, 
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papilloedema, Neurologic Examination, conscious level, capillary refill time) at first 
Assessment. eSF investigations (opening pressure, wee, we differential, RBe, 
Gram stain, Proteins, Sugar, culture, Meningococcal peR): Blood investigations 
[FBe (Hb, wee, Ree, platelet count), eRP, peR-meningococcal, sugar, clotting 
screen}. 
REFERENCE: 
1. Begg, N., K. A. Cartwright, et al. (1999). "Consensus statement on diagnosis, 
investigation, treatment and prevention of acute bacterial meningitis in 
immunocompetent adults. British Infection Society Working Party." J Infect 39(1): 1-
15. 
2. Expert opinion, panel including: J. Stuart, K. Cartwright, J. Cohen, S Granier, R. 
Heyderman, M. Jacobs, T Nichols, N. Ninis, H. Prempeh, A. Whitehouse. 
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Appendix 4. 
The study instrument (questionnaire) for data collection of 
review of clinical management (case-report form) 
1110912002 Confidential 
Community Acquired Acute Meningitis and Meningococcal Septicaemia in adults: An Audit of Clinical 
Diagnosis and Management" 
Instrument for the study 
1) Hospital setting 
Hospital code:, ______ _ 
Was the patient assessed or managed in: 
Tick aI/ that apply 
Accident & Emergency Dept 
Medical Assessment Unit? 
General medical ward? 
Infectious diseases ward? 
Neurology ward? 
HDUlICU? 
Paediatric ward? 
YIN I K 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
Studyno: __ 
Date of review: _ / _ _ 
Region code: _____ _ 
The main specialty of the consultant in charge of the patient: ____ (codes) 
2) PatIent Demographics 
Age: __ Date of birth: _1_'_ Sex (please circle as appropriate): M IF 
dd 'mm , yy 
Recently visited country outside UK: YIN I NK 
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If yes, specify the country: _________ _ 
3) Arrival at Hospital, Date: _I_I ~ Time:_:_ 
Did diagnoses on arrival include meningitis or meningococcal septicaemia: V I N I NK 
Is this a referral from another hospital: V I N I NK 
Death at Hospital V I N I NK Date: _,_,_; Time: _:_ 
Transfer to other Hospital: V I N I NK Date: , , . Time: : 
---' --
Discharge home: V I N I NK Date: _,_,_; Time: _:_ 
HDUIICU stay: From (date): _,_,_, time: _:_; 
4) Final Diagnosis 
Bacterial meningitis? 
If YES 
if Lab confirmed 
to _,_,_, time: _:_ 
V I N I NK 
Clinical: VI N I 
NK Lab confirmed: YIN I NK (pis circle as appropriate) 
Which organism isolated:1), ___ ,2) __ -----:3) ___ (codes 1-10) 
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Meningococcal septicaemia YIN I NK 
If YES 
Clinical: YI N NK Lab confirmed: YIN' NK 
if Lab confirmed 
Which organism isolated:1), ___ 2) ___ ,3) ___ (codes 1-10) 
5) Sequelae (recognised at discharge or at follow up) 
Deafness? 
Neurological deficit? 
Severe scarring or plastic surgery? 
Loss of digits or limbs? 
Other, please specify: 
Was a hearing test done: YI NI NK; 
6) Pre-Hospital Management 
if YES: 
YIN I K 
DDD 
DDD 
DDD 
DDD 
During Hospital stay 
If YES describe: 
______ (codes 1-~ 
During first 4 weeks after discharge 
Later 
Was the patient seen by a GP before admission to the hospital? 
" YES 
YIN I NK 
Time when seen by GP for this episode, date: _,_,_ , time:_:_ 
If referred to the hospital by the GP, time of referral, date: I , , time: : 
--- --
No of times seen by a GP for this episode: o 
Did the GP observe a rash? YIN I NK 
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YIN I NK 
Was meningitis / meningosepticaemia suspected by the GP? DDD 
" YES 
Was Benzylpenicillin given before admission? DOD 
if Yes dose: __ mg ; route: __ 
If NOT 
Was the patient allergic to penicillin? 
If yes, was the allergy anaphlyaxis? 
Were oral antibiotics administered for this episode? 
7) Initial Hospital Assessment 
First assessment*, Date: _,_,_ ; Time: _:_ 
*Time when first assessed by a medical staff (consultant, Registrar, SHO, JHO) 
Did the differential diagnosis include meningitis or meningococcal 
septicaemia at: first assessment YIN I NK 
If Yes, Date: _,_,_ ; Time: _: _ 
D (codes 
First assessment made by: 1-10) 
Did the consultant assessed the patient YIN I NK 
if Yes, Date: _,_,_ ; Time:_:_ 
Did the leu assessed the patient YIN I NK 
if Yes, Date: _'_'_ Time: _: _ 
Vital signs Pulse __ -,/min 
DOD 
DOD 
DOD 
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Temp __ C 
Blood Pressure: Systolic: __ mmHg ; Diastolic: __ mmHg 
Rash YIN INK 
Respiratory comprise 
If YES: 
Non-haemorraghic 
Purpuric: 
Not known 
Rapid progressing rash 
RR __ /min NK 
YIN I NK 
D 
D 
D 
Y/N/NK 
Cyanosis 
Convulsions 
>24hrs: DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
If YES: nature. ___ _ 
Neck stiffness 
Papilloedema 
Fundus examination done? 
Neurological examination? 
Focal nerve signs 
Conscious level 
Shock 
8) Management at the hospital 
GCS score ___ _ NK 
Capillary refill time __ sec NK 
Peripheral perfusion assessed: YIN I NK 
Did the antibiotic management Include iv antibiotics within 1 hr of addmission: 
Iv antibiotics: First dose Date: _'_'_: Time: _ : _ 
Given at first assessment: YIN , NK 
ifNK 
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Name of the antibiotic: 1 ). ________ Dose: ___ mg ;Route: ___ (code 10r 2) 
2) ________ 00se: ___ mg ;Route: ___ (code 10r 2) 
3) Dose: mg ;Route: (code 10r 2) 
-------- --- ----
I.V. antibiotics through out the treatment course 
Fluid management! resuscitation plan recorded? YIN I NK 
9) Lumbar puncture 
if Yes 
if No 
Was a lumbar puncture performed? 
Were antibiotics given first? 
Was a CT scan performed first? 
Where there specific contra indications 
Were the following results requested: 
eSF Opening Pressure 
eSFwee 
eSF we differential 
CSF RBe 
eSF Gram stain 
CSF Protein 
eSF Sugar 
eSF peR (meningococcal) 
eSF culture 
YIN I NK 
DOD 
DOD 
DOD 
DITJ 
YIN I NK 
DDD 
DOD 
DOD 
DOD 
DOD 
ODD 
DOD 
DOD 
DOD 
YIN I NK 
if YES date: _1_I_Time: 
if YES raised ICP: YIN I NK 
if YES specify: __ (codes 1-5) 
If YES record results: 
___ (predominant) 
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10) Investigations 
Were the following investigations performed: 
Throat swab? 
Scrapings or biopsy of skin lesions? 
Blood Culture? 
Were strains sent to reference laboratory 
Were the following investigations performed: 
Meningococcal serology 
CRP (ESR or blood viscosity)? 
Blood PCR (meningococcal)? 
pH blood 
Urea 
Chest X-Ray 
Blood sugar 
Blood gases 
PH blood 
p0 2 
pC02 
HC03 
FBe: Hb 
wcc 
Clotting screen APPT 
Y/N/NK 
DDD 
DDD 
DDD 
Y/N/NK 
YIN I NK 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DDD 
DOD 
DDD 
DDD 
DDD 
DDD 
if YES give results: 
isolate: ____ (codes 1-10 
isolate: ______ _ 
isolate: ______ _ 
if YES give results: 
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INR 
Platelet count DOD 
Was the patient followed up as outpatient after discharge: YIN I NK 
if YES, for how long: ____ months; 
which sequelae: ____ _ 
11) Management of contacts 
Y/N/NK 
Was the CCDC contacted DDD if YES date:_/_'_Time: 
Prophylaxis to index case: 
if no, Ceftriaxone prescribed/given? 
12) Underlying Medical Condition: 
Chronic Heart 
Disease 
Chronic Liver 
Disease 
Occupation: _____ _ 
D 
D 
DDD 
DDD 
Chronic Pulmonary 
Disease 
Chronic Kidney 
disease 
Vaccination status: Vaccinated within last three years: YIN I NK 
Pneumococcal Vacc YIN I NK 
D 
D 
Meningococcal Vacc: Polysaccharide YIN I NK; Conjugate: YIN I NK 
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Appendix 5 
Recommendations for clinical management 
(largely as developed for the DH in 2004) . 
• :. Clinical record keeping in critical illnesses requires improvement 
» I recommend that all clinical records should contain more than 75% of 
essential information. Specific guidance should be given on documentation of 
disease severity which could be incorporated into a standard generic clerking 
proforma. 
» Patient record keeping should be monitored by the supervising consultant 
under the Trust clinical governance framework. 
» Particular focus should be put on recording these standards, as specified in 
the Rep Health Informatics Unit (HiU) evidence-based structured standards 
for record keeping: 
• Standard 6 - date, time, signature of the staff 
• Standard 7 - to record the most senior staff at time of review 
• Standard 18 - discharge summary information should be validated by a 
senior clinician. 
• Standard 30 • doctors should participate in auditing medical records 
against evidence-based standards . 
• :. It Is recommended that "Laying the foundations for good medical practice" 
• a training programme for senior house officers (SHO) developed by the HiU and 
the Education Department of the Royal College of Physicians should be made 
mandatory for all first year SHOs (nowdays Foundation Training (FT)1 post) 
.:. First assessment, diagnosis and Initial treatment Is sub-optlmal. 
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~ In patients with a suspected (by GP, triage nurse, ambulance, or other) 
diagnosis of bacterial meningitis or meningococcal septicaemia >90 should 
be reviewed by a staff grade doctor within 30 minutes of arrival. 
~ All patients with a final diagnosis should have been reviewed within 2 hours 
of arrival. 
~ A diagnosis of bacterial meningitis and meningococcal septicaemia should 
be suspected in >90% of patients with final diagnosis. 
~ Parenteral antibiotics should be given to >90% of patients with final diagnosis 
at first assessment and 100% of patients with suspected diagnosis . 
• :. Assessment and recording of severity of illness is suboptimal 
~ >90% of severely ill patients (as defined in 'Standards and indicators) should 
be reviewed by a staff grade doctor within 30 minutes of arrival. 
~ >90 of severely ill patients should be seen by a ICU team or consultant within 
2hrs of admission. 
~ >90% of indicators of severity of illness should be recorded in the first 
assessment 
.:. Too few patients receive a timely assessment by the supervising consultant 
and specialist teams 
> >90% of all patients with final diagnosis should have been reviewed by a 
consultant within 6hrs of admission 
> >90% of all patients with final diagnosis should have been reviewed by a ICU 
team within 12hrs of admission 
This requires close collaboration between those working in acute medicine, infection 
specialties (microbiology and infectious diseases) and those working in critical care, 
with a greater emphasis on outreach multi-disciplinary consultation services. 
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.:. General recommendations for clinical management 
> Organisation of service 
• In line with recommendations of the RCP working party liThe interface 
between Acute General Medicine and Critical Care" I recommend that 
consultants should participate on a dedicated on-call system where their 
sole responsibility is towards supporting emergency work, relating not only 
to the care of referrals to the medical intake from GPs and from the 
accident and emergency department (A&E), but also to the evaluation and 
management of acutely ill inpatients in all departments. 
• I recommend that junior medical staff be increasingly involved in 
educational and training activities of the Intensive Care Unit services. 
• I support the recommendation for introduction of Early Warning Scoring 
• 
> Training 
Systems appropriate to severely ill medical patients. Junior medical, 
nursing and allied health professionals (AHPs) must be trained in their use, 
both to enhance their recognition of the severely ill and to develop their 
ability to initiate management driven by appropriate protocols. 
I support the recommendation on the introduction of intensive care unit 
(ICU) outreach services, as specified in the publication Comprehensive 
critical care: a review of adult critical services (Department of Health, 
2000). 
• I recommend that training in the recognition and management of acutely ill 
patients should begin In medical school. 
• All undergraduates should receive training in advanced life support. 
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• Medical schools should consider developing training modules which 
focus on the knowledge and skills needed in the initial assessment of 
the severely ill, and which depart from organ system-based training in 
favour of an approach based on the recognition of the significance of 
physiological perturbations. 
• Postgraduate deans should ensure that pre-registration house officers 
(PRHOs) develop these skills and are competent in assessing and 
managing severely ill patents. 
• Postgraduate deans should locally adopt one of the nationally available 
generic training schemes (e.g. the Acute Ufe-threatening Events -
Recognition and Treatment (ALERTTM) programme), designed to teach a 
systematic approach to the assessment and care of the severely ill. 
• and make it a mandatory requirement for career progression beyond 
senior house officer (SHO) year 1. 
• SpR training - I recommend that training in the management of the 
acutely ill patient with an infection should be formally included in both the 
curricula of general medicine and the specialties which are likely to be 
involved in the care of acutely ill medical patients . 
• :. There is currently a major drive to replace existing paper records with electronic 
records by 2008 (this objective has now been changed ''to have 60,000,000 patients 
with a centralized electronic medical record by 2010" 5., but with no good standards 
of recording this would not be a useful exercise (Mann 2001). Structured record 
keeping are easier and quicker to search and therefore can improve decision-making 
and could enhance interpretation and therefore limit clinical errors, improving patient 
S http://www.connectingforhealth.nhs.uklnewsroom 
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outcomes and reducing the costs of healthcare as well as improved data validity for 
secondary purposes (management, audit, etc) 
.:. Minimise differences between hospitals 
> Standardise the graduate and postgraduate training (see 2.2 Training) 
> Standardise service provision across NHS acute trusts (see 2.1 Organisation of 
service) 
> Standardise guidance on clinical management of these particular conditions (see 4.1 
Recommended standards of management) 
.:. Facilitating the adherence to recommended standards of management 
> Developing standards of management 
• The guidance published by the British Infection Society (8IS) is in line with 
the best evidence available and therefore should be reinforced by the 
appropriate bodies of the DH 
• Produce (if not available) and distribute Integrated care pathways and 
Clinical algorithms (use the recently published from the 81S) based on the 
recommendations 
> Dissemination and implementation of guidelines 
• I recommend that a variety of implementation methods are considered 
and integrate them within any existing strategy for change 
• Use education and training incorporated within career progression training 
(JHO, SHO and SpR) as well as continuous professional education 
(CPD) for more senior staff 
• Use active learning in form of seminars within the local hospitals for 
targeted audience 
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• Use also other more active methods and techniques, such as clinical 
leadership, peer influence, facilitation, audit sanctions, marketing and 
reminders to facilitate take-up of recommendations 
• Use feedback and reward for improving effective use of clinical guidelines 
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Appendix 6 
Draft proposal for research funding 
Bacterial meningitis in England and Wales: intervention to improve clinical 
management and examine its association with outcome 
Background and introduction: Bacterial meningitis remains a grave disease 
amongst adults in E&W. 
The progress in the control of meningococcal disease C due to the successful 
vaccination programme has been evidenced and is a great achievement - no deaths 
from confirmed Meningitis C were reported during 2007 in the vaccination age. 
However, the fatality from the other forms of CABM still remains high. 
Two previous reviews of clinical management, amongst both children and adults, 
reviled serious deficiencies. In meantime there have been several interventions with 
aim to facilitate and improve management in line with guidelines, including the 
algorithm of emergency management; the publications of these reports in peer-
reviewed journals; publication of handbook for management in children. 
There isn't, however, evidence in support of change of behaviour on clinical 
management based on publication of guidelines or peer-reviewed publications. There 
is, though, some evidence from a systematic review that interactive interventions, 
such as seminars and the peer-trainer in the hospitals, does result in a better 
adherence to clinical guidelines. 
Other recent structural interventions might also have a potential impact on the 
patients' care, such as: consultants' contract has generally resulted in a reduced 
working hours and the EWT directive also significantly reduced hours of work and 
training of junior doctors. For the clinical management of a relatively rare condition, 
such as meningitis, these could have serious implications. 
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The hospital review of adult management also suggest that some of the key clinical 
practices, including time to antibiotics, assessed by a consultant, time to diagnosis 
might have an impact on the outcome of cases. However as the study was not 
designed to test these associations it lacked power to prove a statistically significant 
association for most of them. The study of management of children and adolescents, 
also, suggested an increased uncertainty of the use of antibiotics in early treatment 
of meningitis; though it has been admitted that the potential unmeasured 
confounders could, at least in part, explain the negative association. It would, 
therefore be important to establish the association of clinical management with the 
outcome of the disease. 
One of the major findings of this review was the substandard and varying level of 
record keeping. Given that this practice has repercussions in the actual management 
of cases, and that not only meningitis but any severe infection, I consider this needs 
further examination to assist the implementation of the management standards. Also, 
the Rep has this year recommended and produced a standard case-records form. 
Experience from the original hospital review would be sufficient to account for the 
need for piloting the study and the instruments to be used. Also the data from my 
original study would be used as a comparison of potential changes in management of 
this disease over the time. 
I would therefore like to propose a study that would aim to: 
Examine the potential improvement in the management of CABM in adults in 
England and Wales against the standards published with the algorithm, including the 
medical record keeping; 
Examine the association of the key clinical practices, including record keeping, with 
the outcome of the disease. 
Study design: random intervention trial, retrospective review of medical case-notes. 
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3months intervention - 3 seminars, every month in 18 hospitals (evidence from 
systematic review as effective on guideline adherence); reminder 'tools': back of 10 
cards; stickers I magnets I plasticised hard sheets ... with a key recommended 
indicators for clinical management of adult CABM and MS. 
1 years review of cases; to start right after intervention. Study period June '10 -
June'11. 
Method - select and allocate hospitals randomly to intervention vs no-intervention. 
Retrospective review of case-records. 
Intervention: peer intervention - selection Irecruitment and training of senior staff to 
be peer trainers (at SpR level); a one day training - central; with support from 
Meningitis Research Foundation (producing standard training materials). The peers 
will then organise and deliver the 3 seminars in their own settings; with support, and 
quality assurance from the study's principal investigator and research fellow. 
Tlmellne: July - Oct 2009: prepare; recruit research fellow, design study instruments 
Start hospital recruitment I allocation Oct 2009 
Selection I training of peer trainers Nov '09 
Intervention Dec 2009 to February 2010 
Data collection: start February 2011 to April 2012. 
Study period of data to be collected: 
i. baseline data1 st November 2008 - 30th October 2009 
ii. intervention data: February 2011 - January 2012. 
Preliminary analysis and report 6 months from start. 
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